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Summary 
It is generally accepted that the causes of cancer could be physical (e.g., radiation), 
chemical (carcinogens), and viral (e.g., oncogenes). The mechanism by which certain 
carcinogens and radiation cause carcinogenesis is believed to be mediated by free 
radicals. A substantial body of evidence has been produced that links the production of 
reactive oxygen radicals, and subsequently oxidative stress and damage, to pathogenesis 
of chronic diseases including cancer. Oxidative stress has been defined as an imbalance 
between oxidants and antioxidants in favour of the former, resulting in an overall increase 
in cellular levels of reactive oxygen species. Free radicals have been shovra to be capable 
of damaging many cellular components such as DNA, proteins and lipids. Proteins can be 
damaged by oxygen radicals leading to a loss of both free radical scavenging enzyme 
activity and structural integrity, leading to compromised host antioxidant defense 
mechanisms and cell membrane structure, respectively. This eventually may culminate in 
neoplastic transformation. 
Environmental factors are recognized to play a major role in the etiology of various 
cancers that account for over 80% of human malignancies. Polycyclic aromatic 
hydrocarbons (PAHs) are ubiquitously distributed environmental chemicals which act as 
carcinogens. 7, 12-dimethylbenz (a) anthracene (DMBA), a prototype carcinogen of PAH 
family, is present in the environment as a product of incomplete combustion of complex 
hydrocarbons. In the present study DMBA was used as a complete carcinogen. It was 
found that DMBA given either orally or topically induced oxidative stress by 
significantly decreasing the activities of SOD, CAT, GR and GST in liver tissues and 
ascorbic acid, glucose, uric acid, SOD and GST in circulation. Hepatic GSH content was 
found depleted with increased levels of MDA (lipid peroxidation). Levels of marker 
enzymes ALP, AGP, LDH, GOT and GPT in liver as well as SGOT and SGPT levels 
were also increased significantly. Further the role of stress alone and on DMBA induced 
oxidative stress was assessed. Increasing evidence suggests that stress and the ability to 
cope with stress may play a role in malignant transformation and tumor progression. 
Although the evidence that stressfiil life events are related to the development of cancer is 
controversial, a number of human studies have correlated stressful life events with 
increased cancer risk and decreased survival probability. However, much attention has 
been paid to the possible influence of stress on prognosis in patients who already have 
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cancer while very limited information is available on any possible direct role of stress on 
the development of neoplasia. The present study was designed to assess the impact of 
stress on early stages of cancer. 
Immobilization stress is a classic and convenient method of inducing both psychological 
(escape reaction) and physical stress (muscle work) resulting in restricted mobility and 
aggression, which been used to study the impact of stress on disease process in 
experimental animals. Exposure to chronic restraint stress resulted in a significant 
decrease in the activities of superoxide dismutase (SOD), catalase (CAT), glutathione 
reductase (GR), gluatathione-S-transferase (GST) and glutathione (GSH) in liver tissues 
as well as vitamin C, glucose, uric acid, SOD and GST in circulation in comparison to 
untreated controls. This was accompanied with significantly increased levels of 
malondialdehyde (MDA) and marker enzymes ALP, ACP, LDH, GOT and GPT both in 
liver and circulation. Similar results were obtained by topical or oral infusion of DMBA, 
though oral treatment showed a profound pro-oxidant effect. Moreover, when DMBA 
treated animals were pre-exposed to chronic restraint stress there was marked increase in 
oxidative stress. This was reflected by a further decrease in the activities of antioxidant 
enzymes and other antioxidants as compared to DMBA alone or stress alone treated 
animals. Levels of marker enzymes in liver and circulation were increased significantly 
with increased levels of MDA indicating an enhanced lipid peroxidation. 
DMBA is an indirect carcinogen and is metabolized in vivo to become an active 
carcinogen. The toxic metabolites and ROS formed during its metabolism, in addition to 
causing oxidative stress, also result in oxidative DNA damage. In the present study, 
DMBA was found to induce DNA damage in lymphocytes, liver and skin cells of 
animals, in terms of increased DNA tail length, measured by alkaline comet assay. 
Damage was induced after single dose of DMBA, which increased further with 
increasing number of doses, in a dose-dependent manner. Restraint stress though unable 
to induce any significant damage enhanced the DMBA induced DNA damage in 
lymphocytes, liver as well as skin cells. Alterations in biochemical parameters of these 
animals were also dose-dependent after each DMBA treatment. Restraint stress in 
addition to causing oxidative stress by itself enhanced the pro-oxidant effect of DMBA. 
Formation of oxidative stress-related molecules, increased lipid peroxidation with 
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decreased activities of free radical scavenging enzymes may serve as the mediator to 
modulate tissue and cellular events responsible for DMBA induced carcinogenesis. 
Since free radicals are involved in initiation and promotion stages of carcinogenesis, one 
may expect that free radical scavengers should function as inhibitors in the neoplastic 
processes. Antioxidants have been shown to inhibit both initiation and promotion in 
carcinogenesis and counteract cell immortalization and transformation. A number of 
natural and synthetic antioxidants are known to retard chemical carcinogenesis in 
experimental animal models through chemoprevention. Chemoprevention is the use of 
one or several agents to prevent the occurrence of cancer. In this study two compounds-
melatonin and resveratrol, studied extensively for their antioxidant properties, were used 
to evaluate their effectiveness on DMBA induced carcinogenesis and the modulatory 
effect of restraint stress on it. Both melatonin and resveratrol exerted their antioxidant 
role against DMBA induced carcinogenesis. This was assessed in terms of DNA damage, 
fluorescent studies and biochemical parameters. DNA damage, measured as increased 
DNA tail length, induced by DMBA was prevented largely when animals were 
supplemented with either melatonin or resveratrol. The biochemical events during 
pathological conditions are known to differ from their normal counter parts, which can be 
detected sensitively using fluorescent spectroscopy. DMBA induced carcinogenesis was 
detected from altered ratio of fluorescent intensity (Fl 530nm/630nm) which is otherwise 
definite for a given normal tissue. This ratio was however, comparable to control values 
after treatment with melatonin or resveratrol. The results of biochemical parameters 
showing decreased oxidative stress were also in line with those of comet assay and 
fluorescent studies, thus confirming the chemopreventive properties of melatonin as well 
as resveratrol against DMBA induced carcinogenesis. However, when animals were pre-
exposed to restraint stress the chemoprevention by both the compounds was abolished 
and results were comparable to that of DMBA alone treatment. 
Thus, it is concluded that the complete carcinogen DMBA induces in vivo oxidative 
stress when administered either orally or topically. Exposure to chronic restraint stress 
also causes oxidative stress and exacerbates the pro-oxidant effect of DMBA, irrespective 
of mode of DMBA administration. Further DMBA induces oxidafive stress and DNA 
damage following a single topical application, which increases with increasing number of 
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doses, in a dose dependent manner. Restraint stress, besides causing oxidative stress, 
enhances DMBA induced oxidative stress as well as DNA damage following each 
DMBA application, though, it did not incur any significant DNA damage by itself 
Therefore, an additive pro-oxidant effect of stress and DMBA is observed irrespective of 
mode of DMBA treatment, though oral is found to have more pronounced effect. Further, 
exposure to multiple doses of a carcinogenic agent like DMBA directly or indirectly 
(environmental toxins, cigarette smoke) causes dose dependent DNA damage and 
exposure to stress (physical or emotional) exacerbates this DNA damage thus putting an 
individual at an increased risk of developing cancer. 
For chemopreventive studies, the two antioxidants-melatonin and resveratrol were found 
almost equally effective against DMBA induced carcinogenesis. However pre-exposure 
to restraint stress was found to decrease their chemopreventive efficacy, thus playing an 
important role during cancer development as well as cancer chemoprevention. Therefore 
stress management must be considered as a serious factor during cancer chemopreventive 
trials and fiirther studies should be aimed at reducing exposure to stressful conditions 
during chemotherapy. 
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Introduction 
In today's developed world the problem of cancer is increasing and is now second only to 
cardiovascular diseases as a cause of death, affecting millions of people throughout the 
world. Various disciplines come into play in the multifaceted attack on the enigmatic 
origins of cancer. Carcinogenesis is a multistage process and depends on multiple factors. 
The combined effect of stimulatory factors (e.g., hormones, cytokines), stress mediators 
(oxygen radicals) and exogenous aggressions (viruses, radiation and chemical 
carcinogens) can affect the control of cellular proliferation and lead to tissue 
transformation. For more than half a century numerous proposals have been advanced for 
the mode of action of carcinogens. A substantial body of evidence has been produced that 
implicates oxidative stress in many aspects of oncology, including formation of reactive 
oxygen species (ROS) by the major classes of carcinogens, cancer stages and oncogene 
activation. 
Psychological stress, a common phenomenon, generally a state of disturbed 
homeostasis, harmony and equilibrium is attracting increasing attention due to its 
implication in wide range of diseases including cancer. Increasing evidence suggests that 
stress and the ability to cope with stress may play a role in malignant transformation and 
tumor progression. Although the studies examining the effect of psychological stress on 
the production of ROS have yielded inconsistent results, it has been shown that exposure 
to stress situations can stimulate numerous pathways leading to increased production of 
free radicals. These free radicals, as already known, generate a cascade producing lipid 
peroxidation, protein oxidation, DNA damage and cell death and contribute to the 
occurrence of pathological conditions. Stress may also impair antioxidant defenses, 
leading to oxidative damage, by changing the balance between oxidant and antioxidant 
factors. Since the involvement of oxidative stress in cancer induction and its subsequent 
development, and associated molecular mechanisms is becoming increasingly clear, the 
influence of stress-inducing conditions on cancer development has been subject of 
several investigators, both at clinical and experimental level. However results are 
contradictory as both exacerbation and attenuation of tumor development by stress has 
been reported. For example, foot shock or electric shock enhanced tumor development, 
while various other stresses inhibited the growth of both transplanted and chemically 
induced tumors in rats. Human studies have focused mainly on the effect of psychosocial 
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factors including stress on prognosis in patients who already have cancer, while very 
limited information is available on any possible direct role of stress in the development of 
neoplasia. Immobilization, used in the present study is a classic method that has long 
been used to study the impact of physical as well as psychological stress on disease 
process in experimental animals. 
To study the genetic and biological changes involved in tumor promotion, mouse or rat 
skin carcinogenesis model has become very useful and was employed in the present study 
using the complete carcinogen 7,12-dimethylbenz (a) anthracene (DMBA). DMBA is a 
polycyclic aromatic hydrocarbon present in the environment as a product of incomplete 
combustion of complex hydrocarbons. It is an indirect carcinogen and is metabolized by 
cytochrome P4501B1 to form toxic metabolites and ROS. These ROS produce 
deleterious effects by initiating lipid peroxidation directly or indirectly by acting as 
second messengers for the primary free radicals and the toxic metabolites of DMBA bind 
to adenine residues of DNA causing damage. Persistent DNA damage can result in either 
arrest or induction of transcription, induction of signal transduction pathways, replication 
errors, and genomic instability, all of which are seen in carcinogenesis. 
Another field that has attracted lot of attention, since the proposition of different 
theories of cancer, is cancer chemoprevention. Due to the growing evidence that 
antioxidants may prevent or delay the onset of some types of cancers, many compounds 
with antioxidant properties have been studied for prevention as well as cure of different 
cancers and were found to be effective in most of the cases. However, the prevention or 
cure of disease in almost every case depends on the response of the host to the 
chemotherapy. It is widely believed that antioxidants help maintain human health by 
decreasing oxidative damage to key biomolecules. However, the antioxidant status in 
general and in vivo in particular has been shown to be modulated by exposure to stressful 
events. Animal studies have shown that exposure to rotational stress decreases the 
antitumor effects of chemotherapeutic drugs in terms of tumor burden, extent of 
metastasis and survival time. 
The present study has been carried out to examine the effect of stress on the early stages 
of carcinogenesis in terms of biochemical parameters and in vivo antioxidant status of 
rats. The work done has been divided into two parts. First part deals with the effect of 
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stress on the antioxidant status of experimental animals exposed to chronic restraint stress 
via the measurement of alteration of various biochemical parameters considered as 
markers of oxidative stress such as the activities of superoxide dismutase (SOD), catalase 
(CAT), glutathione-S-transferase (GST) and the levels of glutathione (GSH), glucose, 
malondialdehyde (MDA), uric acid etc. The marker enzymes of liver function were also 
analyzed in both the liver tissues and circulation. Moreover, the role of stress in the early 
stages of DMBA induced carcinogenesis was also assessed. The effect of mode of 
inftision of DMBA i.e., oral and topical was also studied on alteration of above 
mentioned biochemical parameters in the presence and absence of restraint stress. Further 
studies were carried out to evaluate the effect of restraint stress on DNA damage in 
experimental animals, alone and in context of DMBA induced carcinogenesis. 
In the second part, chemopreventive studies were carried out using well-known 
antioxidants- melatonin and resveratrol. The chemopreventive effects of both the drugs 
were evaluated on DMBA induced skin carcinogenesis in the presence and absence of 
stress in terms of DNA damage, fluorescent studies and alteration of various biochemical 
parameters and antioxidant enzymes. 
The experimental model currently employed might provide an insight at the most basic 
level of cell mutation, for investigating the effect of both physical and psychological 
stress on the etiology of DMBA induced carcinogenesis. This study may aid in the 
understanding of cancer initiation and can serve as a useful tool for further studies aimed 
at the development of interventions for disease prevention by identifying the relation 
between psychological factors and carcinogenesis. 
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2.1. CARCINOGENESIS 
Carcinogenesis is the process by which normal cells are transformed into cancer cells. In 
today's developed world the problem of cancer is increasing and is now second only to 
cardiovascular diseases as a cause of death, affecting millions of people worldwide 
(Jemal et al., 2002). The term cancer refers to more than hundred types of the disease. 
Almost every tissue in the body can spawn malignancies and some can yield several 
types (Waris and Ahsan, 2006). The induction of cancer (carcinogenesis) is a multistage 
process and its stages have been defined experimentally as initiation, promotion and 
progression (Pitot et al., 1981). 
Initiation involves the formation of a mutated, preneoplastic cell from a genotoxic event 
due to mutation of DNA resulting in the activation of oncogenes and the inactivation of 
tumor suppressor genes. Initiation is thought to be irreversible, dose-dependent process 
and consist of a single gene mutation that is caused in most cases by environmental 
genotoxic agents such as chemicals, radiation and viruses (Bishop. 1991; Marshall, 
1991). 
Promotion follows initiation and involves the process of gene activation such that the 
latent phenotype of the initiated cell becomes expressed through cellular selection and 
clonal expansion. This can occur through a variety of mechanisms including toxicity, 
terminal differentiation or mitoinhibition of the non-initiated cells and mitogenesis or 
decrease in apoptosis of the initiated cell population (Slaga 1984; DiGiovanni 1992). 
While promotion occurs over a long period of time, events of this process are dose-
dependent and reversible upon removal of the tumor promotion stimulus (Schulte-
Hermann et al., 1994). 
Progression, the third stage, involves genetic damage that results in the conversion of 
benign tumors into malignant neoplasms capable of invading adjacent tissues and 
metastasizing to distant sites (Slaga, 1984; DiGiovanni 1992). This stage is irreversible 
which involves genetic instability, changes in nuclear ploidy, and disruption of 
chromosome integrity (Klaunig & Kamendulis, 2004). 
Carcinogenesis depends on inherited and acquired susceptibility factors, on exposure to 
initiation factors i.e., exogenous and endogenous carcinogens and on promotion and 
progression factors (Walaszek et al., 2005). It is generally accepted that the causes of 
cancer could be physical (e.g., radiation), chemical (carcinogens), and viral (e.g.. 
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oncogenes). The combined effect of stimulatory factors (e.g., hormones, cytokines), 
stress mediators (oxygen radicals) and exogenous aggressions (viruses, radiation and 
chemical carcinogens) can affect the control of cellular proliferation and lead to tissue 
transformation (Garry et al., 2000). The mechanism by which certain carcinogens and 
radiation cause carcinogenesis is believed to be mediated by free radicals. Numerous 
antecedent studies have demonstrated that ROS participate in all the three stages of 
carcinogenesis (Li et al., 1997). Much of the evidence has come from the fact that 
antioxidants that scavenge free radicals directly, or that interfere with the generation of 
free radical-mediated events, inhibit the neoplastic process (Sun, 1990). Extensive 
evidence is documented which indicates that reactive oxygen species are pervasive 
mutagens, e.g., oxy radicals (Hasan et al., 1984), hydrogen peroxide (Kenese et al., 
1989), as well as various endogenous ROS (Simic et al., 1989). ROS can also interfere 
with cell signaling by altering protein kinase cascades and transcription factors, 
ultimately leading to tumor development (Kovacic & Jacintho, 2001). There is 
convincing evidence that cellular oxidation states, i.e., the relative levels of ROS, 
antioxidant defense entities, and radical scavengers can promote initiated cells to 
neoplastic growth (Cerutti, 1985; Kenseler & Tarffe, 1986). Investigations dealing with 
involvement of ROS have continued into recent years (Abdi & Ali, 1999; Huang et al., 
1999). One of the most powerful tumor promoters is phorbol myristate acetate and it is 
well established that its activation is accompanied by appearance of ROS, including 
superoxide (Delclos & Blumberg. 1982), as well as hydroxyl radicals and lipid 
peroxidation (Nakamura, 1985). 
2.2. STRESS AND CANCER 
The term 'stress' although having a very broad meaning, generally describes a state of 
disturbed homeostasis, harmony and equilibrium (Levine & Ursin, 1991; Weiner, 1992; 
Johnson et al., 1992). The disturbing forces or inputs, which result into such state are 
known as stressors, while the counteracting forces as adaptation. Stress can be classified 
as physical or psychological; of the two classes, psychological stress appears to be more 
potent stressor (Johnson et al., 1992). Physical and psychological stressors experienced in 
combination could further exacerbate the stress response. 
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Stress is a common phenomenon which is attracting increasing attention as it is found to 
affect many aspects of physiology and has an important influence on health and diseases. 
Stress has long been associated with gastric and duodenal ulcers, hypertension, 
cardiovascular and cerebrovascular diseases, cancer and aging (Cooper 1984; Chrousos et 
al., 1995; Csermely, 1998). Long-term exposure to stress has detrimental effects on 
several cell functions in many species, including humans (Kovacs e al., 1996). The 
influence of stress-inducing conditions on cancer development has been subject of 
several investigators, both at clinical and experimental levels (La Barba, 1970; Pradhan & 
Prabhati, 1974; Greer et al., 1979; Riley, 1981; Justice, 1985; Fox, 1995; Croyle, 1998). 
Stress has been shown to markedly influence incidence, growth, and metastasis and 
rejection of chemically induced or implanted tumors (Amkraut & Solomon, 1972; 
Dechambre & Gosse, 1973; Benchfleld et al., 1978; Goldman & Vogel, 1984; Laconi et 
al., 2000). However, results are contradictory in that both exacerbation and attenuation of 
tumor development. Animal experiments have generally documented a positive 
association between the two variables (Sklar & Anisman, 1979; Sklar & Anisman, 1980; 
Steplewski et al., 1985; Matsukawa et al., 1997), although some studies have led to 
opposite conclusions (Amkraut & Solomon, 1972; Pradhan & Prabhati, 1974; Justice, 
1985). For example, foot shock enhanced the growth of transplanted neoplastic cells in 
mice (Sklar & Anisman, 1979) and a similar pattern of results have been reported when 
psychosocial stress (isolation) was used in animals bearing grafted tumors (Dechambre & 
Gosse, 1973; Sklar & Anisman, 1980). Tumor rejection of rats receiving Walker 256 
sarcoma and inescapable electric shock was lower than that seen in unstressed controls 
(Visintainer et al., 1982). Perhaps more interesting are reports indicating a beneficial 
effect of stress on tumor development. The size of virally induced sarcomas in mice was 
reduced when stress was elicited prior to virus inoculation, while an enhancing effect on 
tumor growth was seen when stress followed exposure to the virus (Amkraut &. Solomon, 
1972). In addition, significant inhibition in the growth and development of DMBA-
induced mammary tumors was found by exposure of the animals to immobilization, 
electric shock and an overcrowding-sound situation (Pradhan & Ray, 1974; Bhattacharya 
& Pradhan, 1979; Ray & Pradhan, 1979). Animals exposed to electroconvulsive shock 
and cold showed better rejection and reduced growth of murine sarcoma and lymphoma 
tumors (Amkraut & Solomon, 1972; Benchfield, 1978). Among many factors, the 
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intensity and duration of stress seem to play a major role. In experiments on tumor 
induction by DMBA, it was found that animals stressed after the injection of carcinogen 
had protective effect of stress whereas no protection was observed if stress began before 
first injection (Steplewski et al., 1985). 
It has also been considered that the ability of the organism to cope with stress is critical in 
determining its overall effect. Consistent with this proposition, escapable foot shock had 
no effect on the growth of transplanted tumors in mice, while inescapable shock 
increased tumor size under the same experimental conditions (Sklar & Anisman, 1979). 
Furthermore, the effect of inescapable shock was mitigated if mice received long-term 
shock treatment, suggesting a type of adaptation to stress (Sklar & Anisman, 1979). The 
nature of the relationship between stress associated conditions and cancer has also been 
investigated in humans. However much attention has been paid to the possible influence 
of stress on prognosis in patients who already have cancer (Greer et al., 1979; Fox, 1981; 
Cassileth et al., 1985), while very limited information is available on any possible direct 
role of stress in the development of neoplasia, at any step (Fox, 1995). 
Various mechanisms have been considered as possible mediators of the effect of stress on 
neoplastic process, which include alteration in the immune and/or neuroendocrine system 
and in the antioxidant defense status (Boyd et al., 1981; Steplewski et al., 1985; Banu 
et.al., 1988; Wakikawa et al., 1997; Harada et al., 1997). Altered antioxidant status 
indicates production of reactive oxygen species such as peroxides, hydroxyl and 
superoxide anion radicals. There is accumulating evidence to indicate that stress can 
stimulate numerous pathways leading to an increased production of free radicals (Kovacs 
et al., 1996; Liu et al., 1996; Liu & Mori, 1999; Matsumoto et al., 1999; Olivenza et al., 
2000; Zaidi et al., 2005). It is well known that free radicals generate a cascade, producing 
lipid peroxidation, protein oxidation, DNA damage and cell death thus contribute to the 
occurrence of pathological conditions (Kovacs et al., 1996; Liu et al., 1996; Liu & Mori, 
1999). 
2.2.1. Stress and oxidative stress 
Based on the known pathophysiological effects of stress, it is plausible that associated 
increases in metabolism may lead to increased oxidant production and oxidative damage 
to cellular macromolecules. Chronic exposure to stress alters the prooxidant-antioxidant 
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balance, which might lead to the development of various human pathological states 
(Stojilkovic et al., 2005). A single short-term emotional pain stress produced a transient 
increase of the lipid peroxidation level (Taranova et al., 1994). Marked changes were 
observed in erythrocyte antioxidant enzymes SOD, CAT and GR and lipid peroxidation 
levels of rats exposed to acute, repeated and chronic restraint stress (Sahin et al., 2004). 
Moreover, different stress models are found to have different degrees of influences on 
enzymatic and non-enzymatic defense systems, protein oxidation and lipid peroxidation 
(Sahin & Gumuslu, 2004). Emotional stress induced by 24 h immobilization causes 
TBARS increase in the brain, liver and heart in Wistar rats (Sosnovskii et al., 1992; 
Sosnovskii & Kozlov, 1992). Stress causes an increase in TBARS and protein carbonyl 
content and a decrease in the glutathione content suggesting stress does cause universal 
oxidative damage. Rats subjected to 30 min cold-immobilization stress show increased 
TBARS and conjugated dienes in the liver, heart and stomach (Kovacs et al., 1996). The 
potentiation of lipid peroxidation by stress may be due to insufficiency of the protective 
systems (Aydin et al., 2005) as depletion of antioxidants and antioxidant enzymes by 
stress have been observed in different tissues of rats (Al-Qirim et al., 2002; Zaidi et al., 
2005). To understand the role of antioxidant enzymatic defenses in ROS injury following 
immobilization stress, the effect on mRNA expression of antioxidant enzymes was 
examined. The mRNA levels of all antioxidant enzymes were markedly decreased in the 
liver, while no effect was observed in heart, lung and kidney (Oishi & Machida, 2002). 
Antioxidant defense status in peripheral tissues is thus influenced by immobilization 
stress and tissue specific regulation mechanisms of antioxidants exist in rats. 
2.2.2. Stress and DNA Damage and Repair 
The mechanisms that would account in part for the relationship between stress and tumor 
development may be damage to DNA or DNA repair (Glaser et al., 1985). Several studies 
have examined the effect of stress on DNA integrity as stress has been found to cause 
production of ROS resulting in oxidative stress and increased lipid peroxidation. The 
levels of methyltransferase, a DNA repair enzyme induced in response to carcinogen 
alkylation damage, were significantly lower in spleens from stressed animals (Glaser et 
al., 1985). Glaser and coworkers (1985) assessed the differences in DNA repair in 
lymphocytes and showed that lymphocytes from highly stressed humans had significantly 
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poorer DNA repair when exposed to X-irradiation than those from lowly stressed 
subjects. The biomarker of oxidative damage to DNA, 8-OH-dG, is elevated in the liver 
nuclear DNA of rats subjected to psychological stress (Adachi et al., 1993). These data 
provide evidence for a direct pathway through which stress could play a role in the 
incidence of cancer. 
2.3. CHEMICAL CARCINOGENESIS 
People are continuously exposed exogenously to varying amounts of chemicals that have 
been shown to have carcinogenic or mutagenic properties in experimental systems. 
Exposure can occur exogenously when these agents are present in food, air or water, and 
also endogenously when they are products of metabolism or pathophysiologic states such 
as inflammation. It has been estimated that exposure to environmental chemical 
carcinogens may contribute significantly to the causation of a sizable fraction, perhaps a 
majority, of human cancers, when exposures are related to life style factors such as diet, 
tobacco use etc. Chemically induced neoplasia is a multistep process involving DNA 
damage and cell proliferation. Chemical carcinogens impact on various stages of this 
process and function through modification of cellular and molecular events. On the basis 
of the apparent differences by which chemicals participate in the carcinogenic process, 
they may be defined as genotoxic or epigenetic (non-genotoxic) (Williams & Weisburger, 
1983). Genotoxic agents usually refer to chemicals that directly damage genomic DNA, 
which in turn can result in mutation and/or clastogenic changes. Such chemicals are 
frequently activated in the target cell and produce a dose-dependent increase in neoplasm 
formation (Pitot et al., 1981). In contrast, non-genotoxic compounds appear to function 
through non-DNA reactive or indirect DNA reactive mechanisms. Although much less is 
known about the exact mode of action of non-genotoxic carcinogens, they modulate cell 
growth and cell death. Changes in gene expression and cell growth parameters are 
paramount in the action of nongenotoxic carcinogens. These agents frequently function 
during the promotion stage of the cancer process (Kolaja & Klaunig, 1996). Two possible 
mechanisms have been proposed for the induction of cancer. In one, an increase in DNA 
synthesis and mitosis by a nongenotoxic carcinogen may induce mutations in dividing 
cells through misrepair. With continual cell division, mutations will result in an initiated 
preneoplastic cell that may clonally expand to a neoplasm. In addition, nongenotoxic 
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agents may serve to stimulate the selective clonal growth of already spontaneously 
initiated cells (Ames & Gold, 1990). In maintaining cell number within a tissue, 
equilibrium exists between cell proliferation and cell death. The cancer process thus is a 
result of an imbalance between cell growth and death. Experimental evidence supports an 
important role for reactive oxygen species in the cancer process. Increases in the reactive 
oxygen in the cell, through either physiological modification or through chemical 
carcinogen exposure, contribute to the carcinogenic processes. This may be via genotoxic 
effects resulting in oxidative DNA adducts or through modification of gene expression 
(Klaunig &Kamendulis, 2004). There are plethoras of carcinogens, of which few are 
described below. Although oxidative stress is described herein as a unifying thread, other 
modes of action may also be involved. ROS are commonly generated by electron 
transfer, although non-electron transfer routes can also occur, e.g., Radiation. The activity 
of peroxides and radiation provide compelling evidence for the important participation of 
oxidative stress. 
2.3.1. Radiation: 
The specific types and levels of radiation that cause cancer remain a matter of speculation 
(Doll, 1998; Jaworowski, 1999; Marks, 1999). Each day, over a billion particles of 
radiation cross paths with a human body. In spite of the disputation, there is a strong 
correlation between radiation exposure (generally, wavelengths under 320 nm) and 
cancer (Fry & Ley, 1984). Radiation damage to DNA may come about either directly or 
indirectly. Non-melanoma skin cancers are the most common, and are thought to be 
brought on by excessive exposure to UV rays (Sarasin, 1999). Those with xeroderma 
pigmentosum syndrome - a rare disease wherein the skin contains very little repair or 
defense mechanisms - have very high skin cancer incidences. Hence, DNA repair and 
defense are important in the promotion and progression of skin cancer. High-energy 
radiation, e.g., x-rays, gamma rays, and particle radiation, affect matter by breaking 
molecular bonds or ejecting electrons (ionization). When ionizing radiation impinges 
upon an aqueous environment, 0-H bonds within water molecules break to form the 
highly reactive 'OH moieties (Plumb et al., 1999). "OH insults DNA primarily by 
abstracting H» at various places on the helix. This process leaves behind radical lesions, 
which can form various oxyl and peroxyl radicals by reacting with O2 or superoxide 
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abstracting H« at various places on the helix. This process leaves behind radical lesions, 
which can form various oxyl and peroxyi radicals by reacting with O2 or superoxide 
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radical, the resultant peroxides can undergo Fenton type reactions (Rashid et al., 1999). 
Malonaldehyde, formed by oxidative degradation of the ribose portion of DNA, is a chief 
product in such a sequence, in addition to 8-OH dG. Since the proximate nuclear 
environment is aqueous, at low to average levels of radical scavengers, "OH induced 
DNA damage is the predominant type caused by ionizing radiation (Plumb et al., 1999). 
The mechanistic picture is complicated by generation of cationic-type species that 
alkylate cellular constituents (Seifter et al., 1984). 
2.3.2. Peroxides: 
Various peroxides have long been associated with carcinogenesis (Hix & Augusto, 1999). 
More than forty years ago, hydrogen peroxide was reported to be an initiator (Kovacic, 
1959). In fact, many carcinogens indirectly generate H2O2, which in turn brings about 
increased amounts of ROS (Kovacic, 1959). More recent experimentation has elucidated 
many specifics concerning H202-induced DNA damage (Korzets et al., 1999), including 
its role in tumor promotion, oncogene activation, and gap-junction disruption (Huang et 
al., 1999). Hydrogen peroxide has also been implicated in apoptosis by attacking 
regulatory proteins (Riou et al., 1999). The cytotoxicity and tumor-promoting ability of 
benzoyl peroxide (BPO) have also been dealt with (Gopalakrishna et al., 1999). BPO is 
involved in the oxidation of several key enzymes, including protein kinases, which may 
play an important mechanistic role in promotion. Tumors may be caused by tert-Butyl 
hydroperoxide by forming DNA adducts via reactive methyl radicals (-CHS) (Hix & 
Augusto, 1999). Transition metal ions attached to the DNA are apparently involved in the 
radical sequence. Enzymatic and non-enzymatic cleavage of peroxides generates three 
predominant types of radicals: alkoxyl, peroxyl, and hydroxyl. These ROS have been 
implicated in DNA cleavage (Adam et al., 1998) as well as oxidation of DNA bases 
(Simandan et al., 1998). 
2.3.3. Haloalkanes (HAs) 
Carbon tetrachloride (CCI4) and other haloalkanes (HAs) are widely used industrial 
solvents. The carcinogenicity and toxicity associated with CCI4 exposure is well 
established (Frezza et al., 1994; Brennan & SchiestI, 1998). Many HAs, including CCI4, 
are procarcinogens that become activated via a sequence of redox reactions whereby 
I I 
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CYP450 acts as the principal catalyst in the dehalogenation (Yao et al., 1994). In a study 
involving '*0, several oxidative paths and oxidative species were verified and the isotope 
was found to be present in large amounts in lipids and other macromolecules, indicating 
oxidation (Hatch et al., 1988). 
e c u ^ »CCU- -CI » C b C - ^ CbCOO-Jil^CbCOOH • Oxy Radicals 
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Most carcinogens or their metabolites appear to interact directly with DNA as an 
important component in the oncogenic sequence. The radicals generated, during 
metabolism, in the immediate vicinity of the nucleic acids then effect chain scission. HA 
activity is marked by an ability to penetrate biological membranes (Ludek et al., 1998). 
Research involving HAs dealt with their effects on enzyme signaling (Roghani et al., 
1987), tissue repair proteins and oncogenes (Camandola et al., 1999), including induction 
of human proto-oncogenes in transgenic mice (Tsunematsu et al., 1994). Studies with 
CHCI3 (Brennan & Schiestl, 1998) and CBr4 (DeGroot &. Noll, 1989) indicate activity 
resembling that of CCI4 while BrCH2CH2Br and CCI4 were found to be synergistic 
(Camandola et al., 1999). 
2.3.4. Aromatic amines 
(i) Hydrocarbon Types 
A detailed review incorporates a large body of knowledge concerning aromatic amines 
and their link to cancer (Vineis & Pirastu, 1997). Human exposure is primarily through 
various dyes, rubber, and oil industries, agricultural settings, and tobacco smoke. There 
are numerous case studies linking naphthylamine and benzidine to bladder cancer. It is 
proposed that bladder cancer in smokers comes about primarily through exposure to 
ArAs, not PAH or other smoke byproducts. Twenty carcinogenic ArAs and ten 
noncarcinogenic ones were analyzed using real-time, organ specific testing (Sasaki et al., 
1999). Of the twenty, aniline, benzidine, many of their derivatives and other aromatic 
amines damaged DNA. Nine of the ten non-carcinogenic amines exhibited no adverse 
effects. Ring size of aromatic amines is directly related to their potency (Shapiro et al.. 
1998). Larger ring adducts intercalate and bind DNA grooves, which can distort the 
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helical shape and inhibit repair. Some studies also suggest a role for ROS in aromatic 
amines carcinogenicity (Loft et al., 1999). 
(ii) Heterocyclic Types (Cooked Foods) 
Pyrolysis of food can create several types of heterocyclic amines, many of which are 
suspected in carcinogenesis (Schut & Synderwine, 1999; Adamson et al., 1996). They are 
generated primarily by reactions of amino acids in meats, and the amount produced 
depends upon the duration and temperature of cooking (Zheng et al., 1998; Skog et al., 
1998). Carcinogenic mechanisms involve ring epoxidation to form a phenol, or a multi-
step process beginning with N-hydroxylation by CYP450 to create the RNHOH moiety 
which is esterified to RNHOCOR by N-acetyl transferase (NAT) (Manson & Benford, 
1999). The two most prevalent heterocyclic amines in cooked foods are the 
imidazoquinoxaline (Ryu et al., 1999) and the imidazopyridine (Nagao et al., 1998). 
Exposure to former causes DNA damage and overexpression of oncogenes (Ryu et al., 
1999), and later induces guanine specific DNA adducts (Totsuka et al., 1996). 
2.3.5. Aromatic hydrocarbons 
Exposure to monocyclic (Wiemels et al., 1999) and polycyclic aromatic hydrocarbons 
(PAHs) is intimately linked to cancer incidence (Boffetta et al., 1997). The chemicals are 
commonly found in industrial settings, diesel exhaust, foods and cigarette smoke 
(Schoket, 1999). Monocyclic and PAHs are procarcinogens; various endogenous entities, 
including CYP450, oxidize the rings to the active forms which are implicated in DNA 
binding and oxidative stress. PAH potency rises as the number of aromatic rings 
increases (Till et al., 1999), whereby the larger adducts may interfere to a greater extent 
with various repair processes. Dibenzopyrene (DBP), a six-ringed aromatic hydrocarbon, 
is a more potent carcinogen than dimethylanthracene (3 rings) or benzopyrene (5 rings) 
(Arif et al., 1999). Several endogenous moieties can be involved as catalysts in their 
metabolism, including CYP450, which can oxidize the rings to various epoxides. Since 
the repeated application of the carcinogenic PAHs alone results in production of tumors, 
many of which are malignant carcinomas (Shubik, 1950), they are considered complete 
carcinogens (Berenblum, 1974). Complete carcinogens carry out both initiating and 
promoting functions. When used in both initiating and promoting stages, they yield a 
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higher incidence of carcinomas than does initiation with a PAH and promotion by TPA 
(Shubik, 1950). It was suggested that malignant tumor formation results from two or 
more carcinogen-induced mutations and that the role of promotion is to enlarge the size 
of the target cell population available for the second mutation (Hennings et al., 1983). 
Papillomas induced by repeated carcinogen application arise from significantly more 
cells than those induced by the carcinogen promoter sequence (Reddy & Fialkow, 1983) 
23.5.1. Metabolic activation of PAHs 
PAHs are ubiquitously distributed carcinogens in the environment and their carcinogenic 
potentials have been extensively studied in experimental animal models (Conney, 1982). 
PAHs acquire carcinogenecity only after they have been activated by xenobiotic-
metabolizing enzymes (Phase I enzymes) to highly reactive metabolites capable of 
attacking cellular DNA. Cytochrome P450 (CYP) enzymes are central to the metabolic 
activation of these PAHs to epoxide intermediates, which are converted with the aid of 
epoxide hydrolase to the ultimate carcinogens, diol epoxides(Shimada & Kuriyama, 
2004). Historically, CYPIAl had been thought to be the sole enzyme responsible for the 
metabolic activation of most of the carcinogenic PAHs to reactive electrophiles in mice, 
rats, and rabbits (Conney, 1982). However, recent studies have established that CYPIBI 
also activates PAHs to reactive metabolites at rates similar to or even higher than 
CYPIAl in experimental animals and humans. As a further cause of concern, human 
CYPIBI has also been shown to metabolize 17P-estradiol to a 4-hydroxylated product, a 
chemical considered to cause breast cancer in women (Spink et al., 1998). Both CYPl A1 
and IBI are expressed mainly in extrahepatic organs and thus make a major contribution 
to the incidence of cancers in these organs, when PAHs and other carcinogens are 
ingested into an animal's body (Shimada et al., 1996). PAHs induce several xenobiotic 
metabolizing enzymes, including CYPIAl and IBI, through the aryl hydrocarbon 
receptor. Many studies have demonstrated that most carcinogenic PAHs are activated by 
the combined actions of CYPs and epoxide hydrolases to highly reactive diol-epoxides 
that initiate cell transformation (Gelboin, 1980; Conney, 1982). For a number of PAHs, 
including 7,12-dimethylbenz (a) anthracene (DMBA) the ultimate carcinogen is a so-
called bay-region dihydrodiol epoxide, produced during cellular metabolism (Kapitulnik 
etal., l978;Slagaetal., 1987). 
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Biological systems have developed methods for dealing with electrophilic xenobiotics 
produced during Phase-I metabolisms; they are generally classified as Phase-ll enzymes 
(Fig.3). Many antioxidants and anticarcinogenic compounds that block the toxic and 
neoplastic effects of carcinogen share in common the ability to elevate levels of Phase-ll 
detoxification enzymes, i.e., glutathione-S-transferases (GSTs), quinone reductase, and 
UDP-glucuronosyltransferases (Wattenberg, 1992; Hanausek et al., 2003; Walaszek et 
al., 2004). Substantial evidences have accumulated to suggest that induction of Phase II 
enzymes is a causal mechanism for protection, since these enzymes divert ultimate 
carcinogens from reacting with critical cellular macromolecules (Prochaska et al., 1992). 
Overview of Metabolic Activation of Xenobiotics 
Procarcinogen or 
Parent compound 
Phasel metabolism 
Ultimate carcinogen 
Covalent binding to DNA 
Initiation of carcinogenesis 
Inactive metabolites 
Proximate carcinogen 
Phasell metabolism 
Detoxification 
Fig.3. Phase 1 metabolism can either activate or detoxify. Phase II metabolism makes the 
metabolite more polar so it can be excreted, and usually detoxifies (with some 
exceptions). 
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2.4. DMBA (7,12-diinethylbenz (a) anthracene) 
DMBA, a member of the polycyclic aromatic hydrocarbons, is present in the environment 
as a product of incomplete combustion of complex hydrocarbons. It is also present in 
some amount in cigarette smoke (Rodgman et al., 2000; Bhuvaneswari et al., 2004). 
DMBA has been extensively used as a prototype agent in mutation research and cancer 
research. The main target sites for the potent carcinogenicity of this agent in rodents are 
the skin and the mammary gland (Huggins et al., 1961; Gruenstein et al., 1966). Being an 
indirect carcinogen, DMBA requires metabolic activation to become a carcinogen. 
DMBA is metabolized by CYP4501A1 in liver microsomes and by CYP4501B1 in 
primary bone marrow to form diol epoxides and toxic ROS (Guerin, 1978). 7,12-DMBA 
is converted to the proximate carcinogenic metabolite, namely 7,12-DMBA-3, 4-oxide by 
CYPs (Fig. 4). This epoxide is hydrolysed by epoxide hydrolase to form 7,12-DMBA-3, 
4-diol, which is finally oxidized again by CYPs to the ultimate carcinogenic metabolite 
7,12-DMBA-3, 4-diol-l, 2-epoxide (Conney, 1982; Luch et al., 1999). Indeed, a general 
correlation exists between the strength of a series of dihydrodiol epoxides as initiators, 
and their chemical potential to form the benzylic carbonium ion, which is a reactive, 
electrophilic intermediate that binds to nucleophiles (Jerina et.al., 1976). DMBA 
covalently modifies DNA by reaction of its bay region diol epoxide with exocyclic amino 
groups of deoxyguanosine and deoxyadenosine. 
7,12-DMBA V4-«.W. /.12-DMI»\-,M-cli..l dk.|.l.2-vi>»xicK 
Fig. 4. Metabolic activation of 7,12-DMBA to bay region epoxide by P450 and epoxide hydrolase 
2.4.1. DMBA induced carcinogenesis 
DNA adduct formation is generally accepted as a critical step in the mechanism by which 
polyaromatic hydrocarbons, including 7,12-DMBA, cause mutations resulting in 
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induction of cancer in the target organs (Dippie et al., 1984). Many studies have shown 
that these carcinogenic hydrocarbons after being metabolized by CYP450 (Kadlubar & 
Hammons, 1987; Christou et al., 1987), as an essential first step, are transformed to DNA 
binding meso-region benzylic electrophilic metabolites that result in carcinogenesis 
(Flesher & Sydnor, 1971; Flesher & Sydnor, 1973; Surh et al., 1989; Flesher et al., 
1997a,b). Cavelieri and group, however, proposed that one electron oxidation is the 
predominant mechanism of activation for the most potent PAH including DMBA, 
benzo[a] pyrene and 3-methyI cholanthrene.(Ramakrishna et al., 1992). Mammalian 
peroxidases, including prostaglandin H synthase (Degen et al., 1982; Josephy et al., 1983; 
Boyd & Eling, 1984; Cavalieri et al., 1988), and cytochrome P-450 (Hanzlik & Tullman, 
1982; McDonald et al., 1982; Augusto et al., 1982; Burka et al., 1985; Cavalieri et al., 
1988) catalyse one-electron oxidation, and this mechanism is also involved in the 
binding of PAH to DNA (Cavalieri et al., 1983; Devanesan et al., 1987; Rogan et al., 
1988; Cavalieri et al., 1990). Evidence for activation of DMBA by one-electron oxidation 
comes from observations concerning benz[a]anthracene as well as the chemical 
properties of the DMBA radical cation (Dippie, 1976). The two major DMBA-DNA 
adducts formed by this mechanism are depurination adducts in which specifically the 12-
CH, group is bound to the N-7 of adenine [7-MBA-I2-CH2 - N7 Ade] or guanine[7-
MBA-I2-CH2 - N7 Gua] (Ramakrishna et al., 1991). These two adducts constitute almost 
99% of the total adducts (Ramakrishna et al., 1992). Activation of DMBA by one-
electron oxidation and its specific reaction at the 12 CH3 group with DNA nucleophiles is 
in agreement with the results of several relevant carcinogenicity experiments. 
The interaction product between the chemical and DNA, known as a DNA adduct, is the 
precursor lesion for mutation. Alteration in DNA sequence through genotoxin exposure 
can give rise to myriads of alterations within the cell including switching on or off of 
genes, aberrant protein expression or alterations in cell cycle control (Gamer, 1998). 
Recent evidence supports the concept of mutated genes, which once mutated give rise to 
genetic instability. For example, if a mutation occurring in a gene specifying a DNA-
repair enzyme will result in lack of DNA repair fidelity ensuing cascade of new 
mutations which will lead to further cell dysregulation and dysfunction. Thus, from a 
single genetic event, a much larger group of mutations can result (Bohr, 1995). 
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Chromosome breaks were also seen in bone marrow cells of Chinese hamsters after 
subcutaneous or intraperitoneal inoculation of DMBA (Kato et al., 1969). There are a 
number of possible mechanisms by which DMBA could produce chromosome breakage; 
one is binding of the bulky diol epoxides to DNA and the second involves the induction 
of a pre-oxidant state in treated cells (Cerutti, 1985). ROS formed during DMBA 
metabolism can diffuse from the site of generation to other targets within the cells or 
even propagate the injury outside to intact cells. These ROS produce deleterious effects 
by initiating lipid peroxidation directly or by acting as second messengers for the primary 
free radicals that initiate lipid peroxidation (Das, 2002). Evidence for a role of reactive 
oxygen species in chromosome breakage was found in human leukocyte cultures treated 
with DMBA (Shamberger et al., 1973). DMBA induced about a 3-fold increase in 
chromosome breaks and these could be reduced by as much as 64% by the presence of 
antioxidants during DMBA treatment. The antioxidant effect is corroborated by the 
observation that peroxidation of unsaturated lipids increases in mouse skin ~3-fold by 20 
days after a single application of DMBA (Shamberger, 1972). Further studies showed 
that antioxidants inhibit ex{>erimental carcinogenesis induced by DMBA, thus confirming 
the involvement of ROS (Sharma et al., 2004; Sultana & Saleem, 2004). DMBA, a 
complete skin carcinogen, induces substantial oxidative effects that are similar to those of 
TPA. A prominent effect is oxidative modification of DNA bases, which occurs during 
the same time period that base-DMBA adducts are formed. Major events associated with 
tumor promotion are of longer duration after multiple DMBA treatments than those 
induced by TPA (Frenkel et al., 1995). Moreover, it causes formation of the same types 
of oxidized DNA bases as does ionizing radiation (Dizdaroglu, 1985; Frenkel, 1992) an 
archetypical free radical generating complete carcinogen. Several applications of DMBA 
provide an added complexity to interactions between concomitantly formed carcinogen-
DNA base adducts (initiation) and oxidized bases (promotion). These concurrent 
interactions of initiating and promoting processes then may be the key to complete 
chemical carcinogenesis. 
2.5. REACTIVE OXYGEN SPECIES (ROS): 
A substantial body of evidence has been produced that links the production of reactive 
oxygen radicals, and subsequent oxidative stress and damage, to the pathogenesis of age-
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related and chronic diseases including cancer (Vuillama, 1987; Trush & kensler, 1991; 
Witz, 1991; Guyton & Kensler, 1993). Reactive oxygen species (ROS) are derived from 
the metabolism of molecular oxygen (Halliwell, 1999). Molecular oxygen (dioxygen) has 
a unique electronic configuration and is itself a radical. The addition of one electron to 
dioxygen forms the superoxide anion radical (Of) (Miller et al., 1990). Superoxide 
anion, arising either through metabolic processes or following oxygen "activation" by 
physical irradiation, is considered the "primary" ROS, and can further interact with other 
molecules to generate "secondary" ROS, either directly or prevalently through enzyme-or 
metal catalyzed processes (Valko et al., 2005). These include singlet oxygen ('O2), 
hydrogen peroxide (H2O2), and the highly reactive hydroxyl radical (OH). The 
deleterious effects of oxygen are said to result from its metabolic reduction to these 
highly reactive and toxic species (Buechter, 1988). ROS normally exist in all aerobic 
cells in balance with biochemical antioxidants. Oxidative stress occurs when this critical 
balance is disrupted because of excess ROS, antioxidant depletion, or both (Scandalios, 
2002). To counteract the oxidant effects and to restore redox balance, cells must reset 
important homeostatic parameters. ROS are not always harmful metabolic byproducts; 
when tightly regulated, ROS can act as intracellular signaling molecules (Klein & 
Ackerman, 2003). ROS can be produced by both endogenous and exogenous sources. In 
living cells, the major sources of endogenous ROS are hydrogen peroxide and superoxide 
anion, which are generated as by products of cellular metabolism such as mitochondrial 
respiration (Nohl et al., 2003). Alternatively, hydrogen peroxide may be converted into 
water by the enzymes catalase or glutathione peroxidase. Variability or inductive changes 
in the expression of these enzymes can significantly influence cellular redox potential. 
ROS can cause tissue damage by reacting with lipids in cellular meftnbranes, nucleotides 
in DNA (Ahsan et al., 2003), sulphydryl groups in proteins (Knight, 1995) and cross-
linking/fragmentation of ribonucleoproteins (Waris & Alam, 1998) (Fig.l). The relatively 
unreactive superoxide anion radical is converted by superoxide dismutase (SOD) into 
H2O2, which in turn take part in the "Fenton reaction", with transition metal ion (copper 
or iron) as catalysts, to produce the very reactive hydroxyl radical (Aruoma et al., 1989; 
Halliwell & Gutteridge, 1990; Haliwell & Gutteridge, 1992; Halliwell, 1993). ROS can 
be produced by a host of exogenous processes. Environmental agents including 
nongenotoxic carcinogens can directly generate or indirectly induce ROS in cells (Rice-
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Evans & Burdon, 1993). The induction of oxidative stress and damage has been observed 
following exposure to xenobiotics of varied structure and activities {Klaunig et al., 1997). 
Endogenous sources 
Mitochondria 
Peroxisomes 
Cytochrome P450 
Exogenous sources 
UV light 
loniring radiation 
Inflammatory cytokines 
Pathogens 
I 
Oxidative stress 
I 
Damage to Nucleic acids. 
Proteins and Lipids 
Chromosomal instability. 
Mutations 
Loss of organelle functions. 
(Membrane damage 
i 
Cancer 
Fig.l. Pathways illustrating the sources of reactive oxygen species and its role in the 
development of cancer. 
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2.5.1. Generation of ROS: 
During the earliest periods of life on earth, living organisn\s were chiefly anaerobic 
(Sahnoun et al., 1997). As evolution took place in the presence of steadily increasing 
amounts of atmospheric oxygen, life forms adopted numerous mechanisms to defend 
against, as well as utilize, the reactivity of the molecule. The marked activity can be 
attributed to the propensity of molecular oxygen to form various radical species. The 
formation of ROS is guided by external and internal agents, e.g., irradiation, exogenous 
chemicals, and endogenous entities, e.g., phagocytes and enzymes, such as cytochrome 
P450 mono-oxygenases (CYP450). Likewise, creation of ROS can be ebbed or reversed 
in the presence of certain agents, e.g., antioxidants and various enzymes, including 
superoxide dismutase (SOD), glutathione reductase (GR) and catalase (CAT). Aerobic 
life, as we know it, might be viewed as a contest between the formation and deactivation 
of ROS. In this light, oxidative stress can be defined as a state wherein this process 
becomes unbalanced. CYP 450, a chief enzyme in many oxidative processes, manipulates 
molecular oxygen, with the help of a reducing agent (designated RH2 in reaction 1), in 
order to monooxygenate a targeted substrate (Halliwell & Gutteridge, 1999). Usually, the 
oxidation is helpful to the organism, e.g., hydroxylation of Phenobarbital, leading to 
detoxification and excretion. However, as in the case of aromatic hydrocarbons, carbon 
tetrachloride and others, CYP 450 oxidative metabolites can be harmful. 
Substrate-H + O2 + RH2 • Substrate-OH + R + H2O (I) 
Mono-oxygenation of substrate by cytochrome P450 
Molecular oxygen often undergoes a single electron reduction to form the superoxide 
radical anion (SO") (Hauptmann & Cadenas, 1997). The production of superoxide occurs 
mostly within the mitochondria of a cell (Cadenas & Sies, 1998). The mitochondrial 
electron transport chain is the main source of ATP in the mammalian cell and thus is 
essential for life. During energy transduction a small number of electrons "leak" to 
oxygen prematurely, forming the oxygen free radical superoxide (Vaiko, 2004; Kovacic, 
2005). In vivo, SO"can be converted to various oxidative species, including: peroxides 
and various oxy radicals, namely hydroxyl (OH), peroxyl (ROO) alkoxyl (RO). Such 
entities, including SO' itself, can cause several internal anomalies, including: enzyme 
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inactivatlon, lipid and protein peroxidation, and DMA oxidation (Halliwell & Gutteridge, 
1999). Superoxide radical is usually neutralized by enzymatic conversion to the less 
reactive, non-radical hydrogen peroxide via SOD (reaction 11). This activity is often 
observed occurring along the mitochondrial electron transport chain. 
202' + 2H* • H2O2 + O2 (II) 
Dismutation of superoxide 
Hydrogen peroxide, which has various duties and metabolic fates, can be Fenton 
catalyzed to form one of the most powerful ROS, the hydroxyl radical (reaction 111). The 
Fenton reaction is part of a net transformation called the Haber-Weiss reaction, whereby 
superoxide and molecular oxygen undergo redox cycling with a catalyst, usually iron, 
(reaction IV). The redox state of the cell is largely linked to an iron (and copper) redox 
couple and is maintained within strict physiological limits. It has been suggested that iron 
regulation ensures that there is no free intracellular iron; however, in vivo, under stress 
conditions, an excess of superoxide releases "free iron" from iron containing molecules. 
The release of iron by superoxide has been demonstrated for [4Fe-4S] cluster containing 
enzymes of the dehydratase-lyase family (Liochev & Fridovich, 1994). The released Fe'^ 
can participate in the Fenton reaction, generating highly reactive hydroxyl radical. Thus 
under stress conditions, O2' acts as an oxidant of [4Fe-4S] cluster-containing enzymes 
and facilitates OH production from H2O: by making Fe^ ^ available for the Fenton 
reaction (Leonard et al., 2004; Vaiko et al., 2005). Processes like these compel 
organisms to limit the presence of catalytic entities like metals. 
Fe(II) + H2O2 • Fe(III) + HO-+ HO" (III) 
Fenton reaction 
Fe (III) + O2' ^ Fe(II) + O2 
F e d O + H . O . • Fe(ni) + HO"+H0-
o r + H2O2 • HO- +0H' + 02 (IV)" 
Haber- Weiss reaction 
The hydroxyl radical is the neutral form of the hydroxide ion. The hydroxyl radical has a 
high reactivity, making it a very dangerous radical with a very short in vivo half-life of 
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approx. 10"^ s (Pastor, 2000). Thus when produced in vivo OH reacts close to its site of 
formation. 
Catalase keeps the level of hydrogen peroxide in check via reactions that form water and 
molecular oxygen (reaction V). In addition, glutathione (GSH), which reacts with 
hydrogen peroxide to form water and oxidized glutathione (GSSG), can act in a variety of 
ways to combat radical formation (Halliwel! & Gutteridge, 1999). Many other species, 
including metals, metal chelators, cofactors, antioxidants, singlet oxygen, and enzymes 
are involved in these redox transformations. 
2H2O2 • 2H2O + O2 
Decomposition of hydrogen peroxide by catalase 
Additional reactive radicals derived from oxygen that can be formed in living systems are 
peroxyl radicals (ROO). The simplest peroxyl radical is HOO, which is the protonated 
form (conjugate acid; pKa ~ 4.8) of superoxide and is usually termed either hydroperoxyl 
radical or perhydroxyl radical. With this pKa value, only -0.3% of any superoxide 
present in the cytosol of a typical cell is in the protonated form (De Grey, 2002). It has 
been demonstrated that hydroperoxyl radical initiates fatty acid peroxidation by two 
parallel pathways: fatty acid hydroperoxide (LOOH)-independent and LOOH dependent 
(Aikens & Dix, 1991). The LOOH-dependent pathway of HO2' initiated fatty acid 
peroxidation may be relevant to mechanisms of lipid peroxidation initiation in vivo 
(Vaiko et al., 2007). 
2.5.2. Oxygen radicals and lipid peroxidation: 
Initiation of lipid peroxidation in a membrane or polyunsaturated fatty acid is due to the 
attack of any species that has sufficient reactivity to abstract hydrogen. 
Lipid-H+ OH • Lipid + H2O 
Since hydrogen atom has only one electron this leaves behind an unpaired electron on the 
carbon atom. The carbon radical in a polyunsaturated fatty acid tends to be stabilized by a 
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molecular rearrangement to produce a conjugated diene, which rapidly reacts with O2 to 
give a hydroperoxy radical. 
Lipid" + O2 • Lipid-02' 
(After molecular rearrangement) 
Hydroperoxy radicals abstract hydrogen atoms from other lipid molecules - this is the 
propagation stage of lipid peroxidation and so continues the chain reaction of lipid 
peroxidation. The hydroperoxy radical combines with the hydrogen atom that it abstracts 
to give a lipid hydroperoxide R-OOH (Halliwell & Gutteridge, 1984) 
Lipid-Of + Lipid-H • Lipid-02 H + Lipid 
Pure lipid hydroperoxides are fairly stable at physiological temperatures and a major role 
of transition metals is to catalyze their decomposition. Many metal complexes that can do 
this are present in vivo. They include simple complexes of iron salts with phosphate ion 
or phosphate esters such as ADP. Haem, hemoglobin, peroxidase, cytochrome P-450, 
other cytochromes and non-haem iron proteins are also effective (O'Brien, 1969; 
Kaschnitz & Hatefi, 1975; Gutteridge, 1977; Aust & Svingen, 1982). All these should 
contribute to the propagation of lipid peroxidation in membranes in vivo. A reduced iron 
compound can react with lipid hydroperoxides (lipid-02H), in a similar way to its 
reaction with H2O2 to give alkoxy (lipid-O) radicals. 
Lipid-02H + Fe^*-complex • Fe^ * -complex + OH' + lipid-O" 
(Fenton reaction) 
With an iron (111) compound a peroxy (lipid- O2) radical will form: 
Lipid-02H + Fe^^-complex • lipid- O2 + H"^  + Fe^^-complex 
Both alkoxy and peroxy radicals stimulate the chain reaction of lipid peroxidation by 
abstracting further hydrogen atoms. 
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2.5.3. Lipid peroxidation and carcinogenesis: 
Lipid peroxidation generates a constellation of products among which are reactive 
eiectrophiles such as epoxides and aldehydes (Esterbauer, 1985; Janero, 1990). The major 
aldehyde product of lipid peroxidation other than Malondialdehyde (MDA) (Mamett, 
1999) is 4-hydroxy-2-nonenal (HNE) (Valko et al., 2006). MDA is mutagenic in bacterial 
and mammalian cells and carcinogenic in rats (Mukai & Goldstein, 1976). It is highly 
electrophilic as well as nucleophilic and reacts not only with cellular nucleophiles but 
leads to self-condensation to form MDA oligomers (Golding et.al., 1989). The dimer of 
MDA is approximately equipotent to monomeric MDA as a mutagen (Riggins & 
Mamett, 2001). MDA reacts with nucleic acid bases at physiological pH to form adducts 
to dC, dA and dC (Fig.2) (Seto et.al., 1981; Nair et al., 1984; Mamett et al., 1986; Stone 
et.al., 1990 a,b). 
H 
HO' "H 
0 
0 
DNA r i==^N'^ '^ " -^^ 
N N N 
MDA MiG MiA MiC 
Fig 2. Generation of monomeric adducts from MDA reaction with DNA. 
In addition, MDA can attack amino groups on the protein molecule to form both 
intramolecular cross links and also cross-links between different protein molecules. 
NH2 ^ N H CH ^ 
HCOCH2CHO + protein • protein CH 
NH2 N =CH 
Intramolecular cross-link 
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HCO.CH2.CHO + 2 Protein NH2 
Protein NHCH = CH C H = N Protein 
Intramolecular cross-link 
Enzymes that require -NH2 or —SH groups for their activity are usually inhibited during 
lipid peroxidation e.g., the gIucose-6-phosphate enzyme found in liver microsomal 
fractions is inhibited as its -SH groups are attacked. HNE and other low molecular 
weight products of lipid peroxidation have been shown to inhibit protein synthesis and to 
interfere with the growth of bacteria and animal cells in culture (Halliwell & Gutteridge, 
1999). The production of MDA and its reactions with DNA and proteins provides a link 
between lipid peroxidation and genetic disease. Furthermore, DNA adduction by MDA 
correlates to alterations in cell cycle control and gene expression in cultured cells (Ji 
et.al., 1998). Thus lipid peroxidation must be considered significant endogenous source 
of DNA damage and mutations that contribute to human genetic diseases including 
cancer. 
2.5.4. Oxidative DNA damage and carcinogenesis: 
Damage to DNA by ROS has been widely accepted as a major cause of cancer (Ames, 
1983). In a given cell, an estimated 10^  oxidative lesions per day are formed (Fraga et ai., 
1990). Over 100 oxidative DNA adducts have been identified (Von Sonntag, 1987; 
Dizdaroglu, 1992; Demple & Harrison, 1994). ROS can directly produce single- or 
double-stranded DNA breaks, purine, pyrimidine, or deoxyribose modifications, and 
DNA cross-links. Persistent DNA damage can result in arrest or induction of 
transcription, induction of signal transduction pathways, replication errors and genomic 
instability, all of which are seen in carcinogenesis (Mamett, 2000; Valko et al., 2006). 
Division of cells with unpaired or misrepaired damage leads to mutations. Human studies 
support the experimentally based notion of oxidative DNA damage as an important 
mutagenic and apparently carcinogenic factor (Loft & Poulsen, 1996). The majority of 
mutations induced by ROS appear to involve modification of guanine, causing G—••T 
transversions (Higinbotham et al., 1992; Du et al., 1994; Denissenko et al., 1996; Lunec 
et al., 2002). If it occurs in critical genes such as oncogenes or tumor suppressor genes, 
initiation/progression can result (Ames et al., 1993). Indeed, these species can act at 
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several steps in multistage carcinogenesis. It is now assumed that ROS are involved in 
both the initiation and progression of cancer (Moller et al., 1998). Because of the 
multiplicity of DNA modifications produced by ROS, it has been difficult to establish the 
frequency and specificity of mutations by individual oxygen radical induced lesions. 
Some of these modified bases have been found to possess mutagenic properties. 
Therefore, if not repaired they can lead to carcinogenesis. Studies show that although all 
the four bases are modified by ROS, mutations are usually related to modification of GC 
base pairs, while that of AT base pair rarely leads to mutations (Retel et al., 1993). These 
mutations are usually base pair substitutions, whereas base deletions and insertions are 
less frequent. In human tumors, G to T transversions are the most frequent mutations in 
the p53 suppressor gene (Brash et al., 1991; Hollstein et al., 1991; Harris &. Hollstein, 
1993). Using single stranded DNA template in a sensitive forward mutation system, 
various mutations, including tandem double CC—»TT substitution have been observed in 
DNA treated with oxygen free radicals (Reid &. Loeb, 1993). Elevated levels of modified 
bases in cancerous tissue may be due to the production of large amount of H2O2, which 
has found to be characteristic of human tumor cells (Szatrowski & Nathan, 1991; Olinski 
et al., 1998). Initiation of cancer in humans by ROS is further supported by the presence 
of oxidative DNA modifications in cancer tissue (Ames et al., 1993; Poulsen et al., 1998). 
Many forms of reactive oxygen species are capable of forming oxidized bases. The 
hydroxyl radical in particular has been shown to produce a number of oxidized DNA 
lesions (Mamett, 2000). The reactivity of the hydroxyl molecule is such that its migration 
in the cell is limited and thus reacts quickly with cellular components (Sies, 1985). For 
the hydroxyl radical to react and oxidize DNA, it must be generated adjacent to the 
nucleic acid material. Hydrogen peroxide (H2O2), a precursor to hydroxyl radical, is less 
reactive and more readily diffusible and thus more likely to be involved in the formation 
of oxidized bases (Guyton & Kensler, 1993; Barber & Harris, 1994). Peroxynitrite. 
another strong cellular oxidant, is formed from the coupling of nitric oxide and 
superoxide (Beckman et al., 1990; Koppenol et al., 1992). As with H2O2, peroxynitrite is 
diffusible between cells and is taken up by active transport mechanisms into cells (Radi, 
1998). Equally important to the induction of mutation by reactive oxygen species is the 
fact that nitric oxide and superoxide are produced in activated macrophages, and as such, 
it is likely that peroxynitrite is formed in proximity to these cells. The DNA damaging 
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capability of peroxynitrite may therefore help to explain the reported association between 
inflammation and mutation (Mamett, 2000). 
Oxidation of guanine at the C8 position results in the formation of 8-
hydroxydeoxyguanosine (OH8dG), probably the most studied oxidative DNA adduct. 
This oxidative DNA lesion results in site-specific mutagenesis, is mutagenic in bacterial 
and mammalian cells, and produces G-» T transversions that are widely found in mutated 
oncogenes and tumor suppressor genes (Shibutani et al., 1991; Moriya, 1993; Hussain & 
Harris, 1998). In addition, reactive oxygen species can react with dGTP in the nucleotide 
pool to form 0H8dG. Therefore, it is postulated that during DNA replication, 0H8dG in 
the nucleotide pool will be incorporated into DNA opposite dC or dA on the template 
strand, resulting in A:T to C:G transversions (Cheng et al., 1992; Demple & Harrison, 
1994). 0H8dG also produces dose-related increases in cellular transformation, which can 
be prevented by antioxidants, further supporting the role of 0H8dG in the carcinogenic 
process (Zhang et al., 2000). Other oxidative DNA lesions, such as 8-oxo-adenine, 
thymine glycol, 5-hydroxy-deoxycytidine, as well as several uracil analogs, have been 
shown to be mutagenic (Wang et al., 1998; Kreutzer & Essigmann, 1998). In summary, 
oxidized DNA bases appear to be mutagenic and capable of inducing mutations that are 
commonly observed in neoplasia. 
2.5.5. Oxidative stress and cell growth regulation: 
A role for reactive oxygen species production and oxidative stress has been proposed for 
both the stimulation of cell proliferation and for cell deletion by apoptosis (Burdon, 1995; 
Slater et al., 1995) The mechanisms for the involvement of oxidative stress in the 
induction of the cell proliferation and apoptotic processes are not known, but clearly do 
not involve a universal mechanism. The effects of reactive oxygen species and oxidative 
stress within cells appear to be cell specific and dependent upon the form as well as the 
intercellular concentration of reactive oxygen species. Thus, the involvement of reactive 
oxygen species in cell growth regulation is complex, and dependent on a number of 
cellular and biochemical parameters (Klaunig & Kamendulis, 2004). 
Reactive oxygen species function to induce cell proliferation during the tumor promotion 
stage of carcinogenesis (Cerutti, 1985; Bickers & Athar, 2006). Both H2O2 and 
superoxide anion induce mitogenesis and cell proliferation in several mammalian cell 
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types (D'Souza et al., 1993). Furthermore, a reduction in cellular oxidants via 
supplementation with antioxidants such as superoxide dismutase, catalase, P-carotene, 
and flavonoids inhibits cell proliferation in vitro (Alliangana, 1996). Oxidative stress also 
modulates apoptosis. High concentrations of reactive oxygen species trigger an apoptotic 
signaling pathway, resulting in cell loss (Dypbukt et al., 1994). A number of endogenous 
substances (prostaglandins, and lipid hydroperoxides), redox cycling compounds 
(quinones, adriamycin), and growth factors (transforming growth factor P and tumor 
necrosis factor a) induce apoptosis via the generation of reactive oxygen species 
(Sandstrom et al., 1994; Aoshima et al., 1997). Antioxidants such as N-acetyl cysteine 
(NAC), glutathione, and dithiothreitol inhibit the apoptotic process, further supporting the 
link between reactive oxygen species induction and apoptosis (Sandstrom et al., 1994). 
Although no single mechanism explains the increased cell proliferation and/or inhibition 
of apoptosis observed following conditions that favor increased cellular oxidants, 
mounting evidence is emerging that links reactive oxygen species with altered expression 
of growth regulatory genes. 
2.6. ANTIOXIDANTS 
Exposure to free radicals from a variety of sources has led organisms to develop a series 
of defense mechanisms (Cadenas, 1997). These in vivo defense mechanisms against free 
radical-induced oxidative stress involve: (i) preventive mechanisms, (ii) repair 
mechanisms, (iii) physical defenses, and (iv) antioxidant defenses (Valko et al., 2007). 
Enzymatic antioxidant defenses include superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx). They are considered as primary antioxidant enzymes, since 
they are involved in the direct elimination of active oxygen species. Glutathione-S-
transferase (GST), glutathione reductase (GR) and glucose-6-phosphate dehydrogenase 
(G6PD) are secondary antioxidants which help in the detoxification of reactive oxygen 
species by decreasing peroxide levels (e.g., GST) or by maintaining a steady supply of 
metabolic intermediates like glutathione and NADPH for the primary antioxidant 
enzymes. The non-enzymatic small molecules include sulphydryl compounds such as 
glutathione (GSH) ascorbic acid, flavonoids and other antioxidants (Sun, 1990). Under 
normal conditions there is a balance between both the activities and the intracellular 
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levels of these antioxidants. This balance is essential for the survival of organisms and 
their health. 
2.6.1. Biochemistry of antioxidant enzymes 
Superoxide Dismutase (SOD) (E.C 1.15.1.1) 
SOD was first discovered by McCord and Fridovich in 1969 (McCord & Fridovich, 
1969). The enzyme is believed to be present in all oxygen metabolizing cells but lacking 
in most obligate anaerobes, presumably because its physiological function is to provide a 
defense against the potentially damaging reactivities of the superoxide radical (Of) 
generated by aerobic metabolic reactions (McCord et al., 1971). This enzyme catalyzes 
the reaction 
Of + O2 • H2O2 +O2 
Four different forms of SOD have been found to date (Fridovich, 1974): two containing 
copper and zinc, one manganese and one iron. CuZnSOD is found in the cytosol of most 
eukaryotic cells (Fridovich, 1975), a different form of CuZnSOD is found in extracellular 
fluids (Marklund, 1982; Marklund, 1984). MnSOD is located in the mitochondrial matrix 
as well as in bacteria, while FeSOD is present in many aerobic bacteria (Fridovich, 
1974). FeSOD and MnSOD share considerable homology, they are very different from 
CuZnSODs except in their activity (Banister et al., 1987). Diminished amounts of 
MnSOD have been found in almost all the tumors examined. Lowered amounts of the 
CuZnSOD have been found in many, but not all tumors. At the same time tumors have 
been shown to produce superoxide radicals, therefore, diminished enzyme activities along 
with radical production may lead to many of the observed properties of cancer cells 
(Oberley & Buettner, 1979). Numerous studies in cultured cells suggested that MnSOD 
might function as a new type of tumor suppressor gene (Amstad et al., 1997; Zhao et al., 
2001; Zhao etal., 2002). 
Catalase (CA T) (E.C LI 1.1.6) 
Catalase is one of the oldest known enzymes; it was named by Loew in 1901 (Percy, 
1984). The enzyme catalyzes the reaction 
2 H2O2 • 2H2O + O2 
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Most aerobic cells contain this enzyme. In animals, CAT Is present in all major body 
organs, being especially concentrated in liver and erythrocytes. At the subcellular level, 
CAT is found mostly in peroxisomes (80%) and cylosol (20%) (Sun, 1990). Most 
purified catalases have been shown to consist of four protein subunits, each of which 
contains a heam group bound to its active site (Halliwell & Gutteridge, 1990). Catalase 
activity is found to be low in many animal tumor cell lines (Bozzi et al., 1976). Animal 
studies have also shown lower CAT activity in tumor than in normal tissue (Tisdale & 
Mahmoud, 1983). 
GlutalMone-S-Transferase (GST) (E.C 2.5.1.18) 
GSTs are a family of enzymes that utilise glutathione in reactions contributing to the 
transformation of a wide range of compounds, including carcinogens, xenobiotics, 
therapeutic drugs and products of oxidative stress (Valko et al., 2007). They were 
originally observed in the catalysis of the first step in the formation of the mercapturic 
acids (Booth et al, 1961). GSTs occur in substantial quantities in liver and other 
mammalian tissues e.g., erythrocytes and intestines (Marcus et al., 1978). A large number 
of studies have established an association between cancer incidence and various disorders 
of GSH-related enzyme functions, alterations of GSTs being most frequently reported 
(Pastore et al., 2003). 
Glutathione Reductase (GR) (E.C 1.6.4.2) 
GR was initially observed in livers from various animals by Hopkins and Elliot in 1931 
(Hopkins & Elliot, 1931) and later isolated from ox, sheep and rabbit liver by Mann in 
1932 (Mann, 1932). The enzyme catalyses the reaction: 
GSSG + NADPH + H* • 2GSH + NADP^ 
The enzyme is found in cytosol and mitochondria. GR can also catalyse reduction of 
certain mixed disulphides, such as that between GSH and coenzyme A. Glutathione 
avtivity has been found to be variable in different tumors, however it was found to be 
lowered in most of them. In a wide variety of mouse tumors, GR activities were, in 
general, lower in the tumors as compared to corresponding normal tissues (Tisdale & 
Mahmoud, 1983). 
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Glutathione (GSH) 
Glutathione, the most abundant low molecular-weight thiol in mammalian cells, is 
present in reduced (GSH) and oxidized (GSSG) forms (Meister & Anderson, 1983). The 
main protective roles of glutathione against oxidative stress are: (i) glutathione is a 
cofactor of several detoxifying enzymes against oxidative stress, e.g., glutathione 
peroxidase, glutathions transferase and others; (ii) GSH participates in amino acid 
transport through the plasma membrane; (iii) GSH scavenges hydroxyl radical and singlet 
oxygen directly, detoxifying hydrogen peroxide and lipid peroxides by the catalytic 
action of glutathione peroxidase; (iv) GSH is able to regenerate the most important 
antioxidants, vitamin C and E, back to their active forms; glutathione can reduce the 
tocopherol radical of vitamin E directly, or indirectly, via reduction of 
semidehydroascorbate to ascorbate (Masella et al., 2005). The capacity of GSH to 
regenerate the most important antioxidants is linked with the redox state of the 
glutathione disulphide-glutathione couple (GSSG/2GSH) (Pastore et al., 2003). This ratio 
is normally closely regulated. Disruption of this ratio is involved in several cellular 
reactions involved in signal transduction and cell cycle regulation under conditions of 
oxidative stress (Schafer & Buettner, 2001). It is therefore presumed that decreased GSH 
would contribute to cell death only when oxidative stress becomes prolonged, and 
cellular systems are not sufficient to counteract the reactive oxygen species mediated 
insult (Estrela et al.. 2006). 
Since free radicals are involved in both initiation and promotion stages of 
carcinogenesis, one may expect that free radical scavengers should function as inhibitors 
in the neoplastic processes. Much data has been accumulated on this topic. Antioxidants 
have been shown to inhibit both initiation and promotion in carcinogenesis and 
counteract cell immortalisation and transformation (Sun, 1990). 
2.7. CHEMOPREVENTION 
The term chemoprevention was first introduced by Spom (1976), in contrast to 
chemotherapy, when he referred to the prevention of development of cancer both by 
natural forms of vitamin A and its synthetic analogues. This strategy seems to be 
promising for reducing cancer incidence both in well-defined high-risk groups of people 
and also in the general population. Chemoprevention is now defined as the use of specific 
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agents to suppress or reverse carcinogenesis (Greenwald & Kelloff, 1996). Primary 
prevention of cancer is one of the key approaches to the control of cancer. It includes (i) 
avoiding exposure to known cancer-causing agents, (ii) enhancement of host defence 
mechanisms, (iii) chemoprevention (Kakizoe, 2003). Cancer chemoprevention may target 
various processes as proposed by Kellof et al., (1996) e.g., prevention of carcinogen 
binding to DNA, enhancement of DNA repair, scavenging of oxygen radicals etc. 
2.7.1. Antioxidants in Cancer Prevention 
In the last few years, there has been growing interest in the role played by oxidative 
reactions in human diseases. Since oxidative stress is generally perceived as one of the 
major causes for the accumulation of mutations in the genome, antioxidants are believed 
to provide protection against cancer. A number of natural and synthetic antioxidants are 
known to retard chemical carcinogenesis in experimental animal models, and 
epidemiological studies suggest that a diet rich in plant products containing natural 
antioxidants may be deterrent to carcinogenecity (Sardas, 2003). The mechanisms of the 
anticarcinogenic effects of antioxidants are not fully understood. However, the evidence 
available so far suggest that the most plausible mechanism for the anti-carcinogenic 
activity of antioxidants are: (I) scavenging of reactive oxygen species, free radicals and 
electrophiles; (2) possible attenuation of the formation of activated carcinogenic species 
by phase 1 biotransformation enzymes and; (3) enhancement of detoxification of 
electrophiles by inducing phase II detoxification enzymes such as GST and quinone 
reductase (Sardas, 2003). 
Carcinogens administered to animals are absorbed from the gastrointestinal tract or from 
the site of administration, and are then distributed throughout the body and metabolised 
in tissues including the liver and target sites. They are detoxified or activated 
enzymatically, and activated metabolites or ROS then covalently bind to cellular 
macromolecules thus causing DNA or cellular damage followed by carcinogenesis (Ito & 
Hirose, 1989). Antioxidants can modify the carcinogenic process at different stages, 
including (1) alteration of the metabolic activation of a precarcinogen by (a) inhibition of 
the activating enzyme or (b) alteration of the metabolic pattern of the carcinogen via 
selective enzyme induction; (2) prevention of the reaction between the ultimate 
carcinogen and DNA by (a) direct interaction with the carcinogenic species, (b) increased 
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detoxication by antioxidant-inducible enzymes, or (c) competition between carcinogen 
and antioxidant in the binding process (Wattenberg, 1978a, b, 1981). 
in the process of finding the most efficient agents for better prevention and cure of cancer 
many natural as well as synthetic antioxidants have been studied. Two such antioxidants; 
melatonin and resveratrol, have been extensively studied for their antioxidant properties 
against different cancers and were used in this study as well. 
2.7.2. Melatonin (N-acetyi-5-methoxy-tryptamine) 
Melatonin is the main (indole) hormone of the pineal gland synthesised from tryptophan 
predominantly during the night (Arendt, 1995). Melatonin is critical for the regulation of 
circadian and seasonal changes in various aspects of physiology and neuroendocrine 
function (Arendt, 1995; Pevet et al., 2002). Since 1993, when potent antioxidant 
properties of melatonin were discovered (Tan et al., 1993), many studies have confirmed 
the ability of melatonin to protect DNA from free radical damage. It was shown to be a 
very efficient scavenger of free radicals and was found to be more effective than other 
well known antioxidants such as glutathione and vitamin E (Musatov et al., 1998; Fieri et 
al., 1994)). Rieter et al (1995) reported that melatonin is a potent quencher of hydroxyl 
radicals. Melatonin in vitro directly scavenges OH (Tan et al., 1993), H2O2 (Barlow-
Walden et al., 1995), singlet oxygen (Qi et al., 2001) and inhibits lipid peroxidation (Fieri 
et al., 1994). Likewise, melatonin can stimulate a number of antioxidative enzymes 
including SOD (Antolin et al., 1996). GPx (Pablos et al., 1998), GR (Urata et al., 1999) 
and catalase (Barlow-Walden el al.. 1995). It has been shown that melatonin enhances 
intracellular glutathione levels by stimulating the rate-limiting enzyme in its synthesis, y-
glutamylcysteine synthase, which inhibits the peroxidative enzymes (Pierrefiche & 
Laborit, 1995). There is evidence that melatonin slablizes microsomal membranes; 
thereby probably helping them resist oxidative damage (Karbownik et al., 2001). It has 
also been shown to increase the efficiency of the electron transport chain and, as a 
consequence, to reduce electron leakage and the generation of free radicals (Reiter et al., 
2001). It was shown that melatonin reduced the formation of 8-hydroxy-2'-
deoxyguanosine more effectively than some classic antioxidants (Qi et al., 2001). Thus 
melatonin acts as a direct scavenger of free radicals with the ability to detoxify reactive 
oxygen species and indirectly increasing the activity of the antioxidative defence systems 
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(Reiter et al., 2001; Qi et al., 2001; Tan et al., 2002). These properties allow melatonin to 
preserve macromolecules including DNA, protein and lipid from oxidative damage 
resulted from ionising radiation and chemical carcinogen exposure. Being both lipophilic 
and hydrophilic, melatonin may play an important role in the antioxidant defence system 
in all cells and tissues of the body (Reiter et al., 1995). 
The role of the pineal gland in tumor development has been under intensive study during 
the last years (Blask, 1993; Bartsch et al., 2001; Vijayalaxmi et al 2002; Bartsch & 
Bartsch, 2006). In cancer patients the morphological signs of pineal function is found to 
decrease and disturbances in the circadian secretion pattern of melatonin were observed 
(Vijayalaxmi et al 2002; Bartsch & Bartsch, 2006). The inhibitory effect of melatonin is 
well established in relation to mammary tumors (Cos et al., 2000; Cos et al., 2001; 
Sanchez-Barcelo et al., 2003) and colon cancer (Anisimov et al., 1997; Anisimov, 2001). 
There are few data on the effect of melatonin on tumors of other localizations. 
2.7.3. Resveratrol (3,4% 5-trihydroxy-trans-stilbene) 
The plant polyphenol resveratrol has been classified as a phytoalexin, because it is 
synthesised in spermatophytes in response to certain types of stress, including injury, UV 
irradiation or fungal attack (Langcake &Pryce, 1977; Hain et al., 1990). Resveratrol 
naturally occurs in grapes (Langcake & Pryce, 1976; Romero-Perez et al., 1999; Roldan 
et al., 2003), wine (Siemann & Creasy, 1992), and peanuts (Sobolev & Cole, 1999; Ibem-
Gomez et al., 2000; Sanders et al., 2000). It has been shown to inhibit platelet 
aggregation and eicosanoid synthesis (Pace-Asciak, 1995), to interfere with arachidonate 
metabolism (Kimura, 1985), to exert strong inhibitory effect on reactive oxygen species 
produced by human polymorphonuclear leukocytes (Rotondo, 1998), and to be 
antioxidant more powerful than vitamin E in preventing low-density lipoprotein (LDL) 
oxidation (Frankel, 1993). Lately, due to its ability to serve as an eftective antioxidative 
agent (Fremont, 2000), resveratrol has received wide attention. It inhibits cellular events 
associated with tumor initiation, promotion/progression (Cadenas & Barja. 1999). 
Recently, resveratrol was found to possess cancer prevention activity in several animal 
cancer models, such as by blocking the development of preneoplastic lesions in 
carcinogen-treated mouse mammary glands (Jang et al., 1997). 
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Chemopreventive strategies include the inhibition of phase 1 enzymes responsible for 
activating xenobiotics and the induction of phase H enzymes that conjugate these 
activated compounds to endogenous ligands (e.g., glutathione). Resveratrol being an 
exogenous lipophilic compound, can cross plasma membrane, be subjected to cellular 
metabolism and it possibly interacts with phase I enzymes (Signorelli & Ghidoni, 2005). 
Resveratrol inhibited human recombinant CYP 450 in vitro (Yu et al., 2003). Moreover it 
inhibited CYP450 activity from mouse or human liver microsomes (Ciolino & Yeh, 
1999; Mikstacka et al., 2002). Jang et al (1997) found that resveratrol reduced the 
insurgence of preneoplastic lesions in mouse mammeiry glzind cultures and decreased the 
incidence of tumor formation in mice treated with 7,12-dimethylbenz(a)anthracene 
(DMBA) used as tumor initiator, in combination with phorbol esters used as tumor 
promoter. Since DMBA requires bioactivation by phase I enzymes (Shou et al., 1996), 
the antitumoral activity of resveratrol in vivo includes prevention of the initiation phase 
of carcinogenesis by inhibiting phase I enzymes. Resveratrol was further shown to induce 
phase II enzymes such as UDP-glucuronyltransferase and NAD(P)H:quinone 
oxidoreductase in mouse epidermis (Szaefer et al., 2004). These data strengthen the 
hypothesis that resveratrol may be used in cancer prevention. 
2.8. STRESS AND CHEMOPREVENTION 
Epidemiological (Fox, 1981; Locke, 1982; Temoshok & Fox, 1984) and experimental 
(Sklar & Anisman, 1980; Sklar & Anisman, 1981) evidence suggest that stress and ability 
to cope with stress may play a role in disease processes as well as cure. Psychosocial 
stressors have been associated with reduced efficacy of cancer therapies (Lichtman et al., 
1987; Waxier-Morrison et al., 1991). Other studies have shown that reducing the impact 
of life-stressors through psychosocial intervention or social support may extend survival 
time and decrease the toxic side effects of chemotherapy (Burish et al., 1987; Grossarth 
&Eysenck, 1989). In support of these data, recent animal studies have shown that 
exposure to rotational stress decreases the anti tumor effects of chemotherapeutic drugs in 
terms of tumor burden, extent of metastasis and survival time (Pressin et al., 1991; 
Giraldi et al., 1992; Giraldi et al., 1994; Giraldi et al., 1994). Several factors appear to 
play a role in mediating stressor-induced alterations in the effectiveness of chemotherapy 
treatments, including tumor size and growth rates, hormone levels, and/or immune 
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function, or an interaction among these factors (Corbett et al., 1978; Armitage, 1992; 
Bassukas & Schultze, 1993; Boddy & Idle, 1993; Maclean & Longenecker, 1994). So far, 
many stressors have been evaluated for their possible effect on chemoprevention and 
chemotherapy. Perissin and coworkers investigated the influence of stress on the effects 
of the antitumor cytotoxic drug cyclophosphamide and the selective non-cytotoxic 
antimetastatic agent razoxane (Pressin et al., 1991). In mice bearing Lewis lung 
carcinoma the application of rotational stress significantly decreased the magnitude of the 
effects of both drugs. Further studies showed that the curative action of 
cyclophosphamide was abolished when animals were subjected to restraint stress. The 
application of restraint stress, which by itself has no effects on survival, completely 
abolished the increase in survival time caused by the treatment with cyclophosphamide 
(Zorzet et al., 1998). Although many studies have been carried out to determine the 
impact of stress on chemotherapy, less data is available to-date on the relevance of 
psychological factors in determining the outcome of cancer chemoprevention. 
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3.1. MATERIALS 
Materials & Methods 
Chemical 
7,12- dimethylbenz(a)anthracene (DMBA) 
Histopaque 1077 
HBSS 
Melatonin 
Resveratrol 
Low melting point agarose 
NADPH 
NADP 
Glutathione (reduced & oxidized) 
Thiobarbituric acid (TBA) 
Dinitro phenyl hydrazine (DNPH) 
l-chloro-2,4-dinitrobenzene (CDNB) 
5-5' dithiobis-2-nitrobenzoic acid (DTNB) 
Ethylenediamine tetra-acetic acid (EDTA) 
Bovine Serum Albumin (BSA) 
Hydrogen peroxide 
Thio urea 
Sodium chloride 
Sodium hydroxide 
Magnesium chloride 
Sodium acetate 
p-nitrophenol phosphate 
p-nitrophenol 
Pyrogallol 
Succinic acid 
Sulphosalicylic acid 
Trichloroacetic acid (TCA) 
Sodium pyruvate 
Acetone 
Tris 
Glycine 
Ethedium bromide 
Source 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Himedia, India 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Qualigens laboratories, Banglore 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Qualigens Laboraories, Banglore 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sisco Research Laboratory, Mumbai 
Sigma Chemical Co., USA 
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3.2. METHODS 
3.2.1. Experimental animals 
Four to five week old male Swiss albino rats (40 ±5g) were used in the present study. 
Five animals were kept per cage having a bedding of rice husk and fed standard pellet 
diet (Ashirwad Industries, Chandigarh, India) and water ad libitum. The animals were 
maintained in controlled atmosphere of 12 hr dark/light, 22 ± 2° C temperature and 50-60 
% humidity and sacrificed by cervical dislocation with minimal suffering following rules 
laid down by Animal Welfare Committee of the university. 
3.2.2. Immobilization stress 
Immobilization stress was accomplished by placing the animals individually in body 
sized wire mesh cages attached to wooden boards with no movements allowed (Singh et 
al., 1993). The animals were deprived of food and water during stress exposure. 
3.2.2.1. Animal treatment 
For stress treatment animals were exposed to chronic restraint/immobilization stress for 
3hrs/day for 10 days. Immediately after last stress exposure, animals were sacrificed and 
heparinised blood, liver and skin samples collected for biochemical analysis. 
3.2.3. Preparation of DMBA solution 
7,12-dimethylbenz(a)anthracene was dissolved in pure and fresh sesame oil at a 
concentration of 0.5% (w/v). 
3.2.3.1. Animal treatment 
Topical treatment 
The backs of animals were shaved off with cream hair remover (Anne French, India) two 
days prior to the application of DMBA. The animals which showed no sign of hair 
growth were selected and DMBA was applied topically with No. 4 Camel brush, twice 
weekly till the end of experiment. 
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Oral treatment 
For oral treatment animals were administered 1.0 ml of 0.5 % DMBA per week, through 
gastric intubation with the use of a catheter for a total of four doses. 
3.2.4. Experimental protocol 
To evaluate the effect of DMBA, oral as well as topical on the biochemical parameters of 
rats, alone and on prior exposure to chronic restraint stress animals were divided into six 
groups of 10 rats per group and following treatment schedule was adopted: 
Group 1 Chronic restraint stress (3 h /day) for 10 days, (Stress alone) 
Group II Shaved back of rats painted with 0.5% DMBA solution twice a week for 4 
weeks. (DMBA Topical) 
Group III Pre- exposure to restraint stress followed by DMBA application as in 
Group II. (Pre-stress DMBA topical) 
Group IV Oral administration of 0.5% DMBA solution. (1ml / rat) four doses at 
weekly intervals. (DMBA Oral) 
Group V Pre- exposure to restraint stress followed by DMBA administration as in 
Group IV. (Pre-stress DMBA oral) 
Group VI Untreated control animals. (Control) 
Animals were sacrificed after a period of four weeks following DMBA administration, 
blood and liver samples were collected and subjected to biochemical estimations. 
In another set of experiment sixty rats were divided into four groups of twenty animals 
each. To see the dose-effect relationship of DMBA and DNA damage as well as 
alteration of biochemical parameters and effect of pre-exposure to restraint stress on this 
dose-effect relationship, following treatment schedule was followed. 
Group I Chronic restraint stress (3 h /day) for 10 days. (Stress alone). 
Group II Shaved back of rats painted with 0.5% DMBA solution twice a week for 
a total of four doses (DMBA alone). 
Group 111 Pre- exposure to restraint stress followed by DMBA application as in 
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Group II. (Pre-stress DMBA). 
Group IV Untreated control animals. (Control). 
Five animals from each group were sacrificed after 48 hrs following each DMBA 
treatment. To assess the effect of stress alone five animals from control and stress alone 
group each, were sacrificed immediately after last stress exposure. After each sacrifice 
blood, liver and skin samples were collected for comet assay and biochemical analysis. 
3.2.5. Preparation of homogenate and post mitochondrial supernatant 
A weighed portion of liver was homogenised in chilled O.IM phosphate buffer pH 7.4 
using glass teflon homogenizer and volume adjusted to give 10 % w/v homogenate. The 
homegenates were centrifuged at 10,000 g for 20 mins at 4° C to isolate the post 
mitochondrial supernatant and stored at -20'' C for the biochemical analysis. 
3.2.6. Biochemical parameters 
3.2.6.1. Lipid Peroxidation (LPO) 
The rate of lipid peroxidation (LPO) was determined according to the method of Buege & 
Aust (1978) by estimating malondialdehyde (MDA) formed with 2-thiobarbituric acid 
(TBA). The reaction mixture containing 0.5 ml homogenate (10% w/v) and 1ml of 0.67% 
TBA and 30% TCA (1:1) was taken in a test tube and heated for 20 mins at 100 °C in a 
boiling water bath. The contents were then centrifuged at 5000g for 15 mins and 1.0 ml 
of clear pink colored supernatant was withdrawn. The intensity of developed color was 
measured at 535 nm . For quantitation, molar extinction coefficient of 1.56 x 10'^  M"' cm-
1 for MDA-TBA colored complex was used and results expressed as nanomoies of 
malondialdehyde formed per mg protein. 
3.2.6.2. Superoxide dismutase (SOD) (E.C.I.15.L1) 
Superoxide dismutase was assayed on the method based on the ability of superoxide 
dismutase to inhibit the autooxidation of pyrogallol (Markland & Markland, 1974). 
Reaction mixture in a final volume of 3.0 ml containing 0.05ml of enzyme source with 
2.85 ml of 0.05M tris-succinate buffer pH 8.2 was incubated at 25°C for 20 mins. The 
reaction was initiated by the addition of 0.1 ml pyrogallol (8nm) and change in optical 
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density was measured for 3 mins at 412 nm. A reference set containing 0.05ml distilled 
water instead of sample solution, was run simultaneously. Results were expressed as 
enzyme units/mg protein. One enzyme unit is defined as the amount of enzyme required 
to cause 50% inhibition of pyrogallol autooxidation per 3 ml of assay mixture. 
3.2.6J. Catalase (CAT) (E.C. 1.11.1.6) 
Cataiase activity was determined by the method of Claiborne (1985). Briefly the reaction 
mixture consisted of 2.0 ml phosphate buffer (0.1 M, pH 7.4), 0.95 ml hydrogen peroxide 
(0.019 mM) and 0.05 ml of homogenate (10% w/v) in a final volume of 3.0 ml. Changes 
in absorbance were recorded at 240 nm for 3 mins. Catalase activity was calculated as 
nmol H2O2 consumed min"' mg' protein. 
3.2.6.4. Glutathione-S-transferase (GST)(E.C 2.5.1.1.18) 
GST activity was assayed by the method of Habig et al., (1974) using l-chloro-2, 4-
dinitrobenzene (CDNB) as substrate. The cuvettes in a final volume of 3.0 ml contained 
0.2M phosphate buffer, pH 6.5, 1 mM glutathione, ImM CDNB and 0.1 ml homogenate. 
The change in absorbance at 340 nm was recorded at room temperature against blank 
containing all the reactants except the enzyme source. Calculation was made using 
millimolar extinction coefficient value of 9.6 mM"' cm"' and specific activity was 
expressed as nmoles CDNB conjugate formed per minute per mg protein. 
3.2.6.5. Glutathione reductase (GR) (E.C. 1.66.4.2) 
GR was assayed according to the method of Carlberg & Mannervik (1985). This enzyme 
catalyzes the NADPH dependent reduction of glutathione disulfide to glutathione. The 
reaction mixture in a final volume of 2.0 ml contained 1.65 ml of 0.125 M phosphate 
buffer, pH 7.4; 0.2 ml of O.l mM reduced nicotinamide adenine dinucleotide phosphate 
(NADPH) and 0.05ml of ImM glutathione disulfide (GSSG). The reaction was initiated 
by the addition of 0.1 ml of enzyme to the cuvette and the oxidation of NADPH was 
followed spectrophotometrically at 340 nm after 30-sec intervals for 3 mins. The activity 
was expressed as nmoles of NADPH oxidised per minute per mg protein. 
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3.2.6.6. Reduced glutathione (GSH) 
The reduced glutathione was determined by the method of Jollow et al., (1974). A 1.0 ml 
supernatant (10% w/v) was mixed with 1.0 ml sulphosalicylic acid (4% w/v). the samples 
were incubated at 4oC for atleast I h and then centrifuged at I200g for 15 min at 4''C. 
The reaction mixture contained 0.4 ml of the filtered sample; 2.2 ml phosphate buffer 
(O.IM, pH 7.4) and 0.4 ml of 5,5' dithiobis-2-nitrobenzoic acid (DTNB)(4 mg/ml) in a 
total volume of 3.0 ml. The yellow color developed was read immediately at 412 nm. The 
GSH concentration was calculated as nmolg"'tissue. 
3.2.6.7. Uric acid 
Uric acid levels were measured using commercial kit (Span diagnostics Ltd. India). The 
method is based on the principle that uric acid in alkaline medium reduces 
phosphotungstic acid to 'tungsten blue' which can be measured spectrophotometrically at 
710 nm. In a test tube, 0.5ml of serum was mixed with 4.0 ml distilled water; 0.25 ml of 
2/3N sulphuric acid; 0.25 ml sodium tungstate, 10% w/v and centrifuged after 10 mins. 
For color development 1.5 ml of clear supernatant was mixed well with 0.5 ml of 14% 
w/v sodium carbonate 3 and 0.5 ml phosphotungstate and kept in dark for 15 mins. The 
blue color was read against blank containing all the reagents except the fiIterate. Values 
were expressed as mg uric acid/100 ml of serum. 
3.2.6.8. Glutamate Pyruvate Transaminase (GPT)/Alanine transaminase (ALT) 
(E.C 2.6.L2) 
GPT in serum and liver samples was determined using commercial kit (Span diagnostics 
ltd. India) based on the 2, 4-DNPH method by Reitman and Frankel (1957). GPT (ALT) 
catalyses the following reaction 
a- Ketoglutarate + L-Alanine — — • L-Glutamate + Pyruvate 
This method is based on the principle that pyruvate so formed is coupled with 2, 4-
Dinitrophenyl hydrazine (DNPH) to give the corresponding hydrazone, which gives 
brown color in alkaline medium, measured spectrophotometrically. Briefly the reaction 
mixture contained 0.05 ml of enzyme source mixed 0.25 ml of preincubated buffered 
alanine. The contents were incubated at 37°C for 30 mins and mixed with DNPH reagent. 
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2.5 ml of solution I(prepared by diluting 1 ml of 4N sodium hydroxide to 10 ml with 
distilled water) was added after 20 minutes and read at 505 nm against purified water. 
From a standard curve GPT was calculated and expressed as units/ml. 
3.2.6.9. Glutamate Oxaloacetate Transaminase (GOT)/Aspartate transaminase 
(AST) (E.C 2.6.1.1) 
GOT was measured using commercial kit (Span diagnostics ltd. India) based on the 
method by Reitman and Frankel. The principle behind the method is that the 
transaminase catalyses the reaction 
a-Ketoglutarate + L-Aspatate — — — ^ L-Glutamate + Oxaloacetate 
and the oxaloacetate so formed reacts with 2, 4-dinitrophenyl hydrazine to give brown 
colored hydrazone in alkaline medium which can be measured colorimetrically. The 
reaction mixture contained 0.05 ml of enzyme source mixed 0.25 ml of preincubated 
buffered alanine. The contents were incubated at 37° C for 60 mins and mixed with 
DNPH reagent. 2.5 ml of solution 1 was added after 20 mins and read at 505 nm against 
purified water. From a standard curve GOT was calculated and expressed as units/ml. 
3.2.6.10. Glucose 
The quantitative determination of serum glucose was done by the method of Hultman 
(1959) using O- toluidine as a color reagent. This reagent reacts with the aldehyde group 
of glucose in hot acetic acid solution to form an equilibrium mixture of glusylamine and 
corresponding Schiffs base. The blue-green colored product can be measured at 630 nm. 
Intensity of color developed is proportional to the original concentration of glucose 
present in the sample. An aliquot of serum was mixed with the reagents by lateral shaking 
and kept in a vigourously boiling water bath for exactly 9 mins. After cooling at room 
temperature the tubes were read against blank at 630 nm. The concentration of glucose 
was expressed as mg/dl of serum. 
3.2.6.11. Ascorbic acid 
Plasma ascorbic acid was determined colorimetrically with 2, 4-dinitriphenyl hydrazine 
(DNPH) by the method of Donald & Cormick (1986). Ascorbic acid in plasma is 
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oxidised by Cu (11) to form dehydroascorbic acid, which reacts with acidic DNPH to 
form dehydroascorbic acid red bis hydrazone which is measured at 520 nm. The reaction 
mixture contained 0.5 ml heparinized plasma mixed with 2ml of metaphosphoric acid 
(6% w/v). The contents were centrifijged at 2500 rpm for 10 mins and to 1.2 ml of 
supernatant, 0.4 ml of DTCS (DNPH-Thiourea-Copper sulphate in 1:1:20 ratio) reagent 
was added. Samples after being incubated for 3 hrs at 37°C were chilled and 2.0 ml of 
cold H2SO4 (12M) was added. After vortex the samples were read at 520 nm against 
reagent blank. Concentration of ascorbic acid was calculated from standard curve and 
expressed as mg/dl of plasma. 
3.2.6.12. Alkaline phosphatase (E.C 3.1.3.1) 
The activity of alkaline phosphatase was determined according to the method of Shah et 
al., (1979). The assay mixture contained 1.4 ml of assay buffer (50 mM glycine, 36 mM 
NaCl and 45 mM NaOH, pH 10.5) and 0.1 ml of enzyme. The reaction was started by 
adding 0.015 ml of 0.6 M p-nitrophenol phosphate. The contents were incubated at 30^C 
for required time period and the reaction was stopped by adding 0.05 ml of 5N NaOH. 
The yellow color developed was read at 405 nm against reagent blank. The activity was 
calculated from standard p-nitrophenol curve and expressed as mg/ml. 
3.2.6.13. Lactate dehydrogenase (LDH) (E.C 1.1.1.27) 
LDH activity was assayed by the method of Wroblewski & LaDue (1955). The cuvette in 
a final volume of 3 ml contained lOOmM tris buffer, pH 7.4; 10 mM magnesium chloride 
(MgCb); 0.5 M sodium pyruvate; 0.2% NADH (w/v); 10 |ig of enzyme and distilled 
water. The change in absorbance at 340 nm was recorded at room temperature for 5 mins 
at 30 sec intervals against blank containing all reactants except enzyme. Specific activity 
was expressed as units/mg protein. 
3.2.6.14. Acid phosphatase (ACP) (E.C 3.1.3.2) 
Th is was done by following the method of Verjee (1969). Reaction was started by adding 
0.3 ml of 8 mM p-nitrophenol phosphate to the test tube containing enzyme in 0.08 M 
sodium acetate buffer pH 4.5. After incubation for required time the reaction was stopped 
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by adding 2 ml of 2N NaOH. From standard p-nitrophol curve the activity of acid 
phosphatase (ACP) was calculated and expressed as mg/ml. 
3,2.6.15. Protein 
The protein content in all the samples was estimated according to the method of Lowry et 
al. (1951), using bovine serum albumin as standard. An aliquot of protein sample was 
diluted with distilled water to a final volume of I ml. To this, 5 ml of alkaline copper 
reagent (freely mixed 98 ml of 2% sodium carbonate in 0.1 M sodium hydroxide, 2.0 ml 
of 0.5 % copper sulphate and I % sodium potassium tartarate) was added and the solution 
was kept at room temperature for 10 mins. Color was developed by the addition of Folin-
Ciocalteau reagent and the intensity of blue color was measured after 30 mins at 660 nm. 
The result was expressed as mg protein/ g tissue or /ml plasma. 
3.2.7. Comet assay 
3.2.7.1. Preparation of cells for comet assay 
Lymphocyte Isolation 
Immediately after each sacrifice the heparinised blood was suitably diluted in PBS (Ca^ 
and Mg^ free). Lymphocytes were isolated using Histopaque 1077. The isolated cells 
were finally suspended in RPMI 1640. 
Isolation of Liver and Skin cells 
A small lobe of liver was minced thoroughly with a blade and the tissue mass was 
suspended in ice-cold solution of HBSS. After centrifugation cells were suspended in 
RPMI 1640. Same procedure was followed for skin tissues. The viability of cells was 
assessed using trypan blue exclusion test (Pool-Zobel et al., 1993). 
3.2.7.2. Alkaline comet assay: 
Comet assay was performed under alkaline conditions essentially according to the 
procedure of Singh et al., (1988) with slight modifications. Fully frosted microscopic 
slides precoated with 1.0 % normal melting agarose at about 50"C (dissolved in Ca^ and 
Mg ^ free PBS) were used. Around 10,000 cells (isolated from blood, liver and skin) 
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were mixed with 75 |il of 1.0 % Low melting point agarose (LMPA) to form a cell 
suspension and pipetted over the first layer and covered immediately by a cover slip. The 
slides were placed on a flat tray and kept on ice for 10 min to solidify the agarose. The 
cover slips were removed and a third layer of 0.5 % LMPA (75^1) was pipetted and cover 
slips placed over it and allowed to solidify on ice for 5 min. The cover slips were 
removed and the slides were immersed in cold lysing solution containing 2.5 M NaCl, 
100 mM EDTA, 10 mM Tris, pH 10 and 1 % TritonX 100 added just prior to use for a 
minimum of 1 hour at 4^C. After lysis slides were left for 30 min in alkaline 
electrophoretic solution consisting of 300 mM NaOH, 1 mM EDTA, pH >13, to allow 
DNA unwinding and expression of alkali labile sites as DNA breaks. Using a power 
supply (Techno Source India Pvt. Ltd. India) electrophoresis was performed at 4 C in 
field strength of 0.7 volts/cm and 300 mA current. All these steps were performed under 
dim light to avoid additional DNA damage due to stray light. The slides were then 
neutralized with cold neutralization buffer (0.4 M Tris, pH 7.5), stained with 75 \i] EtBr 
(20 fig/ml) and covered with a cover slip. The slides were placed in a humidified 
chamber to prevent drying of the gel and analyzed the same day. 
Slides were scored using an image analysis system (Komet 5.5, Kinetic Imaging. 
Liverpool, U.K) attached to an Olympus (CX4I) fluorescent microscope and a COHU 
4910 (equipped with a 510-560 nm excitation and 590 nm barrier filters) integrated CC 
camera. Comets were scored at lOOx magnification. Images from 50 cells (25 from each 
replicate slide) were analyzed. The parameter taken to assess cellular DNA damage was 
tail length (migration of DNA from the nucleus, nm) and was automatically generated by 
Komet 5.5 image analysis system. 
3.2.9. Chemopreventive studies 
The chemopreventive effect of two antioxidant compounds; melatonin and resveratrol 
was evaluated on DMBA induced carcinogenesis and also their outcome on pre-exposing 
animals to restraint stress. The prophylactic effect of these compounds was evaluated in 
terms of biochemical parameters and extent of prevention of DNA damage by DMBA 
alone or in presence of stress. 
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Swiss albino rats, four to five week old (40 ±5g) were used in the study. The 
experimental animals were acclimatized for one week under standard laboratory 
conditions and given commercial pellet diet (Ashirwad industries, Chandigarh, India) and 
water ad libitum. The backs of the animals were shaved and hairs were removed 
completely with hair depilatory cream (Anne French, India), two days prior to the 
application of DMBA. All experimental protocols adhered to the guidelines of the 
Animal Welfare Committee of the university. 
Animals were divided into seven groups of 10 animals each and following treatment 
schedule was adopted: 
Group 1 untreated control animals (control) 
Group 11 animals painted with 0.5% DMBA solution twice a 
week for 18 weeks (DMBA alone) 
Group 111 Pre-exposure to chronic restraint stress (3hrs/day for 10 
Days) followed by DMBA application as in group II 
(Pre-stress DMBA) 
Group IV Melatonin (200nl in acetone at cone. 0.05 \ig/m\) 
applied daily as well as 30 mins before DMBA (applied 
as in group 111) (Mlt-DMBA) 
Group V Pre-exposure to restraint stress followed by melatonin 
and DMBA treatment as in group IV (pre-stress Mlt-
DMBA 
Group VI Resveratrol (200^1 in acetone at a cone, of 25nM) 
Applied daily as well as 30 mins before DMBA 
(applied as in group 111) (Res-DMBA) 
Group V'll Pre-exposure to restraint stress followed by resveratrol 
and DMBA treatment as in group VI (Pre-stress Res-
DMBA). 
Melatonin was applied no less than 3hrs before switching off the lights. 
Animals were sacriHced after 18 weeks from the start of the experiment; blood, liver and 
skin samples were collected for comet assay. Blood and liver samples were further 
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subjected to biochemical analysis. Fluorescent studies were also done on blood samples 
of animals from all the groups. 
3.2.9.1. Comet assay 
Comet assay was performed under alkaline conditions essentially according to the 
procedure of Singh et al., (1988) as described under section 3.2.7. 
3.2.9.2. Biochemical parameters 
All the biochemical estimations discussed under section 3.2.6 were done accordingly. 
3.2.9.3. Fluorescent studies: 
Fluorescent spectral analyses were done according to the method of Govindasamy et al., 
(1999). Heparinised peripheral blood was centrifuged at 3000 rpm for 5 mins to separate 
plasma. To separate erythrocytes, the pellets were washed thrice with 0.9 % saline at 
3000 rpm. A known amount of erythrocytes were lysed with ice-cold distilled water for 
60 mins at O C^ and after centrifugation at 15,000 rpm for 20 mins, erythrocyte membrane 
was separated as pale yellow pellet. 2 ml of analytical grade acetone was added to the 
known amount of plasma, erythrocyte and erythrocyte membrane from all the groups, 
vortexed and centrifuged at 5000 rpm for 10 mins. The clear supematants were then 
subjected to fluorescent spectral analysis at 400 nm excitation using a spectrofluorometer 
and the emission spectra were scanned from 430 nm to 700 nm. The experiments were 
repealed thrice and data obtained were statistically analyzed. 
3.2.10. Statistical analysis: 
Statistical analysis was done using student's / test to examine statistically significant 
differences. Analysis of variance was performed using one-way ANOVA. P values < 
0.05 were considered statistically significant. 
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Results-I 
Control 
Control animals did not receive any treatment during the experimental period, however, 
they were handled at the same time as other experimental animals and were deprived of 
food and water during the application of restraint stress to the treatment groups. They 
were subjected to the measurement of all biochemical parameters to assess the alteration 
in treated groups after comparison. TBARS levels were measured in liver and plasma of 
rats along with the activities of antioxidant enzymes SOD, CAT, GR and GST. 
Moreover, GSH levels were also measured in liver tissues, besides marker enzymes of 
liver function, ALP, ACP, LDH, GOT and GPT. Circulatory antioxidants vitamin C, 
glucose, uric acid were assessed along with SGOT and SGPT levels. The levels of 
antioxidant and marker enzymes were found higher in the liver tissues than in circulation. 
Effect of chronic restraint stress 
Animals exposed to chronic restraint stress (3 hrs/day for 10 days) experienced altered 
antioxidant status as well as altered levels of other biochemical parameters. Hepatic and 
plasma MDA levels were found to be increased significantly (p<0.05) in stressed animals 
as compared to controls (figs. 5 & 6). Decreased hepatic GSH content was observed in 
these animals (fig. 7) with decreased activity of antioxidant enzymes SOD, CAT, GST 
and GR (table 1) when compared with that of control animals (p<0.05). This was 
accompanied by significantly increased (p<0.05) levels of marker enzymes GOT, GPT 
(fig. 8,9), ALT, AP and LDH in liver tissues (table 2). The alterafions in the circulatory 
antioxidants as well as biochemical markers of stressed animals were comparable with 
that of tissue levels. Significantly decreased (p<0.05) levels of glucose, ascorbic acid, 
uric acid, SOD and GST (table 3) were observed in these animals while the levels of 
SGOT and SGPT were significantly increased (p<0.05) as compared to untreated control 
animals (fig. l O & l l ) . 
Effect of topical application of DMBA 
The effect of topical application of 0.5 % DMBA solution twice weekly for four weeks, 
on hepatic antioxidant enzymes is tabulated in table 1. The activities of antioxidant 
enzymes SOD, CAT, GST and GR were significantly decreased (p<0.05) as compared to 
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controls. Topically applied DMBA decreased the hepatic GSH content (p<0.05) with 
concomitant increase (p<0.05) in lipid peroxidation (fig. 5). Biochemical markers of liver 
function were also found to be altered. Significantly increased levels (p<0.05) of GOT, 
OPT (fig 8, 9), ALP, AP and LDH were observed in the DMBA treated animals as 
compared to untreated controls. 
Similar alterations were found in circulatory parameters of DMBA treated animals as 
shown in table 3. Levels of circulatory antioxidants ascorbic acid, uric acid, glucose as 
well as SOD and GST were found to be decreased significantly (p<0.05) when compared 
with controls. The decreased antioxidant levels were accompanied with significantly 
increased (p<0.05) levels of SGOT and SGPT in these animals, shown in fig 10 and 11. 
Effect of orally administered DMBA 
Oral administration of DMBA once a week for a total of four doses was found to have 
same effect, as did the topical application of DMBA on antioxidant status as well as 
biochemical parameters in experimental animals. However, the oral infusion was found 
to cause more profound effect as compared to that of topical application. The levels of 
hepatic (fig. 5) as well as plasma MDA (fig. 6) were increased and GSH content (fig. 7) 
was decreased significantly (p<0.05) as compared to controls. Hepatic antioxidant 
enzymes SOD, CAT, GST and GR were significantly decreased (p<0.05), so were 
circulatory antioxidants glucose, ascorbic acid, uric acid, SOD and GST as depicted in 
table 1 and 3. Biochemical markers GOT, GPT, ALP, ACP and LDH were increased 
significantly (p<0.05) in liver tissues (fig. 8 & 9, table 3) with increased levels of SGOT 
and SGPT in the circulation (fig. 10 & 11). 
Pre-exposure to restraint stress 
Animals exposed to restraint stress followed by DMBA doses (oral or topical) resulted in 
altered levels of antioxidant enzymes and biochemical parameters which were 
significantly different from controls as well as DMBA alone or stress alone treated 
groups. Hepatic MDA levels were increased significantly (fig. 5) as compared to controls 
(p<0.001) as well as DMBA alone (p<0.05) with concomitant decrease in GSH content 
(fig. 7). Antioxidant enzymes SOD, CAT, GST and GR were decreased significantly in 
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hepatic tissues as compared to DMBA alone, as shown in table 1, while marker enzymes 
GOT, GPT (fig. 8, 9), ALP, ACP and LDH (table 2) were increased significantly 
(P<0.05). 
Plasma antioxidant levels were fiarther decreased in DMBA treated animals on pre-
exposure to restraint stress (table 3) while SGOT and SGPT were increased significantly 
(fig. 10 & 11) as compared to control (p<0.001) and DMBA treated (p<0.05) animals. In 
all the cases increase or decrease of biochemical parameters was prominent in orally 
treated DMBA fi"om topically applied group. 
The induction of DNA damage following exposure to chronic restraint stress and 
increasing number of DMBA doses, alone and in combination was evaluated in 
lymphocytes, liver and skin cells of control and treated animals. The extent of DNA 
damage was measured in terms of migration of DNA fi"om nucleus by various treatments. 
Antioxidant status as well as biochemical markers in liver tissues and in circulation were 
also assessed in these animals under similar conditions. 
DNA damage 
DNA damage by restraint stress: 
A 3hr/day exposure to restraint stress for 10 days did not damage the lymphocyte, skin 
and liver cell DNA to any significant extent as depicted by no significant migration of 
DNA or change in tail length of DNA. Although damage was observed in stressed rats as 
compared to control rats, this damage however, was not significant as shown in fig. 12, 
13, 14, 15 and tables 4 and 5. 
Effect of consecutive topical doses of DMBA on DNA damage: 
Figs. 12 & 13 shows the effect of multiple doses of DMBA on lymphocyte DNA. DMBA 
induced DNA damage in a dose dependent marmer in lymphocytes as the tail length was 
found to increase significantly (p<0.05) after each dose as compared to controls. Similar 
results were observed in liver (fig. 15) and skin cells however, the effect was pronounced 
in skin cells (fig. 14) for being the target organ of the carcinogen application (tables 4 and 
5). 
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Table 1: The hepatic levels of free radical metabolizing enzymes in rats exposed to stress 
alone, DMBA alone (oral/topical) and pre stress-DMBA treatments. 
Groups 
Control 
Stress alone 
DMBA(topical) 
alone 
Pre-stress-
DMBA(topical) 
DMBA (oral) 
alone 
Pre-stress-
DMBA (oral) 
GST 
Units/mg protein 
253.84 
±3.35 
194.12* 
±3.73 
161.50* 
±1.21 
97.97** 
±1.51 
138.53* 
±1.89 
78.054** 
±1.34 
SOD 
Units/mg protein 
141.58 
±2.38 
103.56* 
±2.54 
79.91* 
±1.50 
49.77** 
±0.91 
65.91* 
±0.74 
39.36** 
±0.70 
CAT 
Units/mg protein 
29.89 
±0.46 
23.36* 
±0.82 
19.18* 
±0.54 
9.45** 
±0.53 
15.15* 
±0.43 
8.20** 
±0.16 
GR 
Units/mg protein 
20.09 
±0.37 
14.11* 
±0.32 
8.40* 
±0.26 
4.78** 
±0.34 
5.57* 
±0.27 
3.04** 
±0.29 
Each value represents the mean ±SEM of 10 animals 
* P< 0.05 when compared to control group. 
** P< 0.05 when compared to stress alone and DMBA alone treated groups 
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Table 2: Levels of liver function enzymes ALP, ACP and LDH in stressed, DMBA 
(topical, oral) and pre stress-DMBA treated rats. 
Group 
Control 
Stress Alone 
DMBA Alone 
(Topical) 
Stress +DMBA 
(Topical) 
DMBA Alone 
(Oral) 
Stress +DMBA 
(Oral) 
ALP(mg/ml) 
1.41 
±0.04 
2.21* 
±0.08 
3.20* 
±0.05 
5.12** 
±0.16 
3.65* 
±0.05 
5.96** 
±0.04 
ACP(mg/ml) 
30.30 
±0.72 
43.92* 
±1.49 
51.81* 
±0.08 
70.27** 
±0.08 
56.14* 
±0.61 
79.26** 
±0.46 
LDH 
Units/n\g protein 
144.58 
±0.59 
162.63* 
±L91 
187.84* 
±1.52 
233.76** 
±2.22 
204.07* 
±4.03 
291.20** 
±1.45 
Each value represents the mean ±SEM of 10 animals. 
* P< 0.05 when compared to control group. 
** P< 0.05 when compared to stress alone and DMBA alone treated groups. 
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Table 3: Effect of stress alone, DMBA alone (oral/topical) and pres-tress-DMBA. 
treatments on various circulatory biochemical parameters. 
Group 
Control 
Stress alone 
DMBA 
(topical) alone 
Pre-stress-
DMBA(topical) 
DMBA (oral) 
alone 
Pre-stress-
DMBA(oral) 
Ascorbic 
acid 
(mg/lOOml) 
2.19 
±0.12 
0.96* 
±0.04 
0.89* 
±0.01 
0.48*# 
±0.02 
0.56* 
±0.03 
0.30*# 
±0.01 
Glucose 
(mg/100ml) 
129.22 
±0.90 
102.55* 
±0.50 
95.33* 
±1.22 J 
67.50*# 
±1.88 
75.39* 
±2.29 
50.35*# 
±0.75 
Uric acid 
(mg/lOOmI) 
6.01 
±0.04 
3.73* 
±0.15 
2.76* 
±0.12 
1.04*# 
±0.05 
3.69* 
±0.06 
1.41 *# 
±0.14 
GST 
(Units/mg 
protein) 
0.42 
±0.01 
0.34* 
±0.01 
0.26* 
±0.02 
0.14*# 
±0.01 
0.10* 
±0.01 
0.03*# 
±0.008 
SOD 
(units/mg 
protein) 
3.55 
±0.13 
2.76* 
±0.09 
2.27* 
±0.01 
1.78*# 
±0.12 
1.78* 
±0.23 
0.74*# 
±0.28 
Each value represents the mean ±SEM of 10 animals. 
* P< 0.05 when compared to control group. 
*# P< 0.05 when compared to stress alone and DMBA alone treated groups. 
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Fig. 5. The effect of restraint stress alone, DMBA alone and restraint stress on DMBA 
infusion in terms of hepatic levels of MDA. 
Values are mean ±SEM of 10 animals. 
* P<0.05 when compared to control. 
** P<0.05 when compared to stress alone or DMBA alone treated groups. 
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Fig. 6. The effect of restraint stress and DMBA. alone and in combination on the plasma 
levels of malondialdehyde (MDA). 
Values are mean ±SEM of 10 animals. 
* P<0.05 when compared to control. 
** P<0.05 when compared to stress alone or DMBA alone treated groups. 
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Fig. 7. The hepatic GSH content in stressed, DMBA treated (oral and topical) and 
prestress-DMBA treated rats. 
Values are mean ±SEM of 10 animals. 
* P<0.05 when compared to control. 
** P<0.05 when compared to stress alone or DMBA alone treated groups. 
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Fig. 8. Hepatic levels of GOT in animals treated with restraint stress alone, DMBA alone 
and pre-stress-DMBA both topical and oral. 
Values are mean ±SEM of 10 animals. 
* P<0.05 when compared to control. 
** P<0.05 when compared to stress alone or DMBA alone treated groups. 
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Fig. 9. Levels of GPT in liver tissues of control and various treatment groups of rats. 
Values are mean ±SEM of 10 animals. 
* P<0.05 when compared to control. 
P<0.05 when compared to stress alone or DMBA alone treated groups. • • 
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Fig. 10. Serum levels of GOT in animals treated with restraint stress alone, DMBA alone 
and pre-slress-DMBA (Topical and Oral). 
Values are mean ±SEM oF 10 animals. 
* P<0.05 when compared to control. 
** P<0.05 when compared to stress alone or DMBA alone treated groups. 
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Fig. 11. SGPT levels of animals treated with restraint stress, DMBA and pre-stress-
DMBA (Topical and Oral). 
Values are mean ±SEM of 10 animals. 
* P<0.05 when compared to control. 
** P<0.05 when compared to stress alone or DMBA alone treated groups. 
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Effect of restraint stress on DMBA induced DNA damage: 
Prior exposure of rats to restraint stress enhanced the DNA damaging potential of DMBA 
significantly as compared to control (p<0.001) or DMBA alone (p<0.05) groups in 
lymphocytes (fig. 12), liver (table 4) as well as in skin cells (table 5). A significant 
increase in the tail length was observed in the skin cell DNA pre-exposed to stress after 
the fourth application of DMBA as compared to stress alone or DMBA alone treatments. 
Moreover, the extent of DNA migration and thus DNA degradation was more 
pronounced in the skin cells as compared to liver or lymphocytes as depicted by Comets 
(100x)(Figs. 13, 14 & 15) 
Biochemical parameters 
TBARS levels as a measure of oxidative stress in plasma and liver 
Levels of TBARS (lipid peroxides) in stressed animals were increased (p<0.05) as 
compared to controls. Consecutive doses of DMBA increased the levels in a dose 
dependent manner and were higher as compared to stress alone or control groups. 
However highest levels of TBARS in both liver and plasma were found in animals 
exposed to restraint stress prior to DMBA infusion, as compared to all other groups (fig. 
16,17). 
Effect on antioxidant enzymes 
Antioxidant enzyme activities in liver tissues of treated and control groups are shown in 
table 6 and 7. Activities of SOD, CAT, GST and GR were significantly decreased 
(p<0.05) in animals after exposure to chronic restraint stress and increasing number of 
DMBA dose, as compared to controls. Consecutive DMBA doses were found to decrease 
their levels in a dose dependent manner. The lowest levels of these antioxidant enzymes 
were found in animals exposed to restraint stress followed by multiple DMBA doses as 
compared to control (p<0.00!) and stress alone or DMBA alone groups (p<0.05). Similar 
pattern was observed in circulating levels of/>? vivo antioxidants of experimental animals 
(table 7,8). The levels of ascorbic acid, uric acid, glucose, SOD and GST were decreased 
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significantly (p<0.05) in stressed and DMBA treated animals, while exposure to restraint 
stress prior to DMBA infusion decreased the levels further (p<O.OOI) compared to control 
animals. Hepatic GSH levels were increased significantly (p<0.05) in stressed animals 
and in dose dependent manner after each DMBA dose with the levels highest (p<0.001) 
in pre-stress DMBA group as compared to control group (Fig. 18) 
Effect on biochemical markers 
The levels of various marker enzymes of liver function GOT, GPT (figs, 19, 20) ALP, 
ACP and LDH (table 6) were significantly increased (p<0.05) in liver tissues of stressed 
as well as DMBA alone treated animals when compared to control group. The levels 
were further increased significantly (p<0.001) in DMBA treated animals pre-exposed to 
chronic restraint stress, as compared to other groups. The increase in the biochemical 
markers/parameters was found to be dose dependent in DMBA alone and pre-stress-
DMBA treated group from first to four applications. SGOT and SGPT levels were also 
altered as observed in liver tissues, however, the levels were too high in liver tissues than 
in circulation as shown in figs. 21 and 22. 
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Fig. 12. DNA damaging effect of stress and 0.5% DMBA solution in sesame oil (multiple 
applications) both alone and after stress exposure on the peripheral lymphocytes 
of rats. 
Values reported are mean ± S.E.M of five animals in each group. 
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Table 4. Effect of consecutive DMBA doses, alone and on pre-exposure to chronic 
restraint stress on DNA damage in skin ceils of rats. 
Groups 
Untreated Control 
Stress Alone 
DMBA alone 
Pre-stress DMBA 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Comet Tail Length (urn) 
1.40 ±0.01 
1.90 ±0.02 
10.00 ±0.03* 
19.00± 1.12* 
28.00 ± 1.24* 
37.10±2.2I* 
15.00 ±1.15*, # 
27.00 ± 1.19*, # 
39.00 ± 2.26*, # 
44.00 ±2.61*, U 
Data represents mean ± SEM of 5 animals in each group. 
* P value < 0.05 and significant when compared to untreated control. 
# P value < 0.01 when compared to DMBA alone group. 
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Fig. 13. Single cell gel electrophoresis of rat lymphocytes showing Comets (lOOx) after 
treatment with 
(A) Four consecutive doses of 0.5% DMBA solution in sesame oil (a to d-first dose to 
4'*' dose). 
(B) Chronic restraint stress (3hrs/day for 10 days) followed by consecutive DMBA 
doses (a' to d' - first dose to fourth dose of 0.5 % DMBA with prior exposure to 
stress). 
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Fig. 14. Single cell gel electrophoresis of rat skin cells showing Comets (lOOx) after 
treatment with 
(A) Four consecutive doses of 0.5% DMBA solution in sesame oil (a to d-first dose to 
4* dose). 
(B) Chronic restraint stress (Shrs/day for 10 days) followed by consecutive DMBA 
doses (a' to d' - first dose to fourth dose of 0.5 % DMBA with prior exposure to 
stress). 
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Table 5. Effect of consecutive DMBA doses, alone and on pre-exposure to chronic 
restraint stress on DNA damage in liver cells of rats. 
Groups 
Untreated Control 
Stress Alone 
DMBA alone 
Pre-stress DMBA 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Dose I 
Dose 2 
Dose 3 
Dose 4 
Comet Tail Length (|am) 
1.00 ±0.01 
1.20 ±0.04 
7.00 ± 1.03* 
16.00±2.1* 
26.30 ±2.2* 
35.10±2.9* 
12.00 ±1.18*, # 
24.70±2.33*,# 
35.50 ±2.9*,# 
42.00 ± 1.86*, # 
Data represents mean ± SEM of 5 animals in each group. 
* P value < 0.05 and significant when compared to untreated control. 
# P value < 0.01 when compared to DMBA alone group. 
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Fig.15. Single cell gel electrophoresis of rat liver cells showing Comets (lOOx) after 
treatment with 
(A) Four consecutive doses of 0.5% DMBA solution in sesame oil (a to d-first dose to 
4^ ^ dose). 
(B) Chronic restraint stress (3hrs/day for 10 days) followed by consecutive DMBA 
doses (a' to d' - first dose to fourth dose of 0.5 % DMBA with prior exposure to 
stress). 
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Fig. l6. Effect of restraint stress, multiple doses of DMBA alone, and pre-stress DMBA 
treatment on TBARS levels in the plasma of rats. 
Data are reported as mean ± S.E.M for 5 rats in each group. 
P<0.05 are statistically significant. 
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Fig. 17. Formation of MDA in the liver tissues of stress, multiple DMBA doses alone and 
Pre-stress-DMBA treated rats as compared to untreated controls. 
Data are reported as mean ± S.E.M for 5 rats in each group. 
P<0.05 are statistically significant. 
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Fig. 18. Hepatic GSH content of animals after treatment with chronic restraint stress, 
multiple DMBA doses and stress followed by multiple DMBA doses. 
Data are reported as mean ± S.E.M for 5 rats in each group. 
P<0.05 are statistically significant. 
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Fig. 19. GOT levels in liver tissues cfanimals after treatment with stress alone and 
DMBA multiple doses alone and in combination. 
Data are reported as mean ± S.E.M for 5 rats in each group. 
P<0.05 are statistically signillcant. 
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Fig. 20. GPT levels in liver tissues o f animals after treatment with stress alone and 
DMBA multiple doses alone and in combination. 
Data are reported as mean ± S.E.M for 5 rats in each group. 
P<0.05 are statistically significant. 
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Fig. 21. SCOT levels in control, stress. DMBA and prestress-DMBA treated animals. 
Data are reported as mean ± S.E.M for 5 rats in each group. 
P<0.05 are statistically significant. 
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Fig. 22. SGPT levels in control, stress. DMBA and prestress-DMBA treated animals. 
Data are reported as mean ± S.li.M for 5 rats in each group. 
P<0.05 are statistically significant. V Aza,. i , .^; 
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Table 6. Hepatic antioxidant enzyme activities in rats after treatment with stress and 
DMBA and pre-stress DMBA. 
Groups 
Untreated Control 
Stress Alone 
DMBA alone 
Pre-stress DMBA 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Dose 1 
Dose 2 
Dose 3 
I^ose 4 
SOD 
(units/mg protein) 
160.22 ±1.21 
132.40±1.41* 
107.53 ±0.91* 
95.21 ±2.10* 
80.12±1.81* 
67.32 ±2.31* 
92.32 ±1.5*# 
75.40 ±2.30*# 
60.11 ±0.82*# 
42.22 ±1.42*# 
CAT 
(units/mg protein) 
42.31 ±2.30 
30.21 ±1.70* 
23.41 ±1.82* 
18.22 ±0.91* 
13.41 ±0.86* 
9.51 ±0.75* 
I9.30±1.32*# 
14.12±1.12*# 
9.02±1.21*# 
7.40±2.10*# 
Data represents mean ± SEM of 5 animals in each group. 
P value < 0.05 and significant when compared to untreated control. 
# P value < 0.01 when compared to DMBA alone group. 
78 
Results-I 
Table 7. Levels of GST and GR in liver tissues of control, stress alone. DMBA alone 
and stress and DMBA (various doses) treated animals. 
Groups 
Untreated Control 
Stress Alone 
DMBA alone 
Pre-stress DMBA 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
GST 
(units/mg protein) 
270.33 ±2.12 
226.42 ±1.32* 
198.52 ±1.63* 
165.24 ±2.32* 
132.42 ±1.83* 
110.12±1.40* 
167.42 ±2.23*# 
140.52 ±2.32*# 
115.61 ±1.60*# 
80.32 ±1.70*# 
GR 
(units/mg protein) 
31.32 ±0.90 
20.10 ±0.61* 
14.22 ±0.44* 
10.13 ±0.51* 
8.22 ±0.21* 
5.60 ±0.02* 
11.I0±0.33*# 
8.32±0.53*# 
5.40±0.34*# 
3.10±0.04*# 
Data represents mean ± SEM of 5 animals in each group. 
P value < 0.05 and significant when compared to untreated control. 
# P value < 0.01 when compared to DMBA alone group. 
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Table 8. Marker enzymes of liver function after treatment with stress, DMBA and pre-
stress DMBA (various doses). 
Groups 
Untreated Control 
Stress Alone 
DMBA alone 
Pre-stress DMBA 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
ALP 
(mg/ml) 
2.51 ±0.07 
3.62 ±0.06* 
5.82 ±0.11* 
6.92 ±0.12* 
8.33±0.16* 
9.82 ±0.21* 
7.01 ±0.17*# 
8.25 ±0.21*# 
9.73±0.14*# 
i2.44±0.17*# 
AP 
(mg/ml) 
42.41 ±1.20 
54.32 ±1.30* 
67.20±1.12* 
79.43 ±1.42* 
91.3 4±1.73* 
102.22 ±2.13* 
80.02 ±2.00*# 
92.33±1.82*# 
108.43 ±2.33*# 
120.14±2.24*# 
LDH 
(Units/mg 
protein) 
150.62 ±1.32 
180.22 ±1.63* 
213.43 ±1.74* 
235.3 0±2.13* 
261.72 ±1.82* 
290.54 ±2.14* 
227.32 ±2.01 *# 
259.10±2.44*# 
285.35 ±2.14*# 
310.45 ±2.63*# 
Data represents mean ± SEM of 5 animals in each group. 
P value < 0.05 and significant when compared to untreated control. 
# P value < 0.01 when compared to DMBA alone group. 
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Table 9. Free radical scavenging enzymes in circulation after treatment with stress and 
DMBA alone and in combination (various doses). 
Groups 
Untreated Control 
Stress Alone 
DMBA alone 
Pre-stress DMBA 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
SOD 
(units/mg protein) 
5.42 ±0.02 
4.06 ±0.03* 
3.40 ±0.01* 
2.52 ±0.02* 
1.81 ±0.03* 
1.03 ±0.01* 
2.71 ±0.02*# 
1.83 ±0.01*# 
0.94 ±0.02*# 
0.62 ±0.01 *# 
GST 
(units/mg protein) 
2.01 ±0.01 
1.52 ±0.002* 
1.12 ±0.03* 
0.97 ±0.02* 
0.80 ±0.004* 
0.55 ±0.02* 
0.91 ±0.01*# 
0.71 ±0.005*# 
0.51 ±0.003*# 
0.23 ±0.002*# 
Data represents mean ± SEM of 5 animals in each group. 
P value < 0.05 and significant when compared to untreated control. 
# P value < 0.01 when compared to DMBA alone group. 
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Table 10. Circulatory levels of antioxidants in animals after treatment with stress and 
DMBA and pre-stress DMBA(various doses). 
Groups 
Untreated Control 
Stress Alone 
DMBA alone 
Pre-stress DMBA 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Ascorbic Acid 
(mg/100 ml) 
3.52 ±0.21 
2.34 ±0.43* 
1.65 ±0.14* 
1.22 ±0.12* 
0.82 ±0.14* 
0.52 ±0.06* 
1.14±0.07*# 
0.75 ±0.01*# 
0.51 ±0.002*# 
0.25 ±0.001*# 
Uric Acid 
(mg/100 ml) 
8.31 ±0.24 
6.06 ±0.52* 
4.51 ±0.14* 
3.32 ±0.13* 
2.24 ±0.11* 
1.43 ±0.10* 
3.12±0.06*# 
2.01 ±0.05*# 
1.5 ±0.06*# 
0.73 ±0.04*# 
Glucose 
(mg/100 ml) 
140.12±1.20 
112.30 ±0.82* 
98.32 ±0.91* 
83.53 ±0.82* 
72.11 ±0.78* 
59.40 ±0.45* 
85.23 ±0.76*# 
70.60 ±0.64*# 
61.32±0.54*# 
48.22 ±0.23*# 
Data represents mean ± SEM of 5 animals in each group. 
P value < 0.05 and significant when compared to untreated control. 
# P value < 0.01 when compared to DMBA alone group. 
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Comet Assay: 
A statistically significant increase in DNA damage was observed in lymphocytes, liver 
and skin cells of animals treated with DMBA, in terms of increased tail length, in 
comparison to controls as shown in table II. Pre-stress DMBA group showed further 
significant (p<O.OOI) increase in tail length that was found to be highest as compared to 
all other groups. In animals treated with melatonin along with DMBA, tail length though 
significantly (p<0.05) increased as compared to control group, but was reduced 
significantly (p<0.01) as compared to DMBA alone treated animals thus showing 
protective effect of melatonin against DNA damage induced by DMBA. However, in 
animals exposed to restraint stress followed by DMBA-Melatonin treatment, the tail 
length was again significantly increased (p<0.01) as compared to DMBA-melatonin 
treated group while insignificantly different from DMBA alone treated group. Like 
melatonin, resveratrol treatment decreased the DMBA induced DNA damage 
significantly but prior exposure to restraint stress inhibited the DNA damage preventive 
potential of resveratrol. 
A comparison of tail lengths of the three types of cells studied revealed that skin cells 
exhibited highest level of DNA damage either on DMBA alone or pre-stress DMBA 
treatment (fig. 23). 
Fluorescent Spectroscopy: 
The fluorescent spectra of control and experimental group of animals are shown in 
Figs.24-29 and the emission characteristics are given in table 12. 
Plasma: At 400 nm excitation, the plasma of control animals showed a prominent 
maxima at 430 nm which decreased at longer wavelengths as shown in Fig 23. In 
experimental groups, plasma of DMBA treated animals, in addition to a peak at 430 nm, 
showed a secondary peak at 630 nm and PI 530nm/630nm was significantly reduced. The 
intensity of secondary peak was increased in pre-stress DMBA group and Fl 
530nm/630nm decreased further as compared to control and DMBA alone group. In 
DMBA-melatonin treated group the secondary peak was significantly reduced and Fl was 
found to be nearly approaching the control values. However, in animals exposed to 
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restraint stress prior to DMBA-Melatonin treatment intensity of secondary peak as well 
as Fl 530nm/630nm increased again and was insignificantly different from DMBA alone 
treated group. 
Resveratroi treatment was found to have same effect on fluorescent spectra of plasma as 
melatonin (fig 27) and exposure to restraint stress prior to resveratroi treatment resulted 
in an insignificantly different spectra from DMBA alone group. 
Erythrocytes: The fluorescent spectra of erythrocyte samples of control and 
experimental animals are comparable to those of plasma as shown in figs 25 & 28. The 
intensity of fluorescence (Fl 530nm/630nm) of these samples however, was more as 
compared to plasma as shown in table 12. 
Erythrocyte membrane: As shown in fig 26 & 29 the erythrocyte membranes of both 
control and treated groups showed a maximum intensity of fluorescence at 440nm and a 
second peak at 630nm while the treated groups also showed a secondary peak at 540nm. 
Fl was found to be increased in treated groups as compared to controls unlike plasma and 
erythrocytes where it was found to be reduced. The increase was maximum in pre-stress 
DMBA group when compared to all other groups. Fl of DMBA-melatonin/DMBA-
Resveratrol treated group was found to be increased insignificantly as compared to 
controls showing protective efTect which was reduced on pretreatment to restraint stress 
as is evident from the significantly increased Fl as compared to control, however 
insignificantly different to that of DMEiA alone group. 
Biochemical parameters 
Both melatonin and resveratroi were found to have protective efTect against DMBA 
induced alterations of various antioxidant enzymes or biochemical markers in liver 
tissues as well as in circulation. A significant decrease (p<0.05) in the activities of SOD, 
CAT, GST and GR was observed in DMBA or Prestress- DMBA treated animals as 
depicted in table 13. Melatonin or resveratroi treatment along with DMBA however, 
resulted in insignificant decrease in these antioxidant enzymes, while pre-exposure to 
restraint stress was found to abolish the protective effect of melatonin and resveratroi as 
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observed by significant decrease (p<0.05) of these antioxidant enzymes as compared to 
control group. Circulatory levels o f in vivo antioxidants showed pattern similar to that of 
hepatic antioxidants as shown in tables 15 & 16. Levels of various biochemical markers 
of liver function and in circulation were increased significantly (p<0.05) in DMBA and 
pre-stress DMBA treated animals, as compared to controls. The increase in their levels 
was reduced significantly when animals were supplemented either with melatonin or 
resveratrol. However on pre-exposure to restraint stress their levels were increased again 
significantly (p<0.05) as compared to control and DMBA-melatonin or DMBA 
resveratrol group and comparable to that of DMBA alone group as shown in tables 14 & 
15 and figs. 33-36. Similar effect was observed on TBARS levels in liver and circulation 
o f control and treated animals as shown in figs 30 & 31 accompanied with decrease in 
hepatic GSH content (f ig. 32). 
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Table 11. 
DNA damaging effect of DMBA alone and pre-stress DMBA and effect of melatonin or 
resveratrol treatment on DMBA induced damage measured in terms of tail length. 
Groups 
(10 rats/ group) 
Untreated Control 
DMBA alone 
Prestress-DMBA 
DMBA-MIt 
Prestress-DMBA 
Mlt 
DMBA-Res 
Prestress-DMBA 
Res 
Liver 
2.5 
±0.07 
45.1* 
±0.12 
75.7** 
±0.54 
10.2* 
±0.08 
39.3** 
±0.22 
15.4* 
±0.14 
41.2** 
±0.3 
Tail Length (nm) 
Skin 
2.1 
±0.07 
37.2* 
±0.16 
67.2** 
±0.32 
12.41* 
±0.11 
30.1** 
±0.32 
13.2* 
±0.06 
±0.11 
Lymphocytes 
2.3 
±0.06 
30.24* 
±0.1 
50.4** 
±0.2 
11.6* 
±0.05 
23.4** 
±0.1 
12.21* 
±0.04 
25.5** 
±0.12 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMFiA alone group. 
**p<0.05,significant when compared to DMBA-MIt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Fig.23. Single cell gel electrophoresis of rat skin cells showing Comets (I OOx). 
(a). Untreated control 
(b). DMBA alone 
(c). Pre-stress DMBA 
(d). DMBA-melatonin 
(e). Pre-stress DMBA-melatonin 
(0- DMBA-resveratrol 
(g). Pre-stress DMBA resveratrol 
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Fig. 24. Emission spectra of plasma of DMBA and pre-stress DMBA alone or along with 
melatonin treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 10 animals in each group. 
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Fig. 25. Emission spectra of erythrocyte membrane of DMBA and pre-stress DMBA 
alone or along with melatonin treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 10 animals in each group. 
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Fig. 26. Emission spectra of erythrocytes of DMBA and pre-stress DMBA alone or along 
with melatonin treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 10 animals in each group. 
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fig. 27. Emission spectra of plasma of DMBA and pre-stress DMBA alone 
or along with resveratrol treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 10 animals in each group. 
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Fig. 28. Emission spectra of erythrocytes of DMBA and pre-stress DMBA alone 
or along with resveratrol treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 10 animals in each group. 
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Fig. 29. Emission spectra of erythrocyte membrane of DMBA and pre-stress DMBA 
alone or along with resveratrol treated animals on excitation at 400nm. 
Data represents mean ± S.E.M. of 10 animals in each group. 
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Table 12. Emission characteristics of Plasma, erythrocyte and erythrocyte membrane of 
control and experimental groups of rats during fluorescent spectral analysis 
excited at 400nm. 
Groups 
Untreated Control 
DMBA alone 
Prestress-DMBA 
DMBA-Melatonin 
Prestress DMBA-
Melatonin 
DMBA-Resveratrol 
Prestress DMBA-
Resveratrol 
(Fl 530/630) 
Plasma 
2.02 ±0.14 
0.70 ±0.07* 
0.51 ±0.03*# 
1.76±0.04# 
0.92 ±0.012** 
1.8±0.06# 
0.96 ±0.01 ## 
(Fl 530/630) 
Erythrocyte 
2.61 ±0.21 
0.24 ±0.06* 
0.19±0.07*# 
1.75 ±0.12# 
0.5 ±0.05** 
1.92 ±0.10# 
0.7 ± 0.07## 
(Fl 530/630) 
Erythrocyte 
Membrane 
1.20 ±0.16 
1.51 ±0,008* 
1.82±0.05*# 
1.30±0.10# 
1.42 ±0.03** 
1.25 ±0.11# 
1.45 ±0.04## 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-Mlt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Fig. 30. Hepatic levels of MDA in animals treated with DMBA, pre-stress DMBA alone 
and along with either melatonin or resveratrol. 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-Mlt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Fig. 31 . Plasma MDA levels in animals after treatment with DMBA, DMBA-melatonin, 
and DMBA-resveratrol alone and on pre-exposure to restraint stress. 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-MIt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Fig. 32. Hepatic GSH content in animals after treatment with DMBA, DMBA-melatonin, 
DMBA-resveratrol alone and on pre-exposure to restraint stress. 
Data represents mean ± S.E.M. o f 10 animals in each group. 
*p<0.01, significant as compared to control. 
#p<0.05, significant as compared to DMBA alone group. 
**p<0.05. significant as compared to DMBA-Melatonin (MIt) group. 
##p<0.05, significant as compared to DMBA-Resveratrol (Res) group 
97 
Results-II 
700 
Control 
VP777J\ DMBA alone 
g^^^^ Prestress-DMBA 
DMBA-Mit 
3 Prestress-DMBA MIt 
rmirn DMBA-RCS 
ffffffH Prestress-DMBA Res 
3 4 5 
Treatment groups 
Fig. 33. Effect of melatonin and resveratrol treatment on SCOT levels in DMBA and 
pre-stress DMBA treated rats. 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<O.OI, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-MIt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Fig. 34. EtTect of melatonin and resveratrol treatment on SGPT levels in DMBA and 
pre-stress DMBA treated rats. 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<O.OI, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-MIt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Fig. 35. EfFect of melatonin and resveratrol treatment on hepatic GOT levels in DMIiA 
and pre-stress DMBA treated rats. 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-MIt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Fig. 36. EfTect of melatonin and resveratrol treatment on hepatic GPT levels in DMBA 
and pre-stress DMBA treated rats. 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<O.Oi, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-MIt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Table. 13. Levels of free radical metabolizing enzymes in liver after treatment with 
melatonin and resveratrol in DMBA and pre-stress DMBA treated 
animals. 
Groups 
Untreated Control 
DMBA alone 
Pre-stress-DMBA 
DMBA-MIt 
Pre-stress-DMBA 
MIt 
DMBA-Res 
Pre-stress-DMBA 
Res 
SOD(units/mg 
protein) 
150.25 
±1.22 
70.32* 
±1.12 
40.45*# 
±0.81 
130.34# 
±2.11 
85.21** 
±1.80 
123.34# 
±1.65 
92.01 ## 
±1.11 
CAT(units/mg 
protein 
40.21 
±0.82 
15.35* 
±0.21 
9.24*# 
±0.13 
32.43# 
±0.76 
25.21** 
±0.52 
30.16# 
±0.45 
22.31## 
±0.56 
GST(units/mg 
protein) 
250.61 
±1.35 
140.24* 
±1.22 
85.21 *# 
±0.87 
220.31 # 
±1.75 
168.13** 
±1.62 
213.72# 
±0.96 
] 74.23## 
±0.87 
GR(units/mg 
protein) 
30.21 
±0.74 
9.34* 
±0.10 
4.26*# 
±0.07 
25.22# 
±0.87 
16.61** 
±0.54 
22.]6# 
±0.24 
15.24## 
±0.16 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-Mlt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Table 14. Levels of liver function enzymes in DMBA and pre-stress DMBA treated 
animals after treatment with melatonin or resveratrol. 
Groups 
Untreated Control 
DMBA alone 
Prestress-DMBA 
DMBA-MIt 
Pre-stress-DMBA 
MIt 
DMBA-Res 
Pre-stress-DMBA 
Res 
ALP (mg/ml) 
3.0 
±0.06 
12.21* 
±0.10 
I7.32*# 
±0.74 
5.23# 
±0.07 
10.31** 
±0.56 
6.01# 
±0.42 
I0.51## 
±0.52 
ACP (mg/ml) 
45.2 
±0.31 
93.70* 
±1.20 
120.21*# 
±1.42 
60.41# 
±0.65 
75.20** 
±0.73 
58.40# 
±0.64 
80.23## 
±1.00 
LDH (mg/ml) 
140.25 
±1.2 
275.60* 
±1.45 
342.32*# 
±1.65 
163.4# 
±1.10 
201.42** 
±1.21 
170.22# 
±1.05 
210.31## 
±1.12 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<O.OI, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-MIt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Table 15. Circulatory antioxidants after melatonin and resveratrol treatment in DMBA 
and pre-stress treated animals. 
Groups 
Untreated Control 
DMBA alone 
Pre-stress-DMBA 
DMBA-Mlt 
Pre-stress-DMBA 
Mlt 
DMBA-Res 
Pre-stress-DMBA 
Res 
Ascorbic acid 
(mg/100ml) 
4.02 
±0.086 
1.50* 
±0.10 
0.42*# 
±0.04 
3.21# 
±0.06 
2.56** 
±0.12 
3.11# 
±0.14 
2.32## 
±0.12 
Uric acid 
(mg/100ml) 
9.20 
±0.21 
3.51* 
±0.23 
1.24*# 
±0.08 
7.52# 
±0.16 
5.21** 
±0.11 
7.I2# 
±0.21 
5.01## 
±0.14 
Glucose 
(mg/lOOml) 
145.42 
±0.45 
60.42* 
±0.21 
45.31*# 
±0.17 
126.32# 
±0.51 
95.20** 
±0.31 
121.02# 
±0.47 
90.41## 
±0.32 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05, significant when compared to DMBA-Mlt group. 
##p<0.05, significant when compared to DMBA-Res group 
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Table 16. Activities of SOD and GST in circulation after treatment with melatonin and 
resveratrol in DMBA alone and prestress DMBA treated animals. 
Groups 
Untreated Control 
DMBA alone 
Prestress-DMBA 
DMBA-Mlt 
Prestress-DMBA Mlt 
DMBA-Res 
Prestress-DMBA Res 
SOD (units/mg protein) 
5.21 
±0.06 
1.52* 
±0.02 
0.50*# 
±0.01 
4.05# 
±0.03 
2.80** 
±0.02 
3.95# 
±0.03 
2.52## 
±0.02 
GST (units/mg protein) 
2.53 
±0.03 
1.08* 
±0.02 
0.32*# 
±0.01 
1.82# 
±0.01 
1.25** 
±0.01 
1.76# 
±0.01 
1.31## 
0.02 
Data represents mean ± S.E.M. of 10 animals in each group. 
*p<0.01, significant when compared to control. 
#p<0.05, significant when compared to DMBA alone group. 
**p<0.05,significant when compared to DMBA-Mlt group. 
##p<0.05, significant when compared to DMBA-Res group. 
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Discussion-I 
The present study indicates that the complete carcinogen 7,12-dimethylbenz(a)anthracene 
(DMBA) induces in vivo oxidative stress when administered either orally or topically and 
pre-exposure to restraint stress further enhances its pro-oxidant effect. Restraint stress 
itself is able to induce prooxidant state in animals, though to a lesser extent as compared 
to DMBA. Both DMBA and restraint stress cause oxidative stress by decreasing the 
activities of free radical scavenging enzymes with increased levels of MDA and marker 
enzymes in liver as well as in circulation. Further, a dose dependent increase in DNA 
damage and oxidative stress by DMBA has been observed. Restraint stress was again 
shown to increase the DMBA induced oxidative stress as well as DNA damage after each 
dose, though it did not induce any significant DNA damage by itself. 
It has been shown that exposure to stressful situations can stimulate numerous pathways 
leading to increased production of free radicals. It is well known that free radicals 
generate a cascade, producing lipid peroxidation, protein oxidation, DNA damage and 
cell death and contribute to the occurrence of pathological conditions (Liu et al., 1996; 
Olivenza et al., 2000). Stress may also impair antioxidant defenses, leading to oxidative 
damage, by changing the balance between oxidant and antioxidant factors (Liu et al., 
1994; Sosnovsky & Kozlov, 1992). The involvement of oxidative stress in cancer 
induction and its subsequent development, and associated molecular mechanisms is 
becoming increasingly clear (Ames et al., 1995; Lahiri et al., 1999). The effect of stress 
on cancer development is controversial and is found to vary depending on the etiology of 
cancer. Stress per se enhances cancer of viral origin while it is found to inhibit 
carcinogenesis induced by chemicals (Justice, 1985). Recent studies from our lab have 
shown that restraint stress resulted in the generation of oxidative stress by decreasing the 
GSH content and the activities of SOD, CAT, and GST in the liver and other tissues of 
rats (Kashif et al., 2005). Similar to the earlier findings the present study also confirms 
the depletion of GSH content with the concomitant increase in TBARS levels (depicted 
by enhanced levels of MDA) by chronic restraint stress treatment. The activities of 
antioxidant enzymes SOD, CAT, GR and GST in liver and glucose, uric acid, ascorbic 
acid and SOD in circulation were decreased significantly. This may be due to the fact that 
OH" radical is indeed generated during the course of stress from endogenous O2 and H2O2 
through the metal catalysed Haber-Weiss reaction, and it plays a direct role in stress 
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induced oxidative damage (Das et al., 1997). Increased lipid peroxidation accompanied 
with compromised host antioxidant status may result in accumulation of free radicals and 
as a consequence the levels of marker enzymes, GOT, GPT, LDH, ALP and ACP in liver 
and SCOT and SGPT in circulation were increased significantly as compared to control. 
Oxidative stress has been reported to be closely associated with initiation and promotion 
stages of carcinogenesis (Jang & Pezzuto, 1998; Klaunig &. Kamendulis, 2004). Many 
carcinogens have been shown to act through the generation of ROS (Blumberg, 1981; 
Cerruti, 1985). The generation of ROS and its subsequent accumulation induces oxidative 
stress at cellular level (Waris & Ahsan, 2006). DMBA, an indirect carcinogen, requires 
metabolic activation to become a carcinogen. During the course of its metabolism, 
DMBA is converted to the ultimate carcinogen, dihydrodioi epoxide, accompanied with 
the generation of toxic ROS (Guerin, 1978). These ROS formed during DMBA 
metabolism can diffuse from the site of generation to other targets and produce 
deleterious effects by initiating lipid peroxidation directly or by acting as second 
messengers for the primary free radicals that initiate lipid peroxidation (Das, 2002). Thus 
enhanced hepatic and plasma lipid peroxidation in DMBA treated animals may be 
attributed to excessive generation of ROS exacerbated by decreased efficiency of host 
antioxidant defense mechanisms that include the antioxidant enzymes. Antioxidants are 
the free radical scavengers and it is reasonable to speculate that abnormality of 
antioxidant enzymes must occur during carcinogenesis. This turned out to be the case. 
When compared to their appropriate normal cell counterparts, tumor cells have abnormal 
activities of antioxidant enzymes. It has been found that tumor cells are nearly low in 
MnSOD activity, usually low in CuZnSOD activity, and almost always low in catalase 
activity. GPx and GR activities are highly variable (Oberley & Oberley, 1986; Oberley & 
Buettner, 1979; Sun, 1990). It was found that SOD, CAT and GR activities were, in 
general, low in the tumors as compared to corresponding normal tissues (Tisdale et al., 
1983). In the present study too DMBA administration caused decreased activities of 
SOD, CAT, GST and GR in liver tissues of animals resulting in compromised host 
antioxidant status. 
The extracellular fluids of animals, such as blood plasma, tissue fluid, CSF etc. contain 
little or no catalase activity and only low activities of SOD. There is also very little 
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reduced glutathione (GSH) in most extracellular fluids-about 20nM in the plasma of rats 
(Haliiwel & Gutteridge, 1990). Therefore, the major antioxidants found in blood plasma 
are ascorbic acid, uric acid and glucose in addition to transferrin and albumin, DMBA 
treatment in the present resulted in decreased levels of serum antioxidants ascorbic acid, 
glucose, uric acid and SOD. Ascorbic acid has multiple antioxidant properties, including 
an ability to regenerate a-tocopherol by reducing a-tocopheryl radicals at the surface of 
membranes. Uric acid can act as antioxidant both by binding iron and copper ions in 
forms that do not accelerate free radical reactions, and also by directly scavenging 
oxidizing species such as singlet O2, HOCl and peroxyl radicals (Davies et.al., 1986). It 
therefore inhibits lipid peroxidation. Glucose also acts as a scavenger of hydroxyl 
radicals with rate constant comparable to that of mannitol (Haliiwel &. Gutteridge, 1990). 
Thus, decreased levels of these antioxidants may result in increased radical generation 
and lipid peroxidation. 
The liver, which is rich in GSH, supplies it to various extrahepatic tissues via a distinct 
GSH transport system. GSH maintains the integrity of the liver when the organ is 
challenged by a wide variety of xenobiotics, ROS and toxic compounds. GSH in 
conjunction with GST detoxifies reactive intermediate species generated during DMBA 
metabolism, thereby enhancing resistance against oxidative stress (Locigno & 
Castronovo, 2001). Thus depletion of GSH in the liver after DMBA treatment may shift 
the redox status towards oxidative stress. Low activities of antioxidant enzymes and other 
free radical scavengers, with low GSH content may cause the accumulation of free 
radicals, which can result in damage to DNA, RNA, lipids and proteins, and perhaps 
finally lead to cancer. 
Liver enzymes such as LDH, GOT, GPT, ACP, and ALP are considered to be the 
biochemical markers for assessing liver function. Increased permeability of cells 
probably due to increased membrane lipid peroxidation may lead to necrosis usually 
characterized by rise in these marker enzymes (Athar, 2004) as seen in DMBA treated 
groups compared to control group. Due to increased cell permeability these enzymes are 
also released into circulation thus altering their normal levels in serum too. Thus 
increased levels of SGOT and SGPT were also observed following DMBA treatment. 
Five to ten fold elevations of these two enzymes are reported in patients with primary or 
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metastatic carcinoma of liver, with GOT usually being higher than GPT (Ellis et ai., 
1978). Serum levels of both GOT and GPT are also elevated, as observed in our study, 
depicting an affect on liver cell integrity 
A high correlation has been found to occur between the dose of administered DMBA and 
the levels of total DNA adducts in liver and target organ epithelial cells (Izzotti et al., 
1999). Similarly in the present study the difference in the levels of biochemical markers 
and antioxidants in oral and topical treatment of DMBA may be due to this dose-effect 
relationship. In case of oral treatment the amount of DMBA reaching to liver tissue is 
always higher than through topical treatment because topical application leaves less 
amount of carcinogen on the skin as compared to oral treatment where easy absorption of 
the carcinogen through gut results in more pronounced effects. However in long term 
experiments the results may be different because of the continuous topical application of 
the carcinogen throughout the experimental period as compared to limited oral doses, in 
skin and mammary carcinogenesis respectively. 
The exposure of animals to restraint stress followed by DMBA infusion resulted in 
significantly increased oxidative stress as compared to controls as well as DMBA alone 
or stress alone treated group. TBARS levels were further increased with decreased GSH 
content and antioxidant enzymes in the liver as well in circulation. The decreased levels 
of GSH along with decreased activity of GST due to prior exposure of rats to restraint 
stress might contribute significantly in enhancing DMBA induced carcinogenesis due to 
its reduced clearance from the system. Prior exposure to restraint stress deranged the 
oxidative status of animals either by enhancing the production or decreasing the clearance 
of free radicals. Under such compromised state the infusion of DMBA further aggravated 
the situation which is observed in terms significantly decreased activities of free radical 
scavenging enzymes SOD, CAT, GR and GST in comparison to stress alone or DMBA 
alone treated groups. The circulatory antioxidants vit C, glucose, uric acid and SOD were 
also found decreased, thus enhancing pro oxidant elTect of DMBA. 
Reactive oxygen species (ROS) have been suggested as causative factors in mutagenesis, 
carcinogenesis and tumor promotion and have been implicated in the etiology and 
pathophysiology of many human diseases (Dhawan et al., 1999, Vaiko et al., 2006). fhey 
induce strand breaks and cause oxidative modification of DNA bases (Cerutti, 1985). 
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Damage to DNA integrity is considered as the basic trigger of various diseases including 
cancer. Damaged DNA also results in impaired ability of cells to repair or prevent disease 
(Hoeijimakers, 2001). Several studies have examined the effect of stress on DNA 
integrity as stress has been found to cause production of ROS resulting in oxidative stress 
and increased lipid peroxidation. During oxidative stress, MDA or other aldehydes are 
formed in biological system, which react with amino acids and DNA resulting in 
alterations in replication, transcription and leading to tumor formation (Perchellet & 
Perchellet, 1989). Exposure to conditional emotional stimuli results in DNA damage in 
rats by increasing the levels of 8-OH-dG significantly as compared to controls (Adachi et 
al., 1993). While DNA fragmentation was observed in gastric mucosa of rats exposed to 
both acute and chronic stress (Bagchi et al., 1999), no such damage was found to be 
induced in T lymphocytes of mice exposed to acute stress (Flint et al., 2005). Stress is 
also found to effect DNA repair system as rotational stress decreased the levels of 
methyltransferase, an important repair enzyme, in spleen of rats (Forlenza et al., 2000; 
Glaser et al., 1985). Psychological stress also impaired the repair of DNA damage 
induced by exposure to a carcinogen, in rats (Glaser et al., 1985). The discrepancies 
between these data remain unresolved and it remains unclear whether the consistent 
effects of stress on DNA integrity stem from ROS production, due to the inconsistent 
results observed on the generation of ROS in stress. However earlier reports from our lab 
have already reported that chronic restraint stress causes increased lipid peroxidation and 
compromised antioxidant status in experimental animals (Kashif et al.. 2005; Al-Qirim et 
al., 2002). 
In the present study too restraint stress was found to cause oxidative stress however, 
damage to DNA of lymphocytes, liver and skin cells of rats was insignificant from that of 
control values. DNA damage was measured in terms of increased DNA tail length as 
compared to controls. A plausible explanation may be that the stressor used here did not 
incur DNA damage within the cell, rather primed the cell to respond to subsequent 
induction of DNA damage either by impairing the ability of cells to repair DNA or by 
causing oxidative stress observed in stressed animals which may be attributed to 
excessive generation of ROS exacerbated by decreased efficiency of host antioxidant 
defense mechanisms. 
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DMBA is an indirect carcinogen and is metabolized by cytochrome P450 IBl to form 
toxic metabolites and ROS resulting in oxidative stress leading to cancer. The toxic 
metabolites of DMBA bind to adenine residues of DNA causing damage. Thus enhanced 
lipid peroxidation accompanied by depletion of GSH, GSH dependent enzymes and free 
radical scavengers in liver and plasma and DNA damage is observed in DMBA treated 
animals. Consecutive doses of DMBA were found to induce oxidative stress as well as 
DNA that increased with increasing the number of applications, in a dose dependent 
manner showing a positive correlation between oxidative stress and DNA damage 
(Guerin, 1978). The DNA breakage may be the result of the generation of hydroxyl 
radicals and other ROS in situ (Valko et al., 2007). Moreover, oxygen radical damage to 
deoxyribose or DNA is considered to give rise to TBA reactive material (Quinlan & 
Gutteridge, 1987). Thus, oxidative stress arising due to ROS overproduction coupled with 
deficiency of host antioxidant defense mechanisms observed in the present study may be 
an important factor contributing to the increase in DNA damage in DMBA treated 
animals. These results are in accordance to the earlier observation that several 
applications of DMBA provide an added complexity to interactions between 
concomitantly formed DMBA-DNA base adducts and oxidized bases (Frenkel et al., 
1995). These concurrent interactions of initiating (adducts) and promoting (oxidized 
bases) processes may be key to complete carcinogenesis. Exposure to stress may play an 
important role from the very early stages of carcinogenesis right at the basic cellular level 
by causing oxidative stress and/or increasing the damaging potential of a carcinogen. 
This is confirmed by the fact that enhanced DNA-damage was observed in rats treated 
with DMBA following exposure to stress as compared to those treated with DMBA 
alone. It may thus be suggested that restraint stress though having no direct effect on 
DNA may act indirectly by impairing the DNA repair ability of cell thereby priming the 
cell for subsequent damage by the carcinogen. Therefore increased DNA damage is 
observed in animals pre exposed to restraint stress followed by DMBA doses, after each 
application, as compared to DMBA alone treated group. 
Thus we conclude that not only DMBA infusion but chronic restraint stress also alters the 
antioxidant status of rats and the condition further deteriorates if animals are exposed to 
stress prior to DMBA administration resulting in the formation of free radicals or ROS 
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which may cause tissue injury and increase membrane lipid peroxidation. As a result, the 
levels of marker enzymes are increased and the increased membrane peroxidation may 
facilitate their release in the circulation. Thus an additive pro oxidant effect of stress and 
DMBA is observed irrespective of its mode of treatment though oral is found to have 
more pronounced effect (Muqbil «& Banu, 2006). Further, exposure to multiple doses of a 
carcinogenic agent like DMBA directly or indirectly (environmental toxins, cigarette 
smoke) causes dose dependent DNA damage and exposure to stress (physical or 
emotional) exacerbates this DNA damage thus putting an individual at an increased risk 
of developing cancer. The experimental model currently employed might provide an 
insight at the most basic level of cell mutation, for investigating the effect of both 
physical and psychological stress on the etiology of DMBA induced carcinogenesis. 
Further studies may be aimed at the development of interventions for disease prevention 
by identifying the relations between psychological factors and DNA damage. 
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The results of the present study indicate that the two compounds used; melatonin and 
resveratrol, both well-known antioxidants were effective in protecting animals against 
DMBA induced oxidative stress and DNA damage, while restraint stress was shown to 
abolish their chemopreventive effect. This observation was supported by the results of 
fluorescent studies, which were comparable to those of comet assay and biochemical 
markers that are considered as hallmarks of oxidative stress. 
In living cells, reactive oxygen species (ROS) are formed continuously as a consequence 
of metabolic and other biochemical reactions as well as external factors. Antioxidant 
defense systems to counter this cannot provide complete protection from the noxious 
effects of ROS, which includes oxidative damage to DNA. Experimental studies in 
animals and in vitro have suggested that ROS are an important factor in carcinogenesis. 
There is a crucial balance between free-radical generation and antioxidant defense as a 
force in disease prevention. An imbalance between protection against free radicals and 
their generation can be associated with the pathogenesis of a wide variety of diseases 
(Halliwel & Gutteridge, 1999). Since oxidative/electrophilic stress is generally perceived 
as one of the major causes for the accumulation of mutations in the genome, antioxidants 
are believed to provide protection against cancer. A number of natural and synthetic 
antioxidants are known to retard chemical carcinogenesis in experimental animal models 
(Sardas, 2003) 
The present study was undertaken to evaluate the effectiveness of melatonin and 
resveratrol on DMBA induced carcinogenesis and the modulatory effect of restraint stress 
on it. DMBA is known to cause oxidative stress and DNA damage in mammalian cells 
through free radical formation and lipid peroxidation activation (Frenkel et al., 1995). 
Restraint stress though itself did not induce any significant DNA damage but it enhanced 
the DNA damaging potential of DMBA (Muqbil et al., 2006) which is evident from 
increased DNA damage of pre-stress-DMBA group animals in comparison to all other 
groups as discussed earlier. This is due to the fact that restraint stress causes oxidative 
stress and increased lipid peroxidation in these animals (Muqbil & Banu, 2006). 
The role of the pineal gland in tumor development has been under intensive study during 
the last few years. In cancer patients the morphological signs of pineal function decrease 
and disturbances in the circadian secretion pattern of the main hormone of the pineal 
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gland, melatonin, were observed (Vijaylaxmi et al., 2002). For a variety of tumors their 
growth is accelerated in pinealectomized animals. The inhibitory effect of melatonin is 
well established in relation to DMBA induced mammary tumors (Cos & Sanchez-
barcelo, 2000) and skin carcinogenesis induced by carcinogens other than DMBA 
(Kumar & Das, 2000). 
While body of data indicates that animal tumor cells lack complex enzyme systems, 
which normally exert protection by scavenging toxic oxygen species (Masotti et al., 
1998). Results of the present study show a significant decrease in the activities of SOD, 
CAT, GR and GST in carcinogen treated rats. This decrease in activities of these 
enzymes was restored by melatonin, bringing the values close to that of controls. The 
mode of action of this antioxidant is probably to prevent free radical damage on enzymes 
by scavenging free radicals produced. Moreover, it is reported that in addition to its 
radical scavenger effect, melatonin contributes to antioxidant capacity by increasing 
mRNA expression of antioxidant enzymes (Reiter et al., 2002). Further, the decrease in 
the levels of circulatory antioxidants ascorbic acid, glucose and uric acid was also 
replenished by melatonin treatment probably by acting directly as free radical scavenger. 
The in vitro studies have revealed that melatonin acts as a direct scavenger of OH, H2O2, 
singlet oxygen (tOy), and inhibitor of lipid peroxidation (Anisimov et al., 2006). The 
amount of MDA, which is a product of lipid peroxidation, is a measure of oxidative stress 
status of a cell or tissue. It is clearly demonstrated that oxidative stress induced by 
DMBA causes considerable lipid peroxidation in liver and plasma of rats. Melatonin 
significantly inhibited lipid peroxidation by lowering MDA levels, as melatonin has been 
proved to be a very efficient neutralizer of the peroxyl radicals generated during lipid 
peroxidation (Lesnikov & Pierpoali, 1994). The depleted GSH content of liver by DMBA 
infusion was found significantly enhanced by melatonin treatment probably due to the 
fact that melatonin stimulates the rate-lim.iting enzyme in the synthesis, 7-
glutamylcysteine synthase (Anisimov et al., 2006). Increased levels of biochemical 
markers of liver function, ALP, ACP, LDH, GOT and GPT were also normalized 
following melatonin treatment. There is evidence that melatonin stabilizes membranes 
thereby helping them resist oxidative damage (Anisimov et al., 2006), which may be 
responsible for decreased SCOT and SGPT levels as compared to DMBA treated animals 
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where oxidative damage to membranes caused the release of these enzymes into 
circulation. Thus, melatonin can be considered as an effective chemopreventive agent 
against DMBA induced carcinogenesis. However, the chemopreventive effect of 
melatonin was significantly reduced in DMBA treated animals pre-exposed to chronic 
restraint stress. Activities of antioxidant enzymes in liver and plasma were decreased 
with increased levels of MDA. Hepatic GSH content was decreased while marker 
enzymes were increased significantly as compared to control and values were comparable 
to those of DMBA alone treated animals. This may due to the reason that restraint stress 
besides causing oxidative stress in animals enhances the DMBA-induced pro-oxidant 
effect as well as DNA damage. Though melatonin has been found to protect animals 
against stress induced gastric ulcer (Bandyopadhyay et al., 2000), its antioxidant property 
may not be sufficient to counter the combined burden of restraint stress and carcinogen 
induced oxidative stress resulting in decreased chemoprevention. 
DMBA in the present study was shown to induce DNA damage in lymphocytes, liver and 
skin cells of rats, measured by alkaline comet assay in terms of increased DNA tail 
length. However, melatonin supplementation for the entire experimental period resulted 
in significant decrease in DMBA-induced DNA damage in all the three types of cells 
studied. Melatonin has been shown to reduce the formation of 8-OhdG (damaged DNA 
product), 60 to 70 times more efficiently than some classic antioxidants (Qi et al., 2001). 
Being both lipophilic and hydrophilic, it acts not only in every cell but also in subcellular 
compartments besides its ability to neutralize free radicals directly, thereby reducing 
oxidative damage (Harman, 1994; Reiter, 1995). These properties allow melatonin to 
preserve macromolecules including DNA, protein and lipid from oxidative damage 
resulting from chemical carcinogen exposure. 
Another compound that has received increased attention in the recent years and used in 
the present study is resveratrol. This trihydroxy-stilbene was found to inhibit the 
initiation and promotion of hydrocarbon induced cancer (Jang et al., 1997). Its potent 
antimutagenic activity was also demonstrated (Uenobe et al., 1997). These observations 
have been extended by a multiplicity of reports confirming by means of m vilro and in 
vivo animal models that trans-resveratrol is a very potent and versatile anticancer agent 
targeting several different sites in the neoplastic process. Its anticancer activity against 
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human neoplasm has been shown by many investigations utilizing human cancer cell 
lines (Elathar & Virji, 1999; Hsieh & Wu, 1999; Ider et al., 2000; Mutoh et al., 2000;De 
et al., 2000; Hiroyuki et al., 2001). One mechanism responsible for this behavior seems to 
be apoptosis (Huang et al., 1999; Ahmad et al., 2001). A different mechanism that may 
be important in the prevention of chemical carcinogenesis by resveratrol implicates the 
aryl hydrocarbon receptor system necessary for the uptake and activation of many 
carcinogens: these processes are blocked by trans-resveratrol at very low concentrations, 
especially in whole animal experiments (Ciolino et al., 1998; Casper et al., 1999). In the 
present study resveratrol was effective in protecting animals against DMBA induced 
oxidative stress and DNA damage. This may be either due to the inhibition of phase I 
enzymes like CYP450 involved in metabolic activation of procarcinogens to active 
carcinogens or induction of phase II enzymes e.g., GSTs which in coordination with GSH 
are involved in the clearance of carcinogenic metabolites from the system, by resveratrol. 
Therefore, resveratrol in the present study was found to protect animals against DMBA 
induced DNA damage and oxidative stress. DMBA-induced DNA damage in 
lymphocytes, liver and skin cells was significantly reduced by resveratrol 
supplementation. Similarly, the decreased activities of antioxidant enzymes SOD, CAT, 
GR and GST and GSH contents in liver, and circulatory antioxidants glucose, vitamin C 
and uric acid induced by DMBA were found to approach normal values following 
parallel resveratrol treatment. DMBA induced increase of MDA levels was also reduced 
by resveratrol treatment. The levels of marker enzymes in liver and serum were increased 
significantly in carcinogen treated animals, these levels were also brought to near normal 
values on resveratrol supplementation, further confirming its protective effect on DMBA 
induced carcinogenesis. 
However, when animals were pre-exposed to restraint stress followed by resveratrol-
DMBA treatment, no protection was observed against DMBA induced DNA damage and 
oxidative stress. The extent of DNA damage and oxidative stress in these animals were 
similar to those of DMBA alone treated group. Recent studies indicate that both physical 
and psychological stress may also be included among the factors which modulate 
cytochrome P450s and other drug metabolizing enzymes (Konstandi et al., 1998). 
Stressed organisms are less capable of defending themselves against cancer cells. 
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infectious agents and other disease processes (Riley, 1989). Restraint stress was found to 
enhance the benzo [a] pyrene induced CYPs and related activities. In addition, restraint 
stress was able to alter the inducibility of monooxygenase activities by strong inducers 
such as B [a] P (Konstandi et al., 2000). Though little is known about the biochemical 
mechanisms by which stress affects xenobiotic metabolism, this may be the possible 
mechanism by which stress diminishes the protective effect of resveratrol in pre-stress-
DMBA resveratrol treated group. As a result increased DNA damage and oxidative stress 
is observed in this group as compared to control or DMBA-resveratrol treated group. 
It is well known that biochemical events during pathological conditions of the tissue 
differ from their normal counterparts. Since tissues contain native 
chromophores/fluorophors, alteration in the pathological status can be detected 
sensitively using fluorescent spectroscopy (Zonios, 1998). As it is well known that tumor 
angiogenesis takes place during the proliferation (Fox et al., 1996) it is thought that 
transport of these fluorophors may be possible and can be detected in blood erythrocytes. 
The natural intrinsic fluorophors mainly NAD(P)H, porphyrins and flavins display their 
characteristic spectra at 470, 520 and 630 nm respectively which characterize the local 
environment (Alfano et al., 1987). The ratio of fluorescent intensity at 530 nm and at 630 
nm (FI530nm/630nm) is definite for a given tissue and an alteration in the ratio of these 
fluorophores depicts a change in the local and native environment. The plasma and 
erythrocytes of DMBA treated animals in addition to a peak at 430nm like control 
samples, showed a prominent peak at 630nm, while erythrocyte membrane showed a 
secondary peak at 540 nm which may be due to the change in the local environment or 
due to the production of new fluorophores induced by the carcinogen. Pre-restraint stress 
significantly increased the Fl at 630 nm and 520 nm and decreased the ratio of 
F1530nm/630nm in plasma and erythrocyte while increased in erythrocyte membrane 
when compared to DMBA treated group. The mechanism is not clear, however, the 
increased oxidative stress in pre-stress DMBA group may result in the increased 
production of fluorophores. The topical treatment of melatonin or resveratrol reduced the 
peaks at 630nm and 540nm and changed FI530nm/630nm significantly as compared to 
DMBA alone group bringing values more or less close to that of control group. This may 
be either due to interaction directly with the metabolic activation process, perhaps by 
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inhibiting the cytochrome P450 dependent monooxygenase enzyme system as discussed 
already in case of resveratrol or indirectly through stimulation of glutathione and 
glutathione peroxidase enzyme, in case of melatonin (Anisimov et al., 2006), thereby 
reducing oxidative damage of the carcinogen. However, both melatonin and resveratrol 
are found less effective on DMBA induced damage when animals are pre-exposed to 
restraint stress. The possible explanation could be that melatonin may be involved 
indirectly, as restraint stress is known to induce oxidative stress and enhances DMBA 
induced pro-oxidant status too (Muqbil & Banu, 2006), while resveratrol interacts 
directly through aryl hydrocarbon receptor system, which is also modulated by restraint 
stress, thereby interfering with their chemopreventive potentials. 
The results of fluorescence spectroscopy are therefore highly comparable with those 
of Comet assay. Thus, we conclude that melatonin which acts as an antioxidant as well as 
through receptor mediated activation of antioxidant enzymes, is highly effective against 
DMBA induced damage and so is resveratrol through modulation of uptake and 
activation system of carcinogens. Restraint stress, in addition to enhancing DMBA 
induced damage, reverses or inhibits the chemopreventive effect of both melatonin and 
resveratrol. Therefore, stress management must be considered as a serious factor during 
cancer chemopreventive trials and further studies should be aimed at reducing exposure 
to stressful conditions during chemotherapy. 

Summary 
It is generally accepted that the causes of cancer could be physical (e.g., radiation), 
chemical (carcinogens), and viral (e.g., oncogenes). The mechanism by which certain 
carcinogens and radiation cause carcinogenesis is believed to be mediated by free 
radicals. A substantial body of evidence has been produced that links the production of 
reactive oxygen radicals, and subsequently oxidative stress and damage, to pathogenesis 
of chronic diseases including cancer. Oxidative stress has been defined as an imbalance 
between oxidants and antioxidants in favour of the former, resulting in an overall increase 
in cellular levels of reactive oxygen species. Free radicals have been shown to be capable 
of damaging many cellular components such as DNA, proteins and lipids. Proteins can be 
damaged by oxygen radicals leading to a loss of both free radical scavenging enzyme 
activity and structural integrity, leading to compromised host antioxidant defense 
mechanisms and cell membrane structure, respectively. This eventually may culminate in 
neoplastic transformation. 
Environmental factors are recognized to play a major role in the etiology of various 
cancers that account for over 80% of human malignancies. Polycyclic aromatic 
hydrocarbons (PAHs) are ubiquitously distributed environmental chemicals which act as 
carcinogens. 7, 12-dimethylbenz (a) anthracene (DMBA), a prototype carcinogen of PAH 
family, is present in the environment as a product of incomplete combustion of complex 
hydrocarbons. In the present study DMBA was used as a complete carcinogen. It was 
found that DMBA given either orally or topically induced oxidative stress by 
significantly decreasing the activities of SOD, CAT, GR and GST in liver tissues and 
ascorbic acid, glucose, uric acid, SOD and GST in circulation. Hepatic GSH content was 
found depleted with increased levels of MDA (lipid peroxidation). Levels of marker 
enzymes ALP, ACP, LDH, GOT and GPT in liver as well as SGOT and SGPT levels 
were also increased significantly. Further the role of stress alone and on DMBA induced 
oxidative stress was assessed. Increasing evidence suggests that stress and the ability to 
cope with stress may play a role in malignant transformation and tumor progression. 
Although the evidence that stressful life events are related to the development of cancer is 
controversial, a number of human studies have correlated stressful life events with 
increased cancer risk and decreased survival probability. However, much attention has 
been paid to the possible influence of stress on prognosis in patients who already have 
Summary 
cancer while very limited information is available on any possible direct role of stress on 
the development of neoplasia. The present study was designed to assess the impact of 
stress on early stages of cancer. 
Immobilization stress is a classic and convenient method of inducing both psychological 
(escape reaction) and physical stress (muscle work) resulting in restricted mobility and 
aggression, which been used to study the impact of stress on disease process in 
experimental animals. Exposure to chronic restraint stress resulted in a significant 
decrease in the activities of superoxide dismutase (SOD), catalase (CAT), glutathione 
reductase (GR), gluatathione-S-transferase (GST) and glutathione (GSH) in liver tissues 
as well as vitamin C, glucose, uric acid, SOD and GST in circulation in comparison to 
untreated controls. This was accompanied with significantly increased levels of 
malondialdehyde (MDA) and marker enzymes ALP, ACP, LDH, GOT and GPT both in 
liver and circulation. Similar results were obtained by topical or oral infusion of DMBA, 
though oral treatment showed a profound pro-oxidant effect. Moreover, when DMBA 
treated animals were pre-exposed to chronic restraint stress there was marked increase in 
oxidative stress. This was reflected by a further decrease in the activities of antioxidant 
enzymes and other antioxidants as compared to DMBA alone or stress alone treated 
animals. Levels of marker enzymes in liver and circulation were increased significantly 
with increased levels of MDA indicating an enhanced lipid peroxidation. 
DMBA is an indirect carcinogen and is metabolized in vivo to become an active 
carcinogen. The toxic metabolites and ROS formed during its metabolism, in addition to 
causing oxidative stress, also result in oxidative DNA damage. In the present study, 
DMBA was found to induce DNA damage in lymphocytes, liver and skin cells of 
animals, in terms of increased DNA tail length, measured by alkaline comet assay. 
Damage was induced after single dose of DMBA, which increased further with 
increasing number of doses, in a dose-dependent manner. Restraint stress though unable 
to induce any significant damage enhanced the DMBA induced DNA damage in 
lymphocytes, liver as well as skin cells. Alterations in biochemical parameters of these 
animals were also dose-dependent after each DMBA treatment. Restraint stress in 
addition to causing oxidative stress by itself enhanced the pro-oxidant effect of DMBA. 
Formation of oxidative stress-related molecules, increased lipid peroxidation with 
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decreased activities of free radical scavenging enzymes may serve as the mediator to 
modulate tissue and cellular events responsible for DMBA induced carcinogenesis. 
Since free radicals are involved in initiation and promotion stages of carcinogenesis, one 
may expect that free radical scavengers should function as inhibitors in the neoplastic 
processes. Antioxidants have been shown to inhibit both initiation and promotion in 
carcinogenesis and counteract cell immortalization and transformation. A number of 
natural and synthetic antioxidants are known to retard chemical carcinogenesis in 
experimental animal models through chemoprevention. Chemoprevention is the use of 
one or several agents to prevent the occurrence of cancer. In this study two compounds-
melatonin and resveratrol, studied extensively for their antioxidant properties, were used 
to evaluate their effectiveness on DMBA induced carcinogenesis and the modulatory 
effect of restraint stress on it. Both melatonin and resveratrol exerted their antioxidant 
role against DMBA induced carcinogenesis. This was assessed in terms of DNA damage, 
fluorescent studies and biochemical parameters. DNA damage, measured as increased 
DNA tail length, induced by DMBA was prevented largely when animals were 
supplemented with either melatonin or resveratrol. The biochemical events during 
pathological conditions are known to differ from their normal counter parts, which can be 
detected sensitively using fluorescent spectroscopy. DMBA induced carcinogenesis was 
detected from altered ratio of fluorescent intensity (FI 530nm/630nm) which is otherwise 
definite for a given normal tissue. This ratio was however, comparable to control values 
after treatment with melatonin or resveratrol. The results of biochemical parameters 
showing decreased oxidative stress were also in line with those of comet assay and 
fluorescent studies, thus confirming the chemopreventive properties of melatonin as well 
as resveratrol against DMBA induced carcinogenesis. However, when animals were pre-
exposed to restraint stress the chemoprevention by both the compounds was abolished 
and results were comparable to that of DMBA alone treatment. 
Thus, it is concluded that the complete carcinogen DMBA induces in vivo oxidative 
stress when administered either orally or topically. Exposure to chronic restraint stress 
also causes oxidative stress and exacerbates the pro-oxidant effect of DMBA, irrespective 
of mode of DMBA administration. Further DMBA induces oxidative stress and DNA 
damage following a single topical application, which increases with increasing number of 
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doses, in a dose dependent manner. Restraint stress, besides causing oxidative stress. 
enhances DMBA induced oxidative stress as well as DNA damage following each 
DMBA application, though, it did not incur any significant DNA damage by itself. 
Therefore, an additive pro-oxidant effect of stress and DMBA is observed irrespective of 
mode of DMBA treatment, though oral is found to have more pronounced effect. Further, 
exposure to multiple doses of a carcinogenic agent like DMBA directly or indirectly 
(environmental toxins, cigarette smoke) causes dose dependent DNA damage and 
exposure to stress (physical or emotional) exacerbates this DNA damage thus putting an 
individual at an increased risk of developing cancer. 
For chemopreventive studies, the two antioxidants-melatonin and resveratrol were found 
almost equally effective against DMBA induced carcinogenesis. However pre-exposure 
to restraint stress was foimd to decrease their chemopreventive efficacy, thus playing an 
important role during cancer development as well as cancer chemoprevention. Therefore 
stress management must be considered as a serious factor during cancer chemopreventive 
trials and further studies should be aimed at reducing exposure to stressful conditions 
during chemotherapy. 
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Abstract 
The current study was designed to assess the effect of immobilization stress on liver toxicity induced by topical as well as oral 
administration of 7.12-dimethyl benzCajanthracene (DMBA) in Swiss Albino rats. The experimental animals were divided into six 
groups. Group ! animals were exposed to chronic restraint stress alone for 10 days (3 h/day), shaved back of animals in group II 
were painted with 0.5% solution of DMBA twice a week for 4 weeks. Group III animals were first exposed to restraint stress similar 
to group 1 followed by DMBA application as in group II, group IV animals were orally administered four doses of 0.5% DMBA 
solution. (1 ml/rat) at weekly intervals, while group V animals were first exposed to restraint stress as in group I followed by oral 
dose of DMBA similar to group IV. The untreated Group VI animals served as controls. Rats were sacrificed after a period of 4 
weeks following DMBA administration. Biochemical measurements were carried out on liver tissues and serum/plasma of control 
and treated animals. Restraint stress was found to have marked efl'ect on DMBA induced alteration of liver function as revealed by 
the increase in tissue marker enzymes viz glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), 
alkaline phosphatase (ALP), acid phosphatase (ACP), lactate dehydrogenase (LDH) with a significant further decrease in 
antioxidant enzymes catalase (CAT), superoxide dismutase (SOD), glutathione-S-transferase (GST), glutathione reductase (GR) as 
compared to controls and DMBA alone(topical/oral) or stress alone treated rats. Increased lipid peroxidation was accompanied by a 
significant decrease in the level of total reduced glutathione (GSH). The changes in the levels of marker enzymes and in vivo 
antioxidants in serum/plasma were comparable to that of liver. The results of the present study indicate that immobilization stress 
markedly enhances DMBA induced alteration of liver and circulatory antioxidant status of the rats irrespective of the mode of 
DMBA administration though with a predominant effect on orally infused DMBA. 
© 2005 Elsevier Ireland Ltd. All rights reserved. 
Keywords: DMBA; Restraint stress; Antioxidant enzymes 
1. Introduction 
Stress is a common phenomenon, generally a state of 
disturbed homeostasis, harmony and equilibrium which 
is attracting increasing attention due to its implication 
in wide range of diseases like cardiovascular, 
* Corresponding author. Tel.; +91 571 2700741; fax: +91 571 
2706002. 
Enuiil address: naheedbanu7@yahoo.coni (N. Banu). 
pulmonary, autoimmune diseases, cancer and aging 
[1,2). The influence of stress-inducing conditions on 
cancer development has been the subject of several 
investigators, both at clinical and experimental level 
[3-5]. Stress has been shown to markedly influence 
incidence, growth and metastasis, and rejection of 
chemically induced or implanted tumors [6,7]. How-
ever, results are contradictory as both exacerbation and 
attenuation of tumor development has been reported by 
stress. For example, foot .shock or electric shock 
0.304-3835/$ - see front matter © 2005 Elsevier Ireland Ltd. All righls reserved. 
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enhanced tumor development [7], while various other 
stresses inhibited the growtli of both transplanted and 
chemically induced tumors in rats [4,8]. Restraint stress 
was found to attenuate tumor growth markedly [9]. 
However, the intensity and duration of immobilization 
stress, among many factors, seem to play a major role, 
and it was found that animals stressed after the third 
injection of carcinogen had protective effect of stress 
whereas no protection was observed if stress began 
before first injection [6]. 
Exposure to stress induces a cluster of physio-
logical and behavioral changes in an effort to 
maintain the homeostasis of the organism. Long-
term exposure to stress, however, has detrimental 
effects on several cell functions such as the 
impairment of antioxidant defenses leading to 
oxidative damage, central to many diseases including 
cancer [10]. Oxidative stress arises when the balance 
between pro-oxidants and antioxidants is shifted 
towards the pro-oxidants [11]. 
Immobilization is a classic method that has long 
been used to study the impact of stress on disease 
process in experimental animals [12] and DMBA is a 
synthetic polycyclic aromatic hydrocarbon (PAH), 
which has been used extensively as a prototype 
carcinogen. The main target sites for the potent 
carcinogenicity of this agent in rodents are the skin 
and the mammary gland [13]. 
In the light of the controversial studies reported 
present study was undertaken to assess the effect of 
immobilization stress on both topical and oral 
administration of DMBA in rats. In addition, most 
of the studies have focused mainly on the effect of 
psychosocial factors, including stress on prognosis in 
patients who already have cancer and less is known 
on any possible influence of stress on cancer 
development when exposure occurs during early 
neoplastic process [14,15). Therefore, our study may 
to some extent throw light on the effect of stress on 
early stages of cancer in terms of biochemical 
markers and antioxidant status. 
2. Materials and methods 
2.1. Chemkiih 
DMBA was purchased from Sigma (St Louis, 
MO), NADPH, Oxidized and reduced Glutathione, 
DTNB, CDNB, Pyrogalloi were purchased from 
SRL India. All other chemicals were of analytical 
grade. 
2.2. Experimental protocol 
Sixty Swiss Albino rats weighing about 40 + 5 g 
were acclimatized for 1 week to rat feed (Ashirwad 
industries, Chandigarh, India) with food and water 
available ad libitum and an alternating light and dark 
cycle of 12 h. Rats were divided in six groups with 10 
rats in each group. Group 1 (stress alone) animals 
were exposed to chronic restraint stress for 10 days 
(3 h/day) from 10 am to 1 pm. Shaved back of group 
II (DMBA Topical) animals were painted with 0.5% 
DMBA solution twice a week for 4 weeks. Group III 
animals were first exposed to restraint stress similar 
to group one animals followed by DMBA application 
as in group II (Pre-stress DMBA topical). Group IV 
animals (DMBA oral) were given oral dose of 0.5% 
DMBA (1 ml/rat) weekly for 4 weeks. Animals in 
group V (Pre-Stress DMBA oral) were exposed to 
restraint stress similar to group one followed by oral 
dose of DMBA as in group IV. Group VI animals 
were left untreated and served as controls (Table 1). 
Immobilization was carried out by placing rats 
individually in body sized wire mesh cages attached 
to wooden boards, with no movement allowed [16]. 
The institutional research committee approved all 
animal procedures. 
Table 1 
Experimental proux-ol 
Groups (10 ryt.s each) TrealnienLs 
Group 1 
Group II 
Group III 
Group IV 
Group V 
Group VI 
Chronic restraint stress (3 h/ilay) for 10 days. (Stress alone) 
Shaved back of rats painted with 0 57r DMB.A solution twice a week for 4 weeks. (DMBA Topical) 
Preexposure to restraint stress followed by DMBA application as in Group II. (Pre-stress DMBA topical) 
Oral administration of 0.57r DMBA solution. (I ml/rat) four doses at weekly intervals. (DMBA oral) 
Pre-exposure to restraint stress followed by DMBA administration as in Group IV. (Pre-slress DMBA oral) 
Untreated control animals. (Control) 
Rats were sacrificeil after a peritxJ of 4 weeks after DMBA administration, blood and liver tissue samples were collected and subjecled for 
biochemical estimations. 
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Animals from all groups were sacrificed after 4 
weeks following first DMBA exposure. Blood and liver 
samples were collected for biochemical studies. Liver 
samples were rinsed with normal saline and homogen-
ized in 0.1 M Phosphate buffer pH 7.4 (10% w/v) 
followed by centrifugalion to remove cellular debris. 
Clear supernatant thus obtained and serum/plasma 
separated from the whole blood were utilized for 
further studies. 
2.3. Biochemical estimations 
2.3.1. Lipid peroxidation 
The levels of MDA formed in liver and plasma were 
assessed by measuring the concentration of thiobarbi-
turic acid reactive substances [17]. 
2.3.9. LDH 
The levels of LDH in liver tissue were measured by 
the method of Wroblewski [251. 
2.3.10. GOTandGPT 
Commercial Kits (Span Diagnostics Ltd India) were 
used for the measurement of the transaminases (GOT 
and GPT) in the liver tissues and serum. 
2.3.11. Uric acid 
Uric acid levels in plasma were measured by using 
commercial Kit. (Span Diagnostics Ltd India). 
2.3.12. Ascorbic acid 
Plasma ascorbic acid levels were measured by the 
method of Teilz using DNPH reagent and ascorbic acid 
as standard. [26|. 
2.3.2. Total reduced glutathione 
Levels of GSH in liver tissues using sulfosalycylic 
acid and DTNB were measured by the method of 
Jollowetal. [18]. 
2.3.3. SOD activity 
SOD activity in tissue and plasma was monitored 
by the inhibition of auto-oxidation of Pyrogallol at 
420 nm [19]. 
2.3.4. GST activity 
Plasma and liver GST activities were measured 
using l-chloro-3,4-dinitrobenzene (CDNB) by the 
method of Habig [20]. 
2.3.13. Protein estimation 
Protein content in serum and tissue samples was 
measured by the method of Lowry et al. using BSA as 
standard [27]. 
2.4. Statistical analysis 
Data were expressed as the mean + standard error of 
mean for each group and statistically analyzed using 
one way ANOVA. When the F ratio was statistically 
significant the data were subjected to Student's /-test 
and Tukey post hoc analysis. Statistical significance 
was set at P<0.05. 
3. Results 
2.3.5. Catalase activity 
Catalase was assayed by following the rate of 
decomposition of H2O2 at 240 nm [21]. 
2.3.6. Glutathione reductase (GR) activity 
GR was assayed by measuring the oxidation of 
NADPH at 340 nm by the method of Carlberg and 
Mannervik [22]. 
2.3.7. ALP 
In liver homogenates, ALP was measured using 
p-nitro phenylphosphate (pNPP) as substrate [23]. 
2.3.8. ACP 
Levels of ACP in liver tissue was measured using 
pNPP as substrate and PNP as standard by the method 
of Shah et al. [24]. 
The levels of MDA in the liver tissues and plasma of 
rats exposed to restraint stress alone or DMBA (oral or 
topical) alone were increased as compared to controls. 
Exposure of stressed animals to DMBA, oral or topical, 
further enhanced the levels as compared to all other 
groups (Fig. 1(A) and (B)). 
Stress alone or DMBA alone treatment decreased the 
levels of reduced GSH in liver tissue as compared to 
untreated controls. In the pre-stress DMBA treated rats 
(either topical or oral) the GSH levels were further 
decrea.sed significantly (/*< 0.001) in comparison to 
controls, stress alone or DMBA alone treated rats 
(Fig. 1(C)). 
Antioxidant enzyme activities in liver tissues of 
treated and control groups are shown in Table 2. The 
activities of GST, SOD, CAT and GR were signifi-
cantly (P<0.05) decreased in stress alone and DMBA 
alone treated groups as compared to controls. 
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Fig. I. (.A-C): Ellect of Restraint .stress on DMBA infusion in terms of circulatory MDA levels and hepatic levels of MDA and GSH: DMBA (0.5%) 
was applied topically or given orally to rats either alone or after 3 h of stress exposure for 10 days. Rats were sacriticed after 4 weeks following 
DMBA exposure. Plasma levels of MDA (lA) Hepatic levels of MDA (IB) Hepatic levels of GSH (IC). Values are niean±SEM of 10 animals. 
*P<0.Q5 when compared to conlrol. **f<0.001 when compared to stress alone or DMBA alone treated groups. 
These activities were further decreased significantly 
(P< 0.001) in DMBA treated groups when pre-exposed 
to restraint stress. The levels of various marker 
enzymes of liver function (Table 3) were significantly 
increased in liver tissues of stressed as well as DMBA 
alone treated rats. The levels were further increased 
significantly (P<Q.OO\) in pre-stress DMBA treated 
rats as compared to other groups. 
Similar pattern was observed in circulating levels of 
biochemical markers and in vivo antioxidant levels 
of control and treated groups (Table 4). The levels of 
ascorbic acid, uric acid and glucose were significantly 
Table 2 
The hepatic levels of free radical metabt)lizing enzymes in rats exposed to stress alone, DMBA alone (oral/topical) and pre-stress DMBA treatment 
Groups 
Control 
Stress alone 
DMBA (topical) alone 
Pre-stress DMBA 
(topical) 
DMBA (oral) alone 
Preslress DMBA (oral) 
GST iinil.s/mg protein SOD units/mg protein CAT units/mg protein GR units/mg protein 
254.0 ±3.4 
194.1* ±3.7 
16l.5*±1.2 
yX.O**± 1.5 
138.5* ±1.9 
78.1** ±1.3 
141.6±2.4 
103.6* ±2.5 
80.0*+1.5 
50.0** ±0.9 
66.0* ±0.7 
39.4** ±0.7 
30.0 ±0.5 
23.4* ±0.8 
19.2* ±0.5 
9.5** ±0.5 
15.2* ±0.4 
8.2**±0.2 
20.1 ±0.4 
14.1*±0.3 
8.4* ±0.2 
4.8** ±0.3 
5.6* ±0.3 
3.0** ±0.3 
Each value represents the mean ± SEM of 10 animals. *P < 0.05 when compared to control group. **/> < 0.(X) I when compared to stress alone and 
DMBA alone treated groups. 
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Table 3 
Levels of liver function enzymes GOT. GPT, ALP, ACP and LDH in stressed, DMBA (topical, oral) and pre-stress DMBA treated rats 
Group GOT units/ml GPT units/ml ALP mg/ml ACP mg/ml LDH units/mg 
protein 
Control 
Stress alone 
DMBA alone 
(topical) 
Stress +DMBA 
(topical) 
DMBA alone (oral) 
Stress +DMBA 
(oral) 
1754.0+18.2 
19I7.3*±I2 
2173.0* ±26 
2774.0** ±36 
2473.2*±52.3 
3091.0** ±30.7 
2374.0 ±44.1 
3022.0* ±42 
3974.2* ±47 
5084.0** ±60.2 
4560.0* ±30.2 
5960.2** ±49 
1.42 ±0.04 
2.2* ±0.8 
3.2* ±0.6 
5.12.0** ±0.2 
3.7* ±0.05 
6.0** ±0.04 
30.3 ±0.7 
44.0* ± 1.5 
52.0* ±0.1 
70.2** ±0.1 
56. I* ±0.6 
79.3** ±0.5 
144.6 ±0.6 
163.0*+ 2 
188.0* ±1.5 
234.0** ±2.2 
204.0*+ 4.03 
291.0** +1.5 
Each value represents the mean±SEMof 10 animals. *P<0.05 when compared to control group. **A'<O.0OI when compared to .stress alone and 
DMBA alone treated groups. 
decreased (P<0.05) in stress alone and DMBA alone 
treated groups, while exposure to stress prior to DMBA 
infusion decreased the levels further. SCOT and SGPT 
levels were altered as observed in liver tissues, 
however, the levels were too high in liver tissues than 
in circulation. 
In all the ca.ses, alterations in either antioxidants or 
biochemical markers were more pronounced when 
stress was followed by oral administration of DMBA 
rather than topical treatment. These results are parallel 
to the alterations in DMBA (oral) alone group as 
compared to DMBA (topical) alone group. No apparent 
carcinogenic lesions were observed in either DMBA 
alone (oral/topical) or pre-stress DMBA treated groups. 
4. Discussion 
It has been shown that exposure to stress 
situations can stimulate numerous pathways leading 
to increased production of free radicals. It is well 
known that free radicals generate a cascade, producing 
lipid peroxidation, protein oxidation, DNA dainage and 
cell death and contribute to the occurrence of 
pathological conditions (28,29]. Stress may also impair 
antioxidant defenses, leading to oxidative dainage, by 
changing the balance between oxidant and antioxidant 
factors [30,311. The involvement of oxidative stress in 
cancer induction and its subsequent development, and 
associated molecular mechanisms is becoining increas-
ingly clear [32,33]. The effect of stress on cancer 
development is controversial and is found to vary 
depending on the etiology of cancer. Stress per se 
enhances cancer of viral origin while it is found to 
inhibit carcinogenesis induced by chemicals [34]. The 
application of stress in experimental animals is found to 
modulate the immune functions of the host via 
neuroendocrine activation. Stress not only facilitates 
the growth of transplanted tumors but also specifically 
enhances the development of secondary tumor meta-
static foci in animal models [35]. 
Most tumor initiating agents either generate or are 
metabolically converted to electrophilic reactants 
Table 4 
Effect of stress alone, DMBA alone (oral/topical) and pre-stre.ss DMBA treatment on various circulatory biochemical parameters 
Group Ascorbic acid Uric acid Glucose SCOT SGPT 
(mg/lOOml) (mg/IOOml) (mg/IOOmI) (unit.s/ml) (units/ml) 
GST SOD 
(units/mg protein) (units/mg protein) 
Control 2.2 + 0.13 I29.2±0.89 6.01 ±0.04 262.2±6.6 2I5.6±3.9 0.42±0.02 3.6±0.13 
Stress alone 0.96*±0.04 I02.5*±0.5 3.74*±0.I5 3I2*±I.9 299*±1.2 0.34*±0.01 2.8*±0.1 
DMBA (topical) 0.89*±0.0I3 95.4*±i.2 2.76*±0.I2 372.8*±5 3I6.7*±2 0.26*±0.0I 2.27*±0.0I 
alone 
Pre-stress DMBA 0.49*#±0.02 67.5*#±l.9 l.04*#±0.06 49l.8*#±l.6 450*#±0.6 0.14*#±0.01 l.8*#±O.I2 
(topical) 
DMBA (oral) 0.56*±0.03 75.4*±2.3 3.7*±0.07 397*±3 322.4*±2.1 O.IO*±0.01 1.8*±0.23 
alone 
Pre-stress DMBA 0.27*#±0.01 50.35*#±0.75 1.4*#±0.I4 520.4*#±0.7 474*#±2 0.04*#±0.0I 0.74*#±0.3 
(oral) 
Each value represents the mean±SEM of 10 animals. *P<Q.05 when compared to control group. *#/'<0.0Olwhen compared to stress alone and 
DMBA alone treated groups. 
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which bind covalently lo cellular DNA [36,37|. For a 
number of PAH's. including DMBA the ultimate 
carcinogen is so called Bay-region dihydrodiol 
epoxide, produced during cellular metabolism [38). 
Free radicals and these modified DNA bases have been 
strongly implicated in carcinogenesis in general 
[39,40]. A high correlation has been found to occur 
between the dose of administered DMBA and the levels 
of total DNA adducts in liver and target organ epithelial 
cells. Presumably this is due to the fact that liver cells 
have a greater capacity of metabolizing PAHs, as 
compared with the target cells for lumorigenicity, 
which become more readily saturated [13]. In the 
present study, the difference in the levels of biochemi-
cal markers and antioxidants in oral and topical 
treatment of DMBA may be due to this dose-effect 
relationship. In case of oral treatment the amount of 
DMBA reaching liver ti.ssue is always higher than 
through topical treatment because topical application 
leaves less amount of carcinogen on the skin as 
compared to oral treatment where ea.sy absorption of 
the carcinogen through gut results in more pronounced 
effects. However, in long term experiments the results 
may be different because of the continuous topical 
application of the carcinogen throughout the exper-
imental period as compared lo limited oral doses, in 
skin and mammary carcinogenesis, respectively. 
Restraint stress, however, was found to have marked 
effect on the antioxidant status as well as the levels of 
biochemical markers irrespective of the mode of 
DMBA administration, though no apparent carcino-
genic lesions were observed due to short duration of the 
present study. Reactive oxygen species (ROS) such as 
superoxide anion (Oi), hydrogen peroxide (H2O2) and 
hydfoxyl radical (0H-) are highly toxic agents 
responsible for a wide variety of tissue damages [411. 
There is evidence thai OH- radical is indeed generated 
during the course of stress from endogenous O2 and 
H2O2 through the metal catalyzed Haber-Weiss 
reaction, and it plays a direct role in the stress-induced 
oxidative damage |42|. Because of this oxidative insult 
tissue damage may occur which may persist longer. The 
stressor used in the present study is chronic and is found 
to cause severe and irreversible alterations in the liver 
and serum parameters with no adaptation ob.served 
even after I month ol stress exposure. 
Liver is the central organ of metabolism and acts 
as an organ of storage. Hepatic cells metabolize many 
p(.)tentiaily toxic substances. The great su.sceptibility 
of liver to damage by chemical agents is presumably 
a consequence of its primary role in the metabolism 
of foreign sub.stances [43|. The liver is thus a 
versatile organ involved in drug metabolism and 
detoxification, hence the antioxidant enzymes and 
other parameters were estimated in liver as well as 
plasma/serum. 
During oxidative stress, MDA and/or other aldehydes 
are formed in biological systems. These can react with 
amino acids and DNA and introduce cro.ss linkages 
between proteins and nucleic acids, resulting in altera-
tions in replication, transcription [44] and leading to 
tumor formation. Our recent study has shown that 
restraint stress resulted in the generation of oxidative 
stress by decreasing the total glutathione content and the 
activities of SOD, CAT and GST in liver and other tissues 
of rats [45]. Similarly the finding of the present study also 
.show depletion of GSH with concomitant increase in 
TBARS level by stress alone and DMBA alone 
treatments. Further decrease of GSH with enhanced 
lipid peroxidation is observed in pre-stress DMBA 
infused rats suggesting that cells deficient in thiol groups 
undergo fast lipid peroxidation, as GSH is one of the 
guarding factors against oxidative stress [46]. Elevated 
levels of MDA are observed in plasma and liver tissues of 
rats exposed to restraint stress and DMBA alone. Further 
enhancement in pre-stress DMBA groups suggests that 
already existing oxidative stress facilitates the effect of 
DMBA on lipid peroxidation. 
The reduced form of GSH is a biological anti-
oxidant present in high amounts, especially in liver 
and its presence is pre requisite for protection against 
oxidative damage. Decreased levels of GSH 
accompanied by decrea.sed activities of antioxidant 
enzymes SOD, GST, CAT, and GR show poor 
antioxidant status of rats treated with either stress or 
DMBA alone or in combination. It has been 
established that GSH reacts with a very large number 
and variety of foreign compounds to form GSH 
conjugates. Compounds with an electrophilic center 
can readily conjugate with GSH either spontaneously 
or catalyzed by glutathione-5-transfera.ses. which 
tx;cur in substantial quantities in liver and other 
mammalian ti.ssues. The reactive ultimate carcino-
genic forms of chemical carcinogens are electro-
philes, dyhydrodiol epoxide in ca.se of DMBA, and 
thus good candidates for detoxification by reactions 
catalyzed by glutathione-S-transferases [47[. If not 
conjugated to GSH these toxic forms are free to bind 
covalently to cellular DNA. RNA or protein causing 
severe cell damage. The decrea.sed levels of GSH and 
GST as observed in restrained rats might help in 
DMBA induced carcinogenesis by decreasing its 
clearance from the system. 
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Liver enzymes such as LDH, GOT, GPT, ACP, and 
ALP are considered to be the biochemical markers for 
assessing liver function. Increased permeability of cells 
and necrosis are usually characterized by rise in these 
marker enzymes [43] as seen in the treatment groups as 
compared to controls. Due to increased cell per-
meability these enzymes are also released into 
circulation thus altering their normal levels. Thus, the 
increased levels of SCOT and SGPT were observed in 
stress and DMBA alone/Pre-stress DMBA groups. Five 
to ten fold elevations of these two enzymes are reported 
in patients with primary or metastatic carcinoma of 
liver, with AST (GPT) usually being higher than ALT 
(GOT). Although serum levels of both GOT and GPT 
become elevated, as observed in our study, whenever 
disease processes affect liver cell integrity [48]. 
The extracellular fluids of animals, such as blotxl 
plasma, tissue fluid, CSF etc. contain little or no 
catalase activity and only low activities of SOD. There 
is also very little reduced glutathione (GSH) in most 
extracellular fluids-about 20 nM in the plasma of rats. 
Therefore, the major antioxidants found in blood 
plasma are ascorbic acid, uric acid and glucose in 
addition to transferrin and albumin. Ascorbic acid has 
multiple antioxidant properties, including an ability to 
regenerate a-tocopherol by reducing a-tocopheryl 
radicals at the surface of membranes. Uric acid can 
act as an antioxidant both by binding to the radicals and 
by directly scavenging oxidizing species. It therefore, 
inhibits lipid peroxidation. Glucose also acts as a 
scavenger of hydroxyl radicals [49]. The levels of all 
these antioxidants were found to be decreased with 
increase in lipid peroxidation in plasma of rats exposed 
either to stress alone or DMBA alone. The levels were 
further decreased when DMBA was given to rats pre-
exposed to stress, which shows that stress itself alters 
the antioxidant status, thus facilitating the DMBA 
induced carcinogenesis. 
Hereby, we conclude that not only chronic restraint 
stress but DMBA infusion also alters the antioxidant 
status of rats and the condition further deteriorates if 
animals are exposed to stress prior to DMBA 
administration resulting in the formation of free radicals 
or ROS which may cause tissue injury and increase 
membrane lipid peroxidation. As a result, the levels of 
marker enzymes are increased and the increased 
membrane peroxidation may facilitate their release in 
the circulation. Therefore, an additive pro oxidant 
effect of stress and DMBA is observed irrespective of 
its mode of treatment though oral infusion is found to 
have more pronounced effect. 
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Abstract Over the years, several lines of evidence have emerged 
supporting the role of stress in the development and progression 
of cancer. Stress can cause an increase in the production of reac-
tive oxygen species (ROS) and decrease in the in vivo antioxi-
dant defense systems. A ROS-induced DNA damage in 
peripheral lymphocytes, liver and skin cells may be revealed by 
Comet assay. To test whether DNA is damaged by stress/ 
DMBA/stress and DMBA, rats were exposed to multiple doses 
of DMBA in the presence and absence of restraint stress, and 
DNA damage was evaluated. Insignificant differences were 
detected in all the three cells tested (peripheral lymphocytes, liver 
and skin cells) between control and stress treatment in terms of 
frequencies of damaged DNA. The extent of DNA migration 
was enhanced in DMBA treated rats in a dose dependent 
manner. Pre-stress DMBA treatment showed still higher fre-
quencies of damage in comparison with control, stress alone or 
DMBA alone groups. Thus, prior exposure to stress clearly 
enhanced the DMBA induced DNA damage, especially so in 
the skin cells (target organ of the carcinogen application) than 
liver and peripheral lymphocytes as observed on the basis of 
the extent of DNA migration (tail DNA) during single cell gel 
electrophoresis. 
© 2006 Federation of European Biochemical Societies. Published 
by Elsevier B.V. All rights reserved. 
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sible mediators of the effect of stress on neoplastic process, which 
include alteration in the immune and/or neuroendocrme system 
and in the antioxidant defense status [7-10]. Altered antioxidant 
status indicates production of reactive oxygen species (ROS), 
such as peroxides, hydroxyl and superoxide anion radicals, 
which induce cellular oxidative damage through DN.A strand 
breaks and lipid peroxidation [11]. Indeed DNA damage in-
duced by oxidative stress and/or deficient DNA-repair may have 
etiological or prognostic role in cancer [12]. Surprisingly, few 
studies have examined the effects of psychological stress on the 
production of ROS, and have yielded inconsistent results [13]. 
Previous studies in our lab have demonstrated the eiTcct of re-
straint stress on the antioxidant status of rats. It was found that 
chronic restraint stress caused increased lipid peroxidation and 
compromised antioxidant status [14,15]. Nevertheless, grealev 
production of ROS in turn has been shown to produce increases 
in oxidative DNA damage Therefore, it is important to under-
stand the factors responsible for such damage and the ways to 
minimize them. Restraint stress, a well-known model to study 
chronic physical and psychological stress was used in the present 
study to assess the effect of psychological factors on DNA dam-
age, both alone and in the context of cancer. The chemical car-
cinogen DMBA used in the present study forms free radicals, 
induces substantial oxidative effects in vivo [ 14] and causes oxida-
tive modification of DNA bases [16]. DNA-damage is measured 
at the cellular level using single cell gel electrophoresis (Comet 
assay) method in peripheral blood lymphocytes, liver and skin 
cells of control and treated rats. 
1. Introduction 
Carcinogenesis is a multistage process and depends on multi-
ple factors. The combined effects of stimulatory factors (e.g. hor-
mones, cytokines), stress mediators (oxygen radicals) and 
exogenous aggressions (viruses, radiation and xenobiotic com-
pounds) can aflect the control of cellular proliferation and lead 
to tissue transformation [1]. There is indeed extensive evidence 
available showing that psychological factors, including stress 
contribute to the progression of cancer [2,3]. Exposure to re-
straint stress was found to exert sizeable effect on cancer devel-
opment [4] as well as facilitated the growth of transplanted 
tumors [5,6]. Various mechanisms have been considered as pos-
Corrcsponding author. 
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2. Materials and methods 
2.1. Chemicals 
DMBA, Histopaque 1077, HBSS, RPMI 1640 were purchased from 
Sigma (St. Louis, MO), GSH. GSSG, NADPH. NADP, CDNB, 
DTNB, Pyrogallol were purchased from SRL, India. All other chemi-
cals were of analytical grade. 
2.2. Animals 
Young fast growing Swiss Albino rats weighing 40 ± 5 g were used 
for the experiment. All experimental protocols adhered to the guide-
lines of the Animal Welfare Committee of the university. The rats were 
housed under standard conditions of temperature and humidity and a 
12 h light/dark cycle (lights on at 8 am) with free access to standard 
pellet diet (Ashirwad Industries, Chandigarh, India) and water. 
2.3. Treatment of animals 
After I week of acclimatization, rats were divided into four groups 
of 20 animals each. Animals in group I (stress alone) and group II 
were exposed to chronic restraint stress for 10 days (3 h/day) by plac-
ing the rats individually in body sized wire mesh cages attached to 
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doi:l().IOI6/j.l"ebslet.2(MX).06.0.30 
3996 /. MiHihil ci III. I FEUS Letters 5X0 '2(H)6! SW5- J'JW 
wtxxJen boards, with no movement allowed. Twenty four hours fol-
lowing last stress exposure, animals in group II (Pre-stress DMBA) 
and that of group III (DMBA alone) with their backs shaved olT. 
were topically treated with 0.5% DMBA in sesame oil (twice a week) 
for a total of four doses. Group IV anunals did not receive any treat-
ment and served as untreated controls, ['ive animals were sacrificed 
from each group after 2 days following each DMBA exposure. To as-
sess the cfTecl of stress alone five animals from control and stress 
alone group were sacrificed immediately following last stress expo-
sure. After each sacrifice blood, liver and skin samples were collected 
for Comet assay. MDA levels (lipid peroxidation) were determined in 
liver and plasma. 
2.4. Preparation oj celts for Comet assay 
2.4.1. Lymphocyte i.iolation. Immediately after each sacrifice, the 
heparinised blood was suitably diluted in PBS (Ca** and Mg** free). 
Lymphocytes were isolated using Histopaque 1077 (Siema). and the 
cells(«2xl(:. ') were finally suspended in RPMI 1640. 
2.4.2. Isolation ofliier and skin cells. A small lobe of liver was cut 
with the help of a sterilized blade and homogenized in ice-cold solution 
of HBSS. After centrifugation cells were suspended in RPMI 1640. 
Same procedure was followed for skin tissues. The viability of cells 
was assessed u.sing trypan blue exclusion test [17). 
2.5. Comet assay 
Comet assay was performed under alkaline conditions essentially 
according to the procedure of Singh et al., [18] with slight modifica-
tions. Fully frosted microscopic slides precoated with l.0"/i normal 
melting agarose at about 50 °C (dissolved in Ca** and Mg** free 
PBS) were used. Around 10.000 cells (isolated from blood, liver 
and skin) were mixed with 75 |il of 1.0% low melting point agarose 
(LMPA) to form a cell suspension, pipetted over the first layer, 
and covered immediately by a cover slip. The slides were placed on 
a Hat tray and kept on ice for 10 min to solidify the agarose. The cov-
er slips were removed, a third layer of 0.5°/i LMPA (75 |il) was pipet-
ted, and cover slips placed over it and allowed to solidify on ice for 
5 min. The cover slips were removed and the slides were immersed in 
cold lysine solution containing 2.5 M NaCl, 100 mM EDTA. 10 mM 
Tris. pi I 10 and 1% Triton xl(K) added just prior to use for a mini-
mum of i h at 4 'C. After lysis DNA was allowed to unwind for 
30 min in alkaline electrophoretic solution consisting of 300 mM 
NaOH. ! mM CDTA, p l l > l 3 . Electrophoresis was performed at 
4 °C 'n field strength of 0.7 V/cm and 300 mA current. The slides 
were then neutralized with cold 0.4 M Tris. pH 7.5, stained with 
75 |al EtBr (20jig/ml) and covered with a cover slip. The slides were 
placed in a humidified chamber to prevent drying of the gel and ana-
lyzed th.' same diiy. Slides were scored using an image analysis system 
(Komci 5.5. Kinetic Imaging, Liverpool. UK) attached to a Olympus 
(CX41) tluorescent microscope and a COIIU 4910 (equipped with a 
510-560 nm excitation and 590 nm barrier filters) integrated CC cani-
eia. Cornels were scored at lOOx magnification. Images from 50 cells 
(25 from each replicate slide) were analyzed. The parameter taken to 
assess cellular DNA damage was tail length (migration of DNA from 
the nucleus. \sir\) and was automatically generated by Komet 5.5 
image analysis system. 
2.6. riiioharbiliiric acid reactive species (TBARSi determination 
Lipid peroxidation was assessed by measuring TBARS concentra-
tion using a spectrophotometric method [19]. Briefly. 0.5 ml of honiog-
enate wa? in \cd with I ml 0.67';;, 1 BA and iQt'A<TCA (1:1) and heate'd 
for 20 min at KV) °C. After centrifugation. the colored supernatant was 
read at 535 nm. TBARS expressed as nmol/nig protein using extinction 
coellicieni as 1..56X 10'M 'cm '. 
2.7. Protein estimation 
I'lotcin content was estimated by the method of Lowry et al.. using 
bovine soruni albumin as standard [20]. 
2.ii Sutiisiical analysis 
The data presented are means ± S.E.M of five values and student's t 
test was used to examine statistically significant dilTerences. Analysis of 
variance was performed using one-way ANOVA. P values <0.05 were 
considered statistically significant. 
?,. Results 
3. /. DNA damage by reslraini stress 
A 3 h/day exposure to restraint stress for 10 days did not 
damage the lymphocyte, skin and liver cell DNA to any signif-
icant extent. Although damage was observed in stressed rats as 
compared to control rats, this damage, however, was not sig-
nificant as shown in Fig. I and Tables i and 2. 
3.2. Effect of consecutive doses of DMBA on DNA damage 
Fig. I shows the effect of multiple doses of DMBA on lym-
phocyte DNA. DMBA induced DNA damage in a dose depen-
dent manner in lymphocytes as the tail length was found to 
increase after each dose. Similar results were observed in liver 
35 
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E 
- 10 
contrcl 
• stress alone 
' DMBA alone 
Prestress-DMBA 
Ooses 
Fig. 1. DNA damaging effect of stress and DMBA (multiple 
applications) both alone and after stress exposure (on pre exposure 
to stress) on the peripheral lymphocytes of rats. The rats were exposed 
to chronic restraint stress (3 h/day) for 10 days, or topically treated 
with 0.5% DMBA (twice a week) for a total of four doses either alone 
or after exposure to stress as described in Section 2. Untreated controls 
were also run simultaneously. Values reported are as mean ± S.E.M. of 
five animals in each group. 
Table 1 
DNA damaging effects of consecutive DMBA do.ses alone and after 
pre-exposure to chronic restraint stress in the skin cells of rats 
Groups Comet tail length (^ im) 
Untreated control 
Stress alone 
DMBA alone 
Dose 1 
Dose 2 
Dose 3 
Dose 4 
Pre-stress DMBA 
Dose I 
Dose 2 
Dose 3 
Dose 4 
1.410.01 
1.9 ± 0.02 
10.010.03^ 
I9.0± 1.12" 
28.0 ± 1.24" 
37.1 ± 2.2r 
15.0+ 1.15"'' 
27.0 ± 1.19"'' 
39.0 ± 2.26"" 
44.0 ± 2.67"'' 
Data represent means ± S.E.M. of 5 animals in each group. 
"P value < 0.05 and significant when compared to untreated control. 
*'P value < 0.01 when compared to DMBA alone group. 
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Tabic 2 
lilTecl of consecutive DMBA doses alone and on pre-exposure !o 
chronic restraint stress on DNA damage in liver cells of rats 
Ciroups 
Untreated control 
Stress alone 
DMBA alone 
Dose I 
Dose 2 
Dose 3 
Dose 4 
Pre-stress DMBA 
Dose I 
Dose 2 
Dose 3 
Dose 4 
Comet tail length (nm) 
1.0 10.01 
1.2 ±0.04 
7.0 ± 1.03" 
16.012.1" 
26.3 1 2.2-' 
35.1 ±2.9" 
12.0 11.18"'' 
24.7 ± 2.33"-" 
35.5 ± 2.9"'' 
42.0 ± 1.86"'' 
Data represent means ± S.E.M. of 5 animals in each group. 
"A* value < 0.05 and significant when compared to untreated control. 
'^P value < 0.01 when compared to DMBA alone group. 
and skin cells however, the effect was pronounced in skin cells 
for being the target organ of the carcinogen (Tables I and 2). 
3.3. Effect of reslraini stress on DMBA induced D.W.4 duiiutge 
Pre exposure of rats to restraint stress enhanced the DNA 
damaging potential of DMBA significantly as compared to 
control or DMBA alone group, in lymphocytes (Fig. I), liver 
(Table I) as well as in skin cells (Table 2). A significant 
DNA damage was observed in the skin cells after the fourth 
application of 0.5% DMBA either alone or after stress expo-
sure as depicted by Comets (lOOx) (Fig. 4). 
3.4. TBA RS levels as a measure of oxidative stress in plasma and 
liver 
The levels of TBARS in stressed animals were increased as 
compared to controls. Consecutive doses of DMBA increased 
the levels in a dose dependent manner and were higher as com-
pared to stress alone or control groups. However highest levels 
of TBARS in both plasma and liver were found in animals ex-
posed to restraint stress prior to DMBA exposure, as com-
pared to all other groups (Figs. 2 and 3). 
i 0.25 
^ controJ 
' ' stress alon3 
^ H 0M6A alone 
1 i Presiress-OMBA 
2 3 
doses 
< 
• • control 
1 ' 1 stress alone 
^ • i DMBA alone 
1 1 Prestress-DMBA 
T 1 
T 
1 1 1 
I 
1 
1 
1 
1 
1 
2 3 
Doses 
I'ig. 2. Effect of restraint stress, multiple doses of DMBA alone, and 
pre-stress DMBA treatment on TBARS levels in the plasma of rats. 
Data are reported as means ± S.E.M for 5 rats in each group. 
Fig. 3. Formation of MDA in the liver tissues of stress, multiple 
DMBA doses alone and pre-stress DMBA treated rats as compared to 
untreated controls. Data are reported as means ± S.E.M. for 5 rats in 
each group. 
4. Discussion 
ROS have been suggested as causative factors in mutagene-
sis, carcinogenesis and tumor promotion and have been impli-
cated in the etiology and pathophysiology of many human 
diseases [21]. They induce strand breaks and cause oxidative 
modification of DNA bases [22]. Damage to DNA integrity 
is considered as the basic trigger of various diseases including 
cancer. Damaged DNA also results in impaired ability of cells 
to repair or prevent disease [23]. Several studies have examined 
the effect of stress on DNA integrity as stress has been found to 
cause production of ROS resulting in oxidative stress and in-
creased lipid peroxidation. During oxidative stress, MDA or 
other aldehydes are formed in biological system, which react 
with amino acids and DNA resulting in alterations in replica-
tion, transcription and leading to tumor formation [24]. Expo-
sure to conditional emotional stimuli results in DNA damage 
in rats by increasing the levels of 8-OH-dG significantly as 
compared to controls [25]. While DNA fragmentation was ob-
served in gastric mucosa of rats exposed to both acute and 
chronic stress [26], no such damage was found to be induced 
in T lymphocytes of mice exposed to acute stress [27]. Stress 
is also found to effect DNA repair system as rotational stress 
decreased the levels of methyltransferase, an important repair 
enzyme, in spleen of rats [28,29]. Psychological stress also im-
paired the repair of DNA damage induced by exposure to a 
carcinogen, in rats [30]. The discrepancies between these data 
remain unresolved and it remains unclear whether the consis-
tent effects of stress on DNA integrity stem from ROS produc-
tion, due to the inconsistent results observed on the generation 
of ROS in stress. However, we have already reported in our 
previous studies that chronic restraint stress not only causes in-
creased lipid peroxidation and compromised antioxidant sta-
tus but also enhances the prooxidant effect of DMBA in rats 
[14]. As an extension of our previous finding, the present study 
was designed to see the effect of chronic restraint stress alone 
on DNA, as well as on the DNA damage induced by a well-
known carcinogen DMBA. 
According to the results restraint stress caused insignificant 
damage to DNA of lymphocytes, liver and skin cells of rats 
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Fig. 4. Single cell gel electrophoresis of rat skin cells showing Comets (lOOx) after treatment with stress and four doses of 0.5"'.i DMBA, (A) 
untreated, (B) stress treated, (C) DMBA alone and (D) pre-stress DMBA. 
as compared to controls. A plausible explanation may be that 
the stressor used here did net incur DNA damage within the 
cell, rather primed the cells to respond to subsequent induction 
of DNA damage either by impairing the ability of cells to re-
pair DNA, or by causing oxidative stress, as enhanced hepatic 
and plasma lipid peroxidation is observed in stressed animals. 
This is confirmed by the fact that enhanced DNA-damage was 
observed in rats treated with DMBA following exposure to 
stress as compared to those treated with DMBA alone. 
DMBA is a polycyclic aromatic hydrocarbon present in the 
environment as a product of incomplete combustion of com-
plex hydrocarbons. It is an indirect carcinogen and is metabo-
lized by cytochrome P45()ini to form toxic metabolites and 
ROS. These ROS produce deleterious effects by initiating lipid 
peroxidation directly or indirectly by acting as second messen-
gers for the primary free radicals and the toxic metabolites of 
DMBA bind to adenine residues of DNA causing damage [30]. 
The DNA breakage may be the result of the generation of 
hydroxyl radicals and other ROS in situ. Moreover, oxygen 
radical dainage to deoxyribose or DNA is considered to give 
rise to TBA reactive material [31]. The increased formation 
of TBA reactive substance (TBARS) both in circulation and li-
ver tissues in a dose dependent manner by DMBA exposure 
either alone or after stress treatment further confirms an en-
hanced DN/\ damage by restraint stress. The present study 
is in accordance to the earlier observation that several applica-
tions of DMB.A provide an added complexity to interactions 
between concomitantly formed DMBA-DNA base adducts 
and oxidized bases [16]. These concurrent interactions of initi-
ating (adducts) and promoting (oxidized bases) processes may 
be key to complete carcinogenesis and exposure to stress plays 
an important role from the very early stages of carcinogenesis 
right at the basic cellular level by causing oxidative stress and/ 
or increasing the damaging potential of a carcinogen. 
Thus we conclude that exposure to multiple doses of a car-
cinogenic agent like DMBA directly or indirectly (environ-
mental toxins, cigarette smoke) causes dose dependent 
DNA damage and exposure to stress (physical or emotional) 
exacerbates this DNA damage thus putting an individual at 
an increased risk of developing cancer. The experimental 
model currently employed might provide an insight at the 
most basic level of cell mutation, for investigating the effect 
of both physical and psychological stress on the etiology of 
DMBA induced carcinogenesis. Further studies may be 
aimed at the development of interventions for disease preven-
tion by identifying the relations between psychological factors 
and DNA damage. 
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